Structural Modification, Polymerization and Applications of Boron Difluoride Formazanates by Barbon, Stephanie M
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
6-19-2017 12:00 AM 
Structural Modification, Polymerization and Applications of Boron 
Difluoride Formazanates 
Stephanie M. Barbon 
The University of Western Ontario 
Supervisor 
Prof. Joe Gilroy 
The University of Western Ontario 
Graduate Program in Chemistry 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Stephanie M. Barbon 2017 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Materials Chemistry Commons 
Recommended Citation 
Barbon, Stephanie M., "Structural Modification, Polymerization and Applications of Boron Difluoride 
Formazanates" (2017). Electronic Thesis and Dissertation Repository. 4611. 
https://ir.lib.uwo.ca/etd/4611 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
ii 
 
Abstract 
This thesis describes the synthesis and characterization of a new family of fluorescent and 
redox-active BF2 complexes of formazanate [R
1-N-N=C(R3)-N=N-R5]− ligands. The 
complexes were easily synthesized in two high-yielding steps, from inexpensive starting 
materials and readily purified by conventional methods. The properties of the resulting 
complexes can be tuned through structural variation – for example, appending electron 
donating or withdrawing substituents, or extending π conjugation. These methods of 
structural variation can bathochromically or hypsochromically shift the maximum 
absorption and emission wavelengths, vary the quantum yields, and allow for tuning of the 
reduction potentials. Using these methods, the properties of these complexes were 
optimized for use as fluorescence cell-imaging agents, and efficient 
electrochemiluminescence emitters. 
In order to expand the scope of this chemistry, copper-assisted azide-alkyne cycloaddition 
(CuAAC) chemistry was used to further modify the BF2 formazanate scaffold. Using this 
method, benzyl groups were appended to the BF2 complexes, which showed that the 
reaction proceeded cleanly, and that the resulting products had red-shifted wavelengths of 
maximum absorption and emission, and increased fluorescence quantum yields. Using the 
same strategy, a tetraethylene glycol based azide imparted water solubility, and the 
resulting complex was used in fluorescence cell-imaging experiments. Additionally, 
ferrocene moieties could be appended, which quenched the fluorescence of the resulting 
complex. Upon oxidation of the ferrocene groups, the fluorescence was regenerated 
allowing for these compounds to be used as redox sensors. Finally, CuAAC was used to 
synthesize copolymers of BF2 formazanate complexes and 9,9-dihexylfluorene. The 
resulting polymers had low band gaps (Eg = 1.67 eV) and good film-forming properties, 
paving the way for their use in organic photovoltaics. 
Finally, reaction of an o-phenol-substituted formazan with BF3•OEt2 and NEt3 resulted in 
a complex reaction mixture, which contained 5 BN heterocycles with unprecedented 
connectivity and interesting optical and electronic properties. Two of the most unique 
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complexes were selected, and their chemical reduction products – a stable anion, radical 
anion and diradical dianion were studied in detail. 
Combined, this work has opened up an entirely new area of molecular materials with 
application in a variety of fields. This thesis describes the details of the work described 
above. 
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Chapter 1  
1 Introduction - BF2 Complexes of N-donor Ligands 
For many centuries, scientists and non-scientists alike have been fascinated by naturally 
occurring luminophores. Many examples of both land and sea animals display fluorescent 
or phosphorescent markings including birds (Figure 1.1a),[1-2] spiders and bugs,[3-5] frogs 
(Figure 1.1c),[6] and a multitude of sea creatures, including coral,[7] turtles (Figure 1.1d),[8] 
shrimp,[9] fish (Figure 1.1e)[10] and jellyfish (Figure 1.1b).[11-12] 
 
Figure 1.1. a) Head of wild-type budgerigars (Melopsittacus undulatus) under white light 
(top) and UV illumination (bottom). b) Jellyfish Periphylla periphylla under white light 
(left) and UV illumination (right). c) Fluorescence of the head and anterior region of the 
loggerhead sea turtle Caretta caretta. d) Adult male tree frog Hypsiboas punctatus 
fluorescence. e) Luminescence from the false stonefish Scorpaenopsis diabolus. Images 
reproduced with permission from Refs. [1], [12], [8], [6], [10], respectively. 
 
There are many different purposes for this luminescence in animals, including 
photoprotective reasons,[7] signalling,[1-3,9] as antioxidants,[13] for camouflage[14] or 
defense,[15] and for attracting prey.[16] The identity of the emissive compound varies from 
species to species, though many animals utilize the same or similar compounds. One of the 
most common examples is luciferin. Luciferase, an enzyme, oxidizes luciferin and 
generates an excited state of the oxyluciferin molecule. This emits light as it relaxes to the 
ground state. There are many different forms of luciferases and luciferins (e.g. 1.1, found 
in fireflies), though all act by the same general mechanism.[17] The Faivovich group 
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identified a new fluorophore 1.2 produced in the glands of a tree frog (Figure 1.1c), that 
has not been attributed to the luminescence of any other living species to date. The pigment, 
which fluoresces blue, gives the tree-frogs their green fluorescence when filtered through 
the skin.[6] Perhaps the most famous contributor to bioluminescence is the green fluorescent 
protein. The chromophore present (1.3, R1,2 = amino acids), is not fluorescent alone, but 
when contained in the cylindrical tertiary structure of the remainder of the protein, is 
fluorescent.[18-20] This protein is most famously expressed in jellyfish, but has been used 
for a multitude of other applications, and ultimately resulted in the Nobel Prize in 
Chemistry in 2008.[11] 
 
The scientific community is similarly interested in naturally occurring redox processes. 
These processes are central to life as we know it. Perhaps the most well-known biological 
redox process is photosynthesis. In photosynthesis, a photon sets in motion a series of 
electron transfer events which ultimately result in the conversion of carbon dioxide and 
water to glucose and oxygen. One of the key parts of this reaction is the Mn4O5Ca cluster 
(1.4) which is part of the photosystem II enzyme. Here, water is oxidized to oxygen, 
releasing two electrons and two protons which can be used to form glucose.[21] 
Glutathione (1.5) is observed in high concentrations in animal cells, and it has important 
function in many different cellular processes. One of the most important of these functions 
is as an antioxidant. Reactive oxygen species will preferentially oxidize glutathione to 
prevent oxidation of cellular components that cause adverse effects.[22] Glutathione also is 
responsible for keeping vitamins C and E in their active, reduced forms.[23] 
Another process which is vital to life is DNA replication. The Barton and Chazin groups 
recently discovered that the redox chemistry of a small Fe4S4 cluster (1.6)
[24] present in 
DNA primase and DNA polymerase, two enzymes that are essential to the DNA replication 
process, plays an important role. They found that when the cluster is in its oxidized (3+) 
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state, DNA is bound tightly to the enzyme, and replication can occur. However, when the 
cluster is in its reduced (2+) state, DNA is more loosely bound, and replication does not 
occur.[25] 
 
Chemists have long been interested in replicating the work of nature, and producing both 
luminescent and redox-active materials. There are many structural motifs often employed 
in the synthesis of materials with one of these properties, however less that offer both traits. 
One such recurring theme is that of boron difluoride (BF2) chelated by N-donor ligands. 
1.1 Boron Difluoride Complexes of N-donor Ligands 
Much of the research involving BF2 complexes of N-donor ligands has focused on 
dipyrromethenes as the N-donor ligand, which, when complexed with BF2, are known as 
boron-dipyrromethenes (BODIPYs, e.g. 1.7).[26] The first example of a BODIPY was 
synthesized in 1968,[27] and similar complexes have since been the focus of hundreds of 
papers.[28-29] The reasons for this research intensity are the desirable properties that most 
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BODIPYs exhibit, including high molar absorptivities, narrow absorption and emission 
bands and typically high fluorescence quantum yields. BODIPYs also are 
electrochemically active, with interesting redox properties in both the ground and excited 
states.[26]  
Though many of the properties of BODIPYs are desirable, there are a few drawbacks 
associated with them, including their often difficult and low-yielding syntheses. Most 
BODIPYs are not water soluble and emit at wavelengths below 600 nm, which limits their 
application, especially in biological settings. In these applications, the primary medium is 
water and red emission is desirable, as it penetrates further through tissue.[26] Additionally, 
the photostability of BODIPYs has been shown to be quite low, though this has been 
improved by replacing the fluorine substituents on the boron with substituted alkynes.[30] 
Finally, due to the planar structure of BODIPYs, molecules tend to pack tightly together in 
the solid state leading to quenched fluorescence, which limits the use of BODIPYs in 
optoelectronics.[26] 
Due to some of these drawbacks, other fluorophores based on BF2 chelates of N-donor 
ligands which address the abovementioned issues have been sought. The first class of these 
molecules take structural inspiration from BODIPYs, and have conjugated planar cores 
consisting of multiple fused heterocycles. Aza-BODIPYs (e.g. 1.8) are structurally very 
similar, with only the replacement of a nitrogen for the carbon in the meso position.[31] The 
synthetic routes to these molecules are also different, which allows for most aza-BODIPYs 
to be decorated with aryl substituents. As a result of these modifications, aza-BODIPYs 
tend to emit at wavelengths of much lower energy, while maintaining high molar 
absorptivities and quantum yields, though they are still produced in low synthetic yields 
from time-consuming syntheses.[31]  
A relatively new and exciting fluorophore of this class is the bis(difluoroboron)-1,2-bis 
((1H-pyrrol-2-yl)methylene)hydrazine (BOPHY, e.g. 1.9), which were first reported in 
2014.[32] These complexes have a fused ring structure, reminiscent of a shortened BODIPY 
dimer. They have high molar absorptivities, as well as outstanding quantum yields. The 
Stokes shifts are typically larger than BODIPYs, which limits reabsorption of emitted 
photons, especially in concentrated solutions. BOPHYs are still relatively    
5 
 
 
 
understudied,[33-34] though most reported complexes exhibit many of the same drawbacks 
as BODIPYs, including low yielding syntheses and emission at ca. 500 nm. 
BF2 complexes of pyridomethene ligands (e.g. 1.10) are also structurally similar to 
BODIPYs, but differ by the two aromatic rings flanking the central six-membered ring – 
two six membered rings, as opposed to the five membered rings of BODIPYs. Though the 
molar absorptivities of these complexes are on-par with many other fluorophores in this 
class, the lower quantum yields, and low synthetic yields, limit the widespread use of these 
dyes.[35]  
 
A second strategy for the design of functional BF2 complexes of chelating N-donor ligands 
is to modify existing fluorophores to have a bidentate N-donating ligand available for 
chelation of boron. This method has been used with two different commonly known 
fluorophores – coumarin and indigo. Coumarin was first isolated from the Tonka bean in 
the 1820s,[36] and has many different uses, some of which take advantage of its fluorescence 
(e.g. laser dyes[37-38] and LED’s[39]), and many which do not (e.g. use in perfumes and 
cosmetics,[40] as anti-HIV agents,[41] and as a commercially available anti-coagulent, 
warfarin[42-43]). Indigo is a blue dye that has been used in Egypt since ca. 2000 B.C., and is 
used mainly today for the production of ~1 billion pairs of blue jeans annually,[44] though 
it has also been used for a variety of organic electronic applications.[45-46] Both dyes were 
modified to include a chelating, bidentate nitrogen pocket, and complexed with BF2.
[47-49] 
In both cases, the whole synthesis was accomplished in >70% overall yield, which is a 
significant improvement over BODIPYs and related systems. The emission of the BF2 
complexes of the coumarin-based ligand (BORICO’s, e.g. 1.11) is quite strong, with 
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quantum yields often >80%. However, the emission still falls outside of the ideal red 
region.[49] On the other hand, BF2 complexes of ‘Nindigo’ ligands (e.g. 1.12), emit at ca. 
800 nm, though the emission is described only as weak.[48] 
 
The final strategy commonly used in the design of fluorescent BF2 based dyes is the use of 
commonly studied, easily synthesized N-donor ligands, with non-rigid N-aryl substituents. 
Three common families of ligands that have been used for this purpose are β-
diketiminates,[50] anilido imines[51] and hydrazones.[52] β-diketiminates are generally 
straightforward to synthesize, and so BF2 complexes of these ligands (e.g. 1.13) are 
produced in high yields. The resulting complexes tend to be highly absorbing, with large 
Stokes shifts, but generally low quantum yields.[53] BF2 complexes of hydrazones 
(BODIHYs, e.g. 1.14) also have large Stokes shifts, and generally low quantum yields in 
solution, however they have been shown to have increased quantum yields in the solid 
state.[54] Finally, anilido-imines and the related anilido pyridines have been complexed to 
BF2 (e.g. 1.15), in high yields. These complexes typically have large Stokes shifts, 
moderate quantum yields, and emission approaching red light. The one drawback to these 
systems are their low molar absorptivities (<10,000 M−1 cm−1).[55-57] 
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1.2 Polymers 
Many classes of BF2 complexes of N-donor ligands have been incorporated into polymer 
frameworks, specifically BODIPYs, aza-BODIPYs and BF2 complexes of β-diketiminates. 
All three of these types of complexes have been incorporated into the main-chain of π-
conjugated polymers. The first example was shown by the Li group in 2008, where iodo- 
and alkyne- substituted BODIPYs were subjected to Sonogashira coupling to produce 
polymer 1.16.[58] The absorption and emission maxima of this polymer were red-shifted 
significantly when compared to the less-conjugated monomer (1.16: λmax = 640 nm, 
monomer: λmax = 535 nm), and also had a good quantum yield of 24%.[58] A similar method 
was used to prepare co-polymers of BF2 β-diketiminate complexes. The Chujo group used 
Suzuki coupling to combine iodo-substituted BF2 complexes and boronic acid-substituted 
fluorene to make conjugated polymer 1.17.[59] These polymers were essentially non-
emissive in solution, though all derivatives exhibited both aggregation-induced emission 
and crystallization-induced emission enhancement. The authors also demonstrated the pH-
responsiveness of these materials. The colour of a thin-film of the polymer could be 
reversibly switched by introduction of acidic or basic vapors.[59] Aza-BODIPY conjugated 
copolymer 1.18 was also synthesized by Sonogashira coupling.[60] This polymer emitted in 
a narrow emission band at 753 nm, in the near-IR region, and also had a quantum yield of 
24%.[60] 
To date, side-chain polymers of BF2 complexes of N-donor ligands have most commonly 
been prepared with BODIPYs. The Chujo group polymerized a methyl-methacrylate 
monomer appended with a BODIPY moiety by RAFT polymerization to produce side-
chain BODIPY polymer 1.19.[61] Nanoparticles of these polymers were observed, due to 
the π-stacking of the BODIPY dyes, which quenched the luminescence. Nanoparticles were 
also synthesized from block copolymers made with the same monomer as 1.20 and 
polystyrene had a quantum yield of fluorescence over 70%, due to the styrene breaking up 
the π-stacking of the BODIPYs.[61] Another method for the synthesis of block-copolymers 
containing BODIPY units in the side-chain was employed by the París group, who first 
synthesized a block copolymer where one of the blocks contained an alkene moiety. After 
polymerization, thiol-ene click chemistry could be used to append the BODIPY units to 
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the polymer backbone.[62] The authors found that the optical properties of the resulting 
polymer were very similar to that of the small-molecule BODIPY starting material, and 
was also unchanged with varying degrees of BODIPY functionalization of the polymer 
backbone.[62] 
 
 
Polymers with BODIPYs, aza-BODIPYs and BF2 complexes of β-diketiminates have 
found many different applications, in a variety of fields, including in a variety of 
biomedical imaging applications,[63-68] organic electronics,[69-74] sensing applications,[59,75-
81] re-writable data storage,[82] photocatalysis,[83-84] as laser dyes,[85-86] 
electrochemiluminescence devices,[87] and plastic scintillators.[88] Some of these 
applications will be discussed in more detail below.  
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1.3 Applications 
The above mentioned families of fluorescent dyes based on BF2 complexes of chelating N-
donor ligands have different strengths, as well as drawbacks, which renders some examples 
better suited for certain applications than others. Because of the many classes of these 
complexes, there are many different fields which these molecular and polymeric materials 
find applications, including photovoltaics, organic electronics, sensing, biomedical 
applications, electrochemiluminescence, and materials science. 
1.3.1 Photovoltaics 
The typically high molar absorptivities, broad absorption range, and redox properties of 
BF2 complexes of N-donor ligands has led to their study in photovoltaics.
[70,89-93] 
Phenothiazine modified pyridomethene BF2 complex 1.21
[94] was incorporated into a dye-
sensitized solar cell and bulk-heterojunction solar cells were fabricated using thiophene-
BOPHY complex 1.22[95] and thiophene-BODIPY copolymer 1.23[72]. 
 
All three complexes were chosen because they absorb strongly through much of the visible 
region, and some into the near-IR. The electronic conjugation of the parent BF2 complexes 
was extended by appending π-conjugated groups such as thiophene and phenothiazine in 
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order to maximize absorption. For example, thin-films of BODIPY polymer 1.23 have a 
wavelength of maximum absorption (λmax) of 848 nm (see Table 1). The extended 
conjugation of these complexes also serves to minimize the band gaps of the complexes, 
with band gaps ranging from 2.41 eV in 1.21 to 1.15 eV in 1.23. The photovoltaic devices 
built containing 1.21−1.23 were successful in solar energy conversion. All three devices 
had comparable fill factors (FF), at around 60%. The efficiency of BODIPY-polymer 1.23 
based bulk heterojunction solar cell reached a maximum of 1.1%, despite having the largest 
absorption window.[72] BOPHY 1.22 based bulk heterojunction solar cell has provided an 
excellent starting point for BOPHY-based photovoltaics. This first example of an organic 
electronic device using BOPHY’s had a good efficiency, at 4.3%.[95] Finally, the dye 
sensitized solar cell containing pyridomethene BF2 complex 1.21 had the highest efficiency 
of 6.6%. This was in part due to the phenothiazine substituent, but the combination of the 
two dyes results in devices with higher efficiencies and better photostabilities.[94] 
 
Table 1.1. Properties of photovoltaic complexes 1.21−1.23. 
Compound Type of Solar Cell λmax, film 
(nm) 
Band gap 
(eV) 
FF (%) Power Conversion 
Efficiency (%) 
1.21 Dye-Sensitized 478 2.41 62 6.6 
1.22 Bulk 
Heterojunction 
656 1.62 57 4.3 
1.23 Bulk 
Heterojunction 
848 1.15 56 1.1 
 
1.3.2 Organic Thin-Film Transistors, Light Emitting Diodes, and 
Batteries 
Similar to their use in photovoltaics, the inherent properties of BF2 complexes of N-donor 
ligands make them well suited for many other types of organic electronics. Both aza-
BODIPYs and BODIPYs exhibit strong π-π stacking interactions, which, combined with 
their excellent ability to accept electrons makes them ideal candidates for electron-only 
devices.[96] The small band-gap, flexibility and solvent processability of conjugated 
BODIPY polymers are properties which make organic thin-film transistors of these 
materials as effective and attractive as they are.[69,74] The typically intense emission of 
BODIPY dyes also makes them useful materials for organic light emitting diodes. OLED’s 
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were fabricated either with thin films of BODIPYs,[97] films of poly(methyl methacrylate) 
doped with BODIPYs,[98] or BODIPY coatings on blue inorganic LED’s to produce white-
light emitting devices.[99] 
The Schubert group has studied redox flow batteries made up of BODIPY polymers.[73] 
Here, it is the reversible and tunable oxidation and reduction properties of BODIPYs which 
make polymers 1.24 and 1.25 excellent materials for this application. The BODIPY core 
was completely substituted to prevent any side reactivity, and co-monomers were selected 
to enhance solubility. Polymer 1.24 was synthesized with an Mn of 17 000 g mol
−1, and Ð 
= 2.3. Polymer 1.25 had an Mn of 4000 g mol
−1 and Ð = 1.5. Two different batteries were 
fabricated – one with 1.24 as the anolyte, and a TEMPO based polymer as the catholyte, 
and the second with 1.24 as the anolyte and 1.25 as the catholyte (Figure 1.2). The first 
battery had a high average discharge voltage of 1.82 V, as well as good reversibility, with 
99% coulombic efficiency after 100 cycles. The second battery, made up of both 1.24 and 
1.25 had a slightly worse performance, with an average discharge voltage of 1.28 V, and 
89% coulombic efficiency retained after 10 cycles.[73]  
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Figure 1.2. Polymeric redox-flow battery schematic. Anode and cathode are separated by 
a size-exclusion membrane. Anolyte and catholyte are polymers 1.24 and 1.25, 
respectively.[73]  
 
1.3.3 Sensing 
Due to their often intense colours and emission properties, as well as sites for structural 
modification, BF2 complexes of N-donor ligands are tailor-made for sensing applications. 
A wide variety of these BF2 complexes have been employed as sensors for many different 
things.[54,100-103] For example, BOPHY 1.26 is modified with a functionality which 
quenches its fluorescence. In the presence of copper (II) ions, which bind to the pocket 
appended to the BOPHY, fluorescence is regenerated. This sensor was quite selective for 
copper, and able to detect Cu2+ ions at concentrations as low as 50 nM.[104] BODIHY dye 
1.27 is highly sensitive to changes in viscosity – as the viscosity of the solvent increases, 
so does the fluorescence of the BODIHY dye, which is an aggregation-induced emission 
(AIE) emitter.[105] Pyridomethene BF2 complex 1.28 reacts in the presence of hydrazine, 
and as a result the colour of the emission is drastically altered. Upon reaction, the emission 
at ca. 650 nm is quenched, and a new emission band at ca. 500 nm appears. This reaction 
is selective for hydrazine, the same response is not observed for a variety of different tested 
ions (e.g. F−, NO3
−, Ca2+ and Na+).[94] BORICO dye 1.29 will react with thiols, including 
the biologically relevant L-cysteine and thiophosphate anion, to produce a complex with 
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increased fluorescence intensity. The detection limit of this system for L-cysteine was 
determined to be 1.76 µM.[106] 
The presence of the selenium ion in complex 1.30 quenches the fluorescence of the 
BODIPY moiety. However, upon exposure to hypochlorous acid (HClO), the selenium is 
oxidized, and the complex becomes strongly fluorescent. Compound 1.30 was used to 
image HClO in cells, which is important, as HClO is a reactive oxygen species.[107] Finally, 
the Chujo group incorporated BF2 complex of β-diketiminate into polymer 1.31 with 9,9-
(2-ethylhexyl)fluorene. This polymer, which is AIE active, is responsive to changes in pH. 
A thin-film of this polymer emits bright yellow light upon exposure to a vapour of 
trifluoroacetic acid, due to the protonation of the dimethylamino group. The introduction 
of a vapour of triethylamine can reverse this protonation, and return the emission of the 
polymer film to a dark-red colour.[59]  
 
1.3.4 Biomedical Applications 
In the biomedical field, two major applications for fluorophores arise – first is visualization 
– whether this is detection of a disease or enabling the visualization of a process or part of 
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an organism. The second is treatment, and in terms of fluorophores, most applications 
revolve around photodynamic therapy.  
BF2 complexes of N-donor ligands have been used for many different imaging applications, 
including imaging biological membranes with BF2 complexes of anilido pyridines,
[55] 
using BODIPYs to image DNA,[108-109] and the detection of reactive oxygen species,[110] 
and using BODIPY polymeric nanoparticles to specifically label breast cancer cells.[66,68] 
BODIPY dyes are ideally suited for fluorescence cell imaging because of their high 
quantum yields and small size, which does not disrupt the function of the cells.[111] The 
dyes can be tailored to localize themselves in a particular region of the cell, for example, 
the cytoplasm,[112] to target specific types of cells, for example, cancerous cells,[113] or to 
act as a sensor in cells, for example, as a sensor for mercury.[114] 
The ability to tune the colour of the emission of BODIPY dyes is also quite useful. The 
Prasad group was able to show that by reaction of green-emissive dye 1.32 with 4-
dimethylamino benzaldehyde, they were able to produce dyes 1.33 and 1.34, which emitted 
in the yellow and red regions respectively (see Figure 1.3).[115] 
 
Figure 1.3 Confocal microscopic images of HeLa cells treated with a) 1.32, b) 1.33 and c) 
1.34. Confocal microscopy images were obtained by using laser excitation at λ = a) 514 
nm, b) 543 nm and c) 643 nm. Scale bar is 47.62 µm long. Image reproduced with 
permission from Ref. [115]. 
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Because of their usefulness as cell imaging agents, many BODIPYs are commercially 
available for this purpose. They are available for purchase in a wide range of colours, and 
for a variety of functions, but can be quite expensive (on average, 420 CAD per 5 mg at 
Thermo Fisher Scientific).[116] 
The Lavilla and Vendrell groups developed an imaging agent based on a BODIPY-amino 
acid conjugate 1.35. The approach taken to modify the amino-acid sequence is unique, as 
it does not entail a post-synthetic conjugation reaction, which requires the removal of 
unreacted fluorophores, and does not rely on reaction of polar groups present in the peptide 
(e.g. alcohols, carboxylic acids) which often disrupt the hydrogen bonding of the peptide, 
changing the biological properties. This amino acid was incorporated into a 6-amino acid 
peptide anti-fungal agent.[117] This BODIPY-containing anti-fungal agent was found to 
have similar anti-fungal activity as the parent peptide, and was 
effective at imaging several different fungal pathogens, including 
Aspergillus fumigatus, which causes Invasive Pulmonary 
Aspergillosis (IPA), a fungal pneumonia with mortality rates up to 
40%.[117] Interestingly, the BODIPY based agent was also found 
to have significantly longer stability than commercially available 
membrane dye Syto82, a red dye. Incubation of A. fumigatus with 
both the BODIPY-peptide and Syto82 led to primarily red 
confocal microscopy images initially, due to the Syto82, though 
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after 3 min, degredation of Syto82 led to an image with almost entirely the green 
fluorescence of the BODIPY (Figure 1.4). The authors found that the BODIPY-peptide 
retained 95% of its fluorescence intensity after 24 h of incubation.[117] Because of its long 
fluorescence lifetime, and minimally-disruptive structure, BODIPY-amino acid 1.35 is 
likely to find application in many imaging probes. 
 
Figure 1.4. A. fumigatus incubated with cell membrane counterstain Syto82 (red) and 
BODIPY-peptide (green) for (i) 0 min, (ii) 1 min, (iii) 3 min, and (iv) 10 min. Scale bar = 
2.5 µm. Image reproduced with permission from Ref. [117]. 
 
The second common biologically-relevant application of BF2 based fluorophores is 
photodynamic therapy, which involves the use of a photosensitizer to destroy tumor cells. 
Upon irradiation with light, the photosensitizer will act as a catalyst, to convert oxygen into 
a variety of reactive oxygen species. These species have been shown to destroy tumors in 
many ways, including necrosis or apoptosis and starvation through the shutdown of blood 
vessels.[118] Due to their typically near-IR absorption and emission, aza-BODIPYs have 
proven quite useful for this application.[119-121] BODIPYs have also been studied 
extensively for their use in photodynamic therapy as well.[122] 
The Han group synthesized a BODIPY based photosensitizer 1.36, which emits in the near-
IR region, and has a high singlet-oxygen yield (67%).[123] These molecules were 
incorporated into cancer-targeting micelles, based on poly(lactic acid)-b-poly(ethylene 
glycol) copolymers, with appended folic acid groups. As a control, similar block 
copolymers were synthesized without the appended cancer-targeting folic acid groups. 
Both of these particles were injected into mice containing breast cancer cells, and the near-
IR fluorescence of the BODIPY dye was measured (Figure 1.5a). It was found that the 
targeting nanoparticles were much more localized in the area of the tumor than the non-
targeting nanoparticles, and maximum imaging intensity occurred ca. 24 h after injection. 
17 
 
 
 
The photodynamic therapy potential of the 
dyes were then tested, with mice being 
divided into 5 groups. The first group was a 
control, group 2 was irradiated with 670-
800 nm light, group 3 were only injected 
with the targeted BODIPY micelles, group 
4 were injected with the non-targeted 
BODIPY micelles and irradiated with light, 
and group 5 were injected with the targeted 
BODIPY micelles and irradiated with light 
(Figure 1.5b). It was found that significant tumor reduction over the control group was only 
observed after injection with the targeted BODIPY micelles, and irradiation with 670-800 
nm light.[123] 
 
Figure 1.5. (a) In vivo NIR fluorescence images of 4T1 tumor-bearing mice after being 
injected with 150 µL of a 50 µg/mL solution of targeted-BODIPY nanoparticles (top row), 
and non-targeting BODIPY nanoparticles (bottom row). The arrow indicates the tumor site. 
(b) Average weights of tumors 10 days after treatment. Treatment varied based on group 
number. Group 1 - control group; 2 - light irradiation only; 3 - targeted-BODIPY 
nanoparticle injection only; 4 - non-targeted BODIPY nanoparticle injection and 
irradiation; and 5 - targeted BODIPY nanoparticle injection and irradiation. Image 
reproduced with permission from Ref. [123]. 
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1.3.5 ECL Devices 
Electrochemiluminescence (ECL) is the generation of luminescence through an 
electrochemically generated excited state. Redox-active fluorescent dyes such as 
BODIPYs and aza-BODIPYs are often highly ECL active.[124] Bard et al. have extensively 
studied a wide range of aza-BODIPY and BODIPY monomers, dimers and polymers 
(including 1.37−1.40) for their ECL properties (Table 2).[87,125] All four complexes are 
emissive at wavelengths greater than 500 nm, with BODIPY monomer 1.37 emitting at the 
lowest wavelength of 513 nm, and aza-BODIPY 1.39 emitting at the highest wavelength 
of 682 nm. BODIPY polymer 1.38 has a fluorescence quantum yield of 35%. In most cases, 
the electrochemically generated luminescence occurs at a similar wavelength to that of the 
fluorescence, except for dimer 1.40, where the ECL emission is red shifted by almost 200 
nm, with respect to the fluorescence (Table 2), indicating the ECL emission occurs from a 
different excited state to that of the fluorescence.[125] In all cases, the efficiency of ECL 
was relatively weak (<1%), compared to that of the [Ru(bpy)3]
2+ standard, for which ΦECL 
= 5%.[87,125] 
 
 
Table 1.2. Optical and electrochemiluminescence properties of complexes 
1.37−1.40.[87,125] 
 λabs (nm) λem (nm) ΦF (%) λmax (ECL) ΦECL (%) 
1.37 501 513 97 538 0.7 
1.38 590 614 35 620 <0.1 
1.39 647 682 30 695 <0.1 
1.40 528 545 39 740 0.6 
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1.3.6 Self-Assembled Micelles 
Self-assembly of polymers appended with fluorescent dyes expands the scope of 
applications of the resulting micelles. For example, the Ambade group synthesized a block 
copolymer of poly(ethylene glycol) and polystyrene, with a BODIPY moiety at the junction 
of the two polymers, with the polystyrene attached directly to the BODIPY via a B-O bond. 
The resulting block copolymer self-assembled into micelles. The B-O bond could be 
cleaved photolytically, resulting in two homopolymers and the degradation of the micelle, 
potentially releasing a payload.[126] Similarly, the Zhu group appended aza-BODIPYs into 
the poly(methacrylic acid) block of a block copolymer consisting of  poly(methacryclic 
acid) and poly(methyl ether methacrylate-graft-poly(ethylene glycol)), which self-
assembled into pH responsive micelles. The aza-BODIPY, which emits in the near-IR 
allowed the authors to image the localization and integrity of their micelles.[127] 
The Manners group appended red, green and blue fluorescent BODIPYs onto 
poly(ferrocenyldimethylsilane)-b-poly(dimethylsiloxane) copolymers, which self-
assemble into cylindrical micelles.[128] By carefully tuning the ratio of the three coloured 
block copolymers, they were able to design micelles which emitted in a variety of different 
colours (both in solid-state and solution), including white light (see Figure 1.6). 
Additionally, the authors showed they could make multiblock micelles, with each block a 
different colour, with the colours only visible under a laser scanning confocal microscope, 
in contrast to the TEM image, where the micelles appear uniform.[128] 
 
Figure 1.6. Selection of colours of micelles which can be produced mixing red, green and 
blue fluorescent block copolymers. Raw images of solutions of these fluorescent micelles 
under UV irradiation, and corresponding laser scanning confocal microscopy (LCSM) 
images. Scale bar = 3 µm. Image reproduced with permission from Ref. [128]. 
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1.4 Formazans 
One class of chelating N-donor ligands which had not been studied as ligands for BF2 
complexes were the formazanate ligands, which are based on formazans. Formazans were 
first reported in the late 1800’s, and have been studied ever since for a variety of different 
applications. Formazans (1.41) possess a R1-NH-N=C(R3)-N=N-R5 backbone, typically 
with aromatic substituents on N1 and N5, and a variety of different substituents on C3, 
including aromatics, alkyls, heterocycles, and cyano and nitro groups. Deprotonation of the 
formazan NH results in a monoanionic formazanate (1.42). Formazans can exist in three 
different isomeric forms – closed, open, or linear. When R3 is a non-linear substituent, such 
as aromatic or nitro, only the closed form is observed. When R3 is less bulky or linear (e.g. 
cyano), free rotation around the C-N bonds of the formazan backbone is possible, resulting 
in the open or linear forms typically being observed. The ratio between the three forms are 
dependent on the N-aryl substituents. 
Formazans are typically synthesized via one of two routes. The first route (see Scheme 1) 
involves the deprotonation of a species with two activated CH bonds (e.g. phenylpyruvic 
acid, cyanoacetic acid, nitromethane), and the subsequent reaction with two equivalents of 
a diazonium salt. This method is straightforward, high yielding and inexpensive, and 
amenable to a variety of R3 substituents with the major limitation to the synthesis being the 
route does not allow for the clean production of asymmetric formazans.[129-130]  
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Scheme 1.1. Synthesis of formazans from active methylene species. 
The second common method for the synthesis of formazans enables the facile production 
of both symmetric and asymmetric formazans, but has only been demonstrated for aromatic 
substituents in the R3 position. This route involves the condensation reaction of an aryl 
hydrazine and benzaldehyde to form a hydrazone. In the same pot, CH2Cl2 and water are 
added to form a biphasic reaction mixture, as well as base and a phase-transfer catalyst 
([nBu4N][PF6]). An aryl diazonium salt can then be added, and the formazan is produced, 
generally in high yields.[131] 
Scheme 1.2. Synthesis of formazans under phase-transfer conditions. 
Formazans have been used for a variety of applications, including tetrazolium assays, in 
the textile industry as dyes, and for metal sequestration and identification. In tetrazolium 
assays, tetrazolium salts (e.g. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide, MTT, 1.43) are introduced into cell cultures. If the cells are viable, the cellular 
reductase enzymes present will reduce the colourless tetrazolium salt to the darkly coloured 
formazan (Figure 1.7).[132] Tetrazolium assays have been used to study superoxide 
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production,[133] the antibacterial properties of fungal extracts,[134] and to quantify 
microbials in different water sources,[135] among others.[132] 
 
 
Figure 1.7. 96-well plate containing (a) blank control wells, (b) untreated cell control 
wells, and (c-e) cell lines with various concentrations of drugs. Image reproduced with 
permission from Ref. [136]. 
 
The first patent for the use of formazans as a dye for wool was granted in 1949,[137] and 
since, many patents and publications have reported the use of formazans, and metal 
complexes of formazans for dyeing wool, protein fibres, and plastics.[138-139] For example, 
blue-coloured copper complex 1.44 was demonstrated to be an excellent dye for cellulose 
fibers and wool.[140]  
The ability of formazans to chelate to metal centres has been exploited in their use as 
selective metal extraction and detection agents. Formazan 1.45 was incorporated into an 
electrode, with which lead, copper, cadmium and zinc could accurately be detected.[141-142] 
Using other formazans, manganese in natural water has been detected.[143] Finally, the 
Kettrup group has shown that silica or polystyrene beads with appended formazans were 
active as ion-exchange materials.[144] 
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Formazans have also been sporadically studied for their use as ligands. Much of this work 
was done in the middle of the twentieth century,[145-148] and so a lot of the metal complexes 
were not structurally characterized. However, there has been a renaissance in the use of 
formazans as ligands in the last ten years. The Otten group reported homoleptic zinc 
complex 1.46a in 2014, and demonstrated the reversible reduction of each of the 
formazanate ligands individually.[149] The same group found that by making the same 
complex with iron (1.46b) they were able to demonstrate spin crossover, a phenomenon 
that is rare in four-coordinate iron complexes.[150] Unique bonding modes were observed 
when coordination of alkali metals to formazans was attempted.[151] Sodium preferred to 
coordinate to the formazan through the N2 and N4 nitrogen’s, where the formazan exists in 
the open form. The cyano substituent acted as a ligand for the sodium as well, forming a 
coordination polymer (1.47). Similar bonding modes were observed for potassium as 
well.[151] 
The coordination of heavier transition metals with formazans has also been studied 
recently. Heteroleptic platinum complex 1.48 was synthesized by the Teets group.[152] They 
demonstrated that coordination to the platinum center resulted in a red-shifted λmax by over 
100 nm from the formazan.[152] Ruthenium complex of formazanate ligand 1.49 was used 
to probe the non-innocent behavior of the formazanate ligand. The authors used EPR 
spectroscopy, UV-vis-NIR spectroelectrochemistry and computational calculations in 
order to assign the location of the various redox processes which were occurring.[153] 
Due to the redox-activity of formazanate ligands, they have the potential to be useful in 
catalysis. The Tolman and Hicks group synthesized copper complexes of formazanates to 
study their activation of dioxygen, which is a pivotal step in many copper-based catalytic 
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systems. Upon reaction of the copper-formazan complexes with oxygen, dimeric species 
1.50 was formed, and this same species was not observed for copper complexes of other 
ligands, indicating the unusual reactivity of formazanate complexes.[154] Finally, bis nickel 
complex 1.51 was studied as a catalyst towards the polymerization of ethylene by the 
Lipunov group. They demonstrated that with a co-catalyst (AlEtCl2), ethylene 
oligomerization was possible – after reaction, analysis of the reaction mixture contained α- 
and β-olefins (up to octene).[155] 
 
Given these examples, formazans are an attractive class of molecules due to their facile 
and inexpensive synthesis, and many available modification sites.[156] Their application in 
tetrazolium assays and as dyes has been quite widely examined. However, their use as 
ligands, and the applications of the resulting complexes is relatively understudied and has 
significant potential to impact many different fields of research. 
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1.5 Scope of Thesis 
BF2 complexes of N-donor ligands are an interesting class of materials, studied for their 
spectroscopic and redox properties. A yet-unstudied ligand for these types of complexes 
are formazanate ligands, which despite being known for over a century, have very little 
known about their coordination to main-group elements. Due to their ease of synthesis, 
formazanate ligands and their complexes have the potential to impact a variety of different 
applications, though this is a significantly underdeveloped field as well. 
This thesis focuses on the coordination of the BF2 moiety by formazanate ligands, and the 
resulting optical and electronic properties of the complexes. It discusses the incorporation 
of these BF2 complexes into polymers, their use as molecular materials, and unprecedented 
boron complexes observed when a specific bis-hydroxy-substituted trianionic, potentially 
tetradentate formazanates were employed. 
Chapter 2 focuses on the effect of substituent variation on the formazanate ligand on the 
resulting BF2 complexes. This includes the effects of electron donating and withdrawing 
substituents on the aryl substituents, and a study of how these substituents affected the 
resulting optical and electrochemical properties of the complex. 
Chapter 3 describes studies of the effect of extending the conjugation of BF2 complexes of 
formazanate ligands. The difference between the 3 R3 substituents (Ph, NO2 and CN) was 
explored. A set of dimers were also synthesized – one being conjugated and one cross 
conjugated, and the properties of these dimers were contrasted with that of a monomeric 
model complex. 
Chapter 4 highlights the use of copper-assisted alkyne-azide cycloaddition (CuAAC) to 
synthesize molecular materials and polymers that would not be possible by other means. 
This includes both a water soluble BF2 formazanate complex, which was used for cell-
imaging applications, and a ferrocene-substituted complex which was employed as a redox 
sensor. Finally, the same methods were used to synthesize a π-conjugated copolymer with 
9,9-dihexylfluorene. Model complexes were synthesized in order to rationalize the 
observed spectroscopic properties of the polymer. 
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Chapter 5 explores the unique reactivity of a 1,5-(2-phenol)-3-cyanoformazan with boron 
trifluoride diethyl etherate. The resulting reaction mixture contained multiple 
unprecedented boron heterocycles. The spectroscopic and electronic properties of these 
complexes was studied in detail. Finally, the chemical reduction of two of the products was 
studied, and the characterization of these reduced species described. 
 Chapter 6 summarizes the results and key conclusions of the previous chapters, and 
suggests future directions for the project. 
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Chapter 2 
2  Structural Modification of BF2 Formazanate Dyes 
Adapted from: 
1. Barbon, S. M.; Price, J. T.; Reinkeluers, P. A.; Gilroy, J. B. Inorg. Chem. 2014, 53,   
10585-10593.  
2. Barbon, S. M.; Reinkeluers, P. A.; Price, J. T.; Staroverov, V. N.; Gilroy, J. B. Chem. 
Eur. J. 2014, 20, 1340-11344.  
 
2.1 Introduction  
Boron difluoride (BF2) complexes of chelating N-donor ligands have been extensively 
studied over the past 20 years[1-10] as functional materials with useful properties that are 
tunable through structural modification, including high molar absorptivities and 
fluorescence quantum yields and unusual redox properties. A wide range of chelating N-
donor ligands have been studied as the backbone of these BF2 complexes, including 
dipyrrins,[11-13] β-diketiminates,[14-16] anilido-pyridines,[17] anilido-imines,[18-19] 
pyridomethenes[20] and indigo-N,N’-diarylamines,[21-22] resulting in complexes 2.1–2.6. 
Complexes derived from dipyrrin ligands 2.1, commonly known as BODIPYs have been 
widely used in a large number of applications due to their high quantum yields, although 
their syntheses can be challenging.[11-13],[23-28] BF2 complexes of β-diketiminates 2.2 are 
redox-active and exhibit high extinction coefficients, but have been shown to have low 
fluorescence quantum yields.[14-16] Piers’ anilido-pyridine BF2 complexes, 2.3, have high 
quantum yields and exhibit large Stokes shifts,[17] as do related complexes based on anilido-
imines 2.4.[18-19] The large Stokes shifts are a key requirement for the potential use of BF2 
complexes as optical imaging agents. Pyridomethane BF2 complexes 2.5 exhibit moderate 
quantum yields in solution and the solid-state,[20] while those derived from indigo-N,N’-
diarylamines, 2.6, have rich redox chemistry and are emissive in the near-IR.[21-22]  
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One family of chelating N-donor ligands that has not been widely studied in this context 
are formazanate ligands 2.7,[29-30] which are derived from formazans 2.8. Formazans have 
been used widely within the textile industry as dyes,[31-34] and as colorimetric indicators of 
cell activity in biology.[35-39] However, their behavior as ligands has only been explored 
intermittently over the past 75 years.[40-49] In the last decade, the Hicks group has reported 
a series of transition metal complexes of 3-cyanoformazanates and 3-nitroformazanates, 
including heteroleptic nickel complex 2.9 and iron and cobalt complexes 2.10a,b derived 
from a tetradentate, trianionic 3-cyanoformazanate ligand.[47] Tolman and co-workers have 
studied copper (II) complexes of 3-nitroformazanates 2.11 during studies designed to 
model oxygen activation processes prevalent in biological systems.[45,49] 
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More recently, while this work was being completed, the Otten group has employed 
triarylformazans, e.g. 2.8a, for the synthesis of homoleptic zinc complexes, e.g. 2.12, and 
demonstrated the utility of formazanate ligands as electron reservoirs.[50] In 2014, a report 
describing the use of these zinc complexes as starting materials for the production of 
formazanate BF2 complexes, e.g. 2.13a, via a transmetallation reaction was published 
(Scheme 2.1).[51] Herein, we report the synthesis and characterization of BF2 complexes of 
3-cyanoformazanate and 3-arylformazanate ligands by a straightforward route to produce 
a series of formazanate BF2 complexes,
[52-53] to afford a series of triarylformazanate BF2 
complexes. Through judicious structural modification, we studied the effect of substituents 
on their optical and electronic properties.  
 
Scheme 2.1. Otten’s synthesis of homoleptic zinc formazanate complex 2.12 and boron 
difluoride formazanate complex 2.13a.[50-51] 
 
 
39 
 
 
 
2.2 Results 
2.2.1 Synthesis 
Triarylformazans 2.8a–i were prepared according to a previously published procedure[54-
55] and exhibited a characteristic NH shift between 14–16 ppm in their 1H NMR spectra 
(Figures A2.1–A2.8). Similarly, 3-cyanoformazans 2.8j−l, prepared according to a 
previously published procedure[47] exhibited NH shifts between 10−12 ppm. Formazanate 
BF2 complexes 2.13a–l were synthesized from their parent formazans by refluxing them in 
a toluene solution containing excess boron trifluoride diethyl etherate and triethylamine for 
16 h (Scheme 2.2, Table 2.1). Purified yields ranged from 55–92%, with the exception of 
2.13b, which was isolated in 16% yield due to difficulties encountered during purification.  
 
Scheme 2.2. Synthesis of BF2 formazanate complexes 2.13a–l. 
 
Table 2.1. List of substituents for formazans 2.8a–l and BF2 formazanate complexes 
2.13a–l.a 
 Ar1 Ar5 R3 
a C6H5 C6H5 p-C6H4-CH3 
b p-C6H4-CN p-C6H4-CN p-C6H4-CH3 
c p-C6H4-OMe p-C6H4-OMe p-C6H4-CH3 
d p-C6H4-CH3 p-C6H4-CH3 C6H5 
e p-C6H4-CH3 p-C6H4-CH3 p-C6H4-CN 
f p-C6H4-CH3 p-C6H4-CH3 p-C6H4-OMe 
g p-C6H4-CN p-C6H4-OMe p-C6H4-CH3 
h p-C6H4-CH3 p-C6H4-CN p-C6H4-OMe 
i p-C6H4-OMe p-C6H4-CH3 p-C6H4-CN 
j C6H5 C6H5 CN 
k p-C6H4-CN p-C6H4-CN CN 
l p-C6H4-OMe p-C6H4-OMe CN 
ap-C6H4-CH3 substituents were chosen as ‘placeholders’ throughout this study, as their 
presence simplified NMR spectra and facilitated purification by crystallization. 
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The incorporation of the [BF2]
+ fragment into the formazanate framework was 
accompanied by a color change from dark red to purple in triarylformazanate BF2 
complexes, and orange to dark red or purple in 3-cyanoformazanate BF2 complexes. The 
reaction could also be monitored by 1H NMR spectroscopy, as the NH signals disappeared 
in the spectra of 2.13a–l (Figures 2.1, A2.9–A2.30). The BF2 formazanate complexes were 
characterized by 11B and 19F NMR spectroscopy, where diagnostic 1:2:1 triplets in the 11B 
NMR spectra between –0.5 and –0.9 ppm, and 1:1:1:1 quartets in the 19F NMR spectra 
between –129.6 and –145.8 ppm were observed. Further analysis by 13C NMR 
spectroscopy, mass spectrometry, IR spectroscopy and elemental analysis confirmed the 
proposed structures of complexes 2.13a–l. 
 
Figure 2.1. 1H NMR spectrum of formazan 2.8d (black) and BF2 complex 2.13d (red) in 
CDCl3. The NH signal for 2.8d is inset.  
 
2.2.2 X-ray Crystallography 
Slow evaporation of concentrated CH2Cl2 solutions of 2.13d–f and 2.13j−l yielded single 
crystals suitable for X-ray diffraction analysis. The solid-state structures show that the 
boron atoms in complexes 2.13d–f and 2.13j−l are four-coordinate and adopt a slightly 
distorted tetrahedral geometry. Each complex has a delocalized formazanate backbone, 
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with all C-N and N-N bond lengths approximately half way between the standard single 
and double bonds for the respective atoms involved.[56] 
The boron atoms are displaced slightly from the N4 plane (plane defined by N1, N2, N3 
and N4) of the formazanate backbone, by 0.192 Å in 2.13j and by 0.025 Å in 2.13k. The 
unit cell of the crystalline structure of 2.13l contains two molecular units in distinct 
conformations (Figure 2.2, A2.31). Conformer A is almost flat and has a geometry very 
similar to 2.13j and 2.13k, with the boron atom displaced from the N4 plane by 0.143 Å. 
The second conformer, conformer B, is shaped like a dragonfly and has the boron atom 
displaced from the N4 plane by 0.376 Å. The structures of the triarylformazanate BF2 
complexes were very similar, as complexes 2.13d and 2.13e were relatively planar, with 
the boron atom displaced by 0.022 Å in 2.13d and 0.290 Å in 2.13e. The solid-state 
structure of 2.13f is similar to the dragonfly shaped conformer of 2.13l, with the boron 
atom displaced from the N4 plane by 0.538 Å in a boat-like conformation. 
The 1,5-aryl substituents of BF2 complexes 2.13d, 2.13e, 2.13j, 2.13k, and 2.13l 
(conformer A) are moderately twisted with respect to the formazanate backbone, with the 
angle between the N4 plane and the plane defined by the N-aryl substituents ranging from 
4.7 to 25.4°. For comparison, the same angles in conformer B of 2.13l are 36.6–37.6°, and 
in 2.13f are 43−50°. Similar BF2 complexes of other monoanionic, bidentate N-donor 
ligands exhibit significantly larger angles between the N-aryl substituents and the ligand 
backbones involved. For example, the aryl substituent in anilido-pyridine BF2 complex 2.3 
(Ar = phenyl) is twisted by 77°,[17] while the aryl substituents in β-diketiminate BF2 
complexes are almost perpendicular to the ligand backbone, with twisting of 76−88°.[14-15] 
These structures are similar to the structure of complex 2.13a reported previously.[51] 
Subtle changes between structures are likely due to crystal packing interactions. 
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Figure 2.2. Solid-state structures - top view (left) and side view (right). Thermal ellipsoids 
are shown at 50% probability and hydrogen atoms are removed for clarity.  
 
Table 2.2. Selected bond lengths (Å) and angles (degrees) for BF2 formazanate complexes 
2.13d–f and 2.13j−l, determined by X-ray diffraction. 
 2.13d 2.13e 2.13f 2.13j 2.13k 2.13lA 2.13lB 
N1-N2,  
N3-N4 
1.3117(18), 
1.3094(18) 
1.3012(17), 
1.3085(17) 
1.315(3), 
1.315(3) 
1.2900(15), 
1.2948(15) 
1.3017(15), 
1.2945(15) 
1.307(2), 
1.304(2) 
1.306(2), 
1.302(2) 
C1-N2,  
C1-N4 
1.339(2), 
1.346(2) 
1.3431(19), 
1.340(2) 
1.344(3), 
1.338(3) 
1.3408(17), 
1.3379(17) 
1.3289(17), 
1.3382(17) 
1.340(3), 
1.335(3) 
1.335(3), 
1.340(3) 
N1-B1,  
N3-B1 
1.561(2), 
1.561(2) 
1.560(2), 
1.576(2) 
1.551(4), 
1.556(4) 
1.5748(18), 
1.5771(17) 
1.5714(18), 
1.5817(18) 
1.558(3), 
1.567(3) 
1.563(3), 
1.563(3) 
N1-N2-C1,  
N3-N4-C1 
118.84(13), 
118.78(13) 
118.24(12), 
118.57(12) 
117.2(2), 
117.3(2) 
117.14(11), 
117.30(11) 
117.28(11), 
117.76(11) 
116.75(18), 
116.90(18) 
116.21(17), 
116.21(17) 
N2-C1-N4 126.66(14) 126.83(13) 124.6(2) 129.33(12) 129.41(11) 130.0(2) 129.32(18) 
N1-B1-N3 106.28(12) 105.17(12) 101.68(19) 105.55(10) 105.65(10) 106.85(17) 104.75(16) 
Boron 
displacementa 
0.022 0.290 0.538 0.192 0.025 0.143 0.376 
Dihedral 
anglesb 
7.20, 5.48, 
6.38 
25.52, 7.78 
6.22 
50.26, 
43.08, 17.20 
18.10, 
25.41 
16.86, 4.71 15.28, 
21.37 
37.63, 
36.62 
aDistance between B1 and N4 plane. 
bAngles between the plane defined by the N1, N3 and 
C1 aryl substituents and the N4 plane.  
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2.2.3 Absorption and Emission Spectroscopy 
The optical properties of BF2 complexes were explored in three different solvents using 
UV-vis absorption and emission spectroscopy (Table 2.3). Firstly we will discuss the 
spectral trends observed upon variation of the 1,5-substitutents (phenyl, p-benzonitrile, p-
anisole) in 3-aryl complexes 2.13a–c (Figures 2.3, A2.32−A2.34). Each complex was 
highly absorbing between 450 and 600 nm, with wavelengths of maximum absorption 
(λmax) in toluene of 523 nm (ε = 22,400 M–1 cm–1) for 2.13a, 550 nm (ε = 20,500 M–1        
cm–1) for 2.13b, and 552 nm (ε = 28,200 M–1 cm–1) for 2.13c. With the electron donating 
1,5-(p-anisole) substituents in 2.13c, the λmax of 2.13c was red shifted by ca. 25 nm with 
respect to the phenyl-substituted analog 2.13a. The λmax of the p-benzonitrile-substituted 
derivative, 2.13b, was also red shifted relative to 2.13a. Although this observation may 
seem counter intuitive, the same trend was observed for monosubstituted benzenes (Figure 
A2.35), and is likely caused by the extended conjugation of the cyano substituent. Each 
complex in the series 2.13a–c was shown to be emissive, with wavelengths of maximum 
emission (λem) of 639 nm, 674 nm and 686 nm, respectively in toluene. The trends observed 
for the emission spectra mirrored those observed for the absorption spectra. The observed 
Stokes shifts (νST) were high, νST = 116 nm (2.13a), 124 nm (2.13b), and 134 nm (2.13c) 
in toluene, and quantum yields (ΦF) were calculated to be between 0.5% and 5.0% and 
were highest in electron-donating p-anisole-substitued 2.13c.  
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Figure 2.3. UV-vis absorption spectra (a) and emission spectra (b) of 2.13a (black), 2.13b 
(red) and 2.13c (blue) and absorption (c) and emission (d) spectra of 2.13j (purple), 2.13k 
(green) and 2.13l (grey) recorded for 10–5 M degassed toluene solutions.  
 
Complexes 2.13d–f were studied in order to assess the influence of the same series of aryl 
substituents at the 3-position of the formazanate framework (Figures A2.36–A2.38, Table 
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2.3). Similar to compounds 2.13a–c, all three complexes were highly absorbing between 
450 and 600 nm, with high molar absorptivities at their respective λmax in toluene [2.13d: 
λmax = 524 nm (ε = 30,300 M–1 cm–1); 2.13e: λmax = 525 nm (ε = 25,300 M–1 cm–1); 2.13f: 
λmax = 544 nm (ε = 25,800 M–1 cm–1)]. Again, the λmax for the 3-(p-anisole)-substituted 
derivative (2.13f), was significantly red shifted with respect to the phenyl-substituted 
complex (2.13d), but unlike the 2.13a–c series, a red shift in λmax was not observed for 
complex 2.13e (Ar3 = p-C6H4-CN). The observed trend was similar for the emission spectra 
of complexes 2.13d–f, where the λem for 2.13f (Ar3 = p-C6H4-OMe, λem = 669 nm) was red 
shifted relative to the λem for 2.13d (Ar3 = C6H5, λem = 640 nm). However, a blue shift in 
λem for the electron withdrawing p-benzonitrile-substituted complex 2.13e (λem = 634 nm) 
was observed relative to 2.13d. The Stokes shifts for complexes 2.13d–f were again 
substantial (110−135 nm), and the calculated quantum yields ranged from 0.5 to 2.0%, with 
the 3-(p-benzonitrile)-substituted BF2 complex (2.13e) exhibiting the highest quantum 
yield in toluene. 
Thirdly, we studied the optical properties of asymmetrically-substituted 3-aryl substituted 
complexes 2.13g–i, which contain p-anisole, p-benzonitrile and p-tolyl substituents in three 
different arrangements (Figures A2.39–A2.41, Table 2.3). All three absorbed visible light 
between 450 and 650 nm, and had λmax values of 561 nm (ε = 24,400 M–1 cm–1), 560 nm 
(ε = 21,500 M–1 cm–1) and 541 nm (ε = 25,100 M–1 cm–1), respectively. In toluene, their 
λem values were 666 nm (2.13g), 672 nm (2.13h) and 651 nm (2.13i). These complexes 
also exhibited high Stokes shifts between 105 and 128 nm and calculated quantum yields 
of 8.7% for 2.13g, 5.3% for 2.13h and 9.8% for 2.13i.  
Finally, we studied the effect of changing the 3-aryl substituent to a withdrawing 3-cyano 
substituent in complexes 2.13j−l. Each complex shows strong, substituent-dependent 
absorption with λmax values increasing from 502 nm (2.13j) to 515 nm (2.13k) to 572 nm 
(2.13l) in toluene (Figures 2.3, A2.42–A2.44). We note that similarly to complexes 2.13a 
and 2.13b the UV-vis and emission spectra of 2.13k (R = CN) are red-shifted relative to 
2.13j (R = H) and is likely caused by the extended conjugation of the cyano substituent, 
which is observed in the DFT calculated HOMO (Figure A2.52). The 3-cyanoformazan 
ligands 2.13j−l are non-emissive across a broad concentration range in THF, CH2Cl2 and 
toluene. Under similar conditions, BF2 complexes 2.13j–l are highly emissive in the visible 
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region, with λem of 586 nm (ΦF = 15%, νST = 84 nm), 598 nm (ΦF = 14%, νST = 83 nm) and 
656 nm (ΦF = 77%, νST = 84 nm) observed in toluene for 2.13j–l, respectively. The 3-cyano 
substituted BF2 formazanate complexes exhibit significantly higher tunability based on the 
1,5 substituents, and also exhibit higher quantum yields than the 3-aryl analogs, however 
they exhibit smaller Stokes shifts.  
 
Table 2.3. Optical properties of BF2 formazanate complexes 2.13a–l. 
Compound Solvent λmax (nm) ε (M–1 cm–1) λem (nm) ΦF (%)a νST (cm–1) νST (nm) 
 THF 517 21,700 641 0.5 3,740 124 
2.13a CH2Cl2 518 24,700 641 0.8 3,705 123 
 Toluene 523 22,400 639 0.7 3,470 116 
 THF 541 22,800 673 1.5 3,625 132 
2.13b CH2Cl2 545 24,500 678 0.9 3,600 133 
 Toluene 550 20,500 674 2.1 3,345 124 
 THF 545 22,300 692 1.5 3,900 147 
2.13c CH2Cl2 544 29,300 690 2.4 3,890 146 
 Toluene 552 28,200 686 5.0 3,540 134 
 THF 520 29,300 641 0.6 3,630 121 
2.13d CH2Cl2 520 36,600 640 0.5 3,610 120 
 Toluene 524 30,300 640 0.9 3,460 116 
 THF 521 33,800 631 0.9 3,350 110 
2.13e CH2Cl2 521 36,600 631 0.7 3,350 110 
 Toluene 525 25,300 634 2.0 3,275 109 
 THF 539 24,600 674 1.1 3,715 135 
2.13f CH2Cl2 539 25,200 673 1.1 3,695 134 
 Toluene 544 25,800 669 1.4 3,435 125 
 THF 552 30,100 667 5.4 3,125 115 
2.13g CH2Cl2 553 27,500 666 6.2 3,070 113 
 Toluene 561 24,400 666 8.7 2,810 105 
 THF 553 22,500 674 4.1 3,245 121 
2.13h CH2Cl2 553 24,500 676 3.8 3,290 123 
 Toluene 560 21,500 672 5.3 2,975 112 
 THF 535 32,500 651 6.4 3,330 116 
2.13i CH2Cl2 534 33,900 651 5.8 3,365 117 
 Toluene 541 25,100 651 9.8 3,125 110 
 THF 489 25,400 585 5.1 3,356 96 
2.13j CH2Cl2 491 34,600 584 9.2 3,243 93 
 Toluene 502 30,400 586 15.0 2,855 84 
 THF 497 22,600 590 12.2 3,172 93 
2.13k CH2Cl2 499 22,400 589 16.7 3,062 90 
 Toluene 515 35,000 598 14.3 2,695 84 
 THF 556 33,400 662 45.7 2,880 106 
2.13l CH2Cl2 558 35,300 661 65.3 2,793 103 
 Toluene 572 42,700 656 77.0 2,239 84 
aQuantum yields were estimated according to published protocols using ruthenium 
tris(bipyridine) hexafluorophosphate as a relative standard and corrected for wavelength-
dependent detector sensitivity (Figure A2.45).[57,58] 
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2.2.4 Cyclic Voltammetry 
The substituent effects for complexes 2.13a–l were studied by cyclic voltammetry (CV), 
referenced to the ferrocene/ferrocenium redox couple. Each complex exhibited two ligand-
centred reversible (or quasi-reversible) one-electron reduction waves corresponding to the 
production of their radical anion (2.14) and dianion (2.15) forms (Scheme 2.3, Figures 2.4, 
A2.46−A2.48, Table 2.4). Most of the complexes studied also exhibited irreversible 
oxidation events in their CVs within the electrochemical window of acetonitrile (Figures 
A2.49–A2.52).  
 
Scheme 2.3. Stepwise reduction of triarylformazanate BF2 complexes. 
 
Again we begin by discussing the 1,5-substituted complexes 2.13a–c (Figure A2.48). 
Phenyl-substituted complex 2.13a was reversibly reduced at Ered1 = −830 mV and Ered2 = 
−1870 mV. The introduction of electron withdrawing p-benzonitrile substituents in 
complex 2.13b substantially decreased the potential required for reduction to Ered1 = −500 
mV and Ered2 = −1470 mV. Electron rich, p-anisole-substituted complex 2.13c was more 
difficult to reduce than 2.13a,b, with reduction waves observed at Ered1 = −970 mV and 
Ered2 = −1940 mV. All 3 complexes have a difference in reduction potentials (ΔE) of 
approximately 1000 mV. 
The trends observed for the 3-substituted formazanate complexes 2.13d–f were not 
obvious. The phenyl-substituted derivative was reduced at potentials of Ered1 = −920 mV 
and Ered2 = −1930 mV, while p-benzonitrile-substituted complex 2.13e was easier to reduce 
(Ered1 = −830 mV and Ered2 = −1920 mV). Unexpectedly, p-anisole-substituted complex 
2.13f was also slightly easier to reduce than 2.13d at Ered1 = −900 mV and Ered2 = −1890 
mV. Similar to complexes 2.13a−c, the ΔE of 2.13d−f were approximately 1000 mV. 
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Interestingly, 2.13e also exhibits a third reversible reduction wave within the solvent 
window, perhaps due to the formation of a radical trianion (Figure A2.49).  
For the series of asymmetrically-substituted BF2 complexes 2.13g−i, the 1,5-substituents 
had the most significant effect on their electrochemical reduction. Complex 2.13g, bearing 
p-anisole and p-benzonitrile substituents at the 1,5-positions, was reversibly reduced at 
Ered1 = –720 mV and Ered2 = −1740 mV. Interchanging the electron donating p-anisole 
substituent with a weakly donating p-tolyl group in complex 2.13h decreased the reduction 
potentials by ca. 30 mV to Ered1 = –690 mV and Ered2 = −1720 mV. Complex 2.13i has two 
donating N-substituents (p-anisole and p-tolyl), and thus was the most difficult to reduce, 
at Ered1 = –860 mV and Ered2 = −1940 mV. The ΔE for these complexes were 1020 mV for 
2.13g, 1030 mV for 2.13h, and 1080 mV for 2.13i. 
All of the expected trends were observed in the electrochemical studies of the 3-
cyanoformazante BF2 complexes 2.13j−l. Each complex exhibited two fully reversible 
reduction waves (Figure 2.4) but only 2.13l gave rise to an irreversible oxidation event 
within the electrochemical window of acetonitrile (Figure A2.52). As with 2.13a−c, the 
reduction potentials followed the expected trend based on the para-substituent introduced 
at the aryl rings. BF2 complex 2.13j (R = H) is reduced to a radical anion and then a dianion 
at –0.53 V and –1.68 V against the ferrocene/ferrocenium redox couple, while 2.13k (R = 
CN) was reduced at –0.21 V and  –1.25 V and 2.13l (R = OMe) was reduced at –0.68 V 
and –1.82 V. Due to the electron withdrawing nature of the 3-cyano substituent, all three 
complexes were significantly easier to reduce (ca. 300 mV) than their 3-aryl substituted 
analogs. 
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Figure 2.4. Cyclic voltammograms of 2.13j (purple), 2.13k (green), and 2.13l (grey) 
recorded at 100 mV s−1 in 1 mM acetonitrile solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte.  
Table 2.4. Electrochemical data (mV vs. Fc/Fc+) for BF2 formazanate complexes 2.13a–l. 
 Ered1
a (mV) Ered2
a
 (mV) ΔEb (mV) 
2.13a –840 –1870 1030 
2.13b –500 –1470 970 
2.13c –970 –1940 970 
2.13d –920 –1930 1010 
2.13e –830 –1920 1090 
2.13f –900 –1890 990 
2.13g –720 –1740 1020 
2.13h –690 –1720 1030 
2.13i –860 –1940 1080 
2.13j –530 –1680 1150 
2.13k –210 –1250 1040 
2.13l –680 –1820 1140 
aCyclic voltammetry experiments were conducted in CH3CN containing 1 mM analyte and     
0.1 M [nBu4N][PF6] as supporting electrolyte at a scan rate of 250 mV s
–1. Voltammograms 
were referenced internally against the ferrocene/ferrocenium redox couple. bDefined as the 
difference between Ered1 and Ered2. 
 
2.3 Discussion 
Through inspection of the electrochemical and optical spectroscopy data collected for 
complexes 2.13a−f, it is clear that the 1,5-substituents have a more pronounced effect on 
the properties observed in triaryl formazanate BF2 complexes. For the series 2.13a−c, 
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predictable trends in reduction potentials based on the electron donating/withdrawing 
character of the N-aryl substituents were observed, including a shift of ca. 500 mV in the 
reduction potentials (Ered1 and Ered2) upon switching from p-benzonitrile to p-anisole 1,5-
substituents. For 2.13d−f, the observed trend is not easily rationalized, as the electron-rich 
3-(p-anisole) derivative was easier to reduce then the 3-phenyl analog. Similarly, the 
absorption and emission properties of 2.13a−f were much more sensitive to the 1,5-
substituents than the 3-substituents. These trends are similar to those observed for Kuhn-
type verdazyls 2.16 and 6-oxoverdazyls 2.17, where the singly occupied molecular orbital 
(π-SOMO) is centered on the four nitrogen atoms, and contains very little electron density 
at the 3-position of the heterocyclic ring due to the presence of a nodal plane.[55],[59] The 
LUMOs of the 3-cyanoformazanate BF2 complexes 2.13j−l were shown to possess very 
similar features,[52] and so similarly, the LUMOs of the triarylformazanate BF2 complexes 
described are not expected to differ significantly from each other.  
 
Breaking the symmetry in derivatives 2.13g−i did not result in significant changes in 
electrochemical or absorption properties relative to symmetrically-substituted analogs 
2.13a−f. However, a modest enhancement in quantum yields was observed for all three 
substituent configurations. This enhancement of emission intensity is consistent with 
trends observed for asymmetrically substituted BODIPYs[60-65] and other BF2 complexes 
of N-donor ligands.[66-69]  
While varying the para-substituent on the 3-aryl ring had little effect on the properties of 
the resulting complexes, directly changing the 3-aryl substituent to an electron withdrawing 
cyano group had a significant effect on the properties. The more electron poor derivatives 
2.13j−l were much easier to reduce and had significantly higher fluorescence quantum 
yields.  
For all of the complexes studied (2.13a−i), the fluorescence intensities, and thus quantum 
yields, were higher in toluene than THF or CH2Cl2. This effect may arise due to the 
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stabilization of polar excited states, by polar solvents, potentially allowing for competing 
deactivation pathways to operate.[70] 
2.4 Applications 
2.4.1 Electrochemiluminescence  
Electrochemiluminescence (ECL) involves the generation of light from an 
electrochemically excited species. Boron difluoride complexes of formazanate ligands 
provide an attractive choice as an electrochemiluminescent material due to their 
inexpensive and straightforward synthesis. The BF2 complex of p-anisole substituted 3-
cyanoformazanate 2.13l was chosen due to its high fluorescence quantum yield, and well-
behaved electrochemical properties. It was found that in the presence of a tripropyl amine 
(TPrA) coreactant, electrochemiluminescence was obtained at 724 nm (Figure 2.5). At a 
scan rate of 200 mV s−1, the ECL efficiency was found to be 4.5 times higher than the 
benchmark Ru(bpy)3/TPrA system.
[71] 
 
Figure 2.5. Spooling ECL spectra of 2.13l in the presence of TPrA acquired over a time 
interval of 1s. The blue and red spectra represent the forward scan and the black spectra 
represent the reverse scan. 
 
2.4.2 Cell Imaging 
The same p-anisole substituted BF2 complex 2.13l proved to be an excellent candidate for 
use in cell-imaging studies, due to its high quantum yield and emission approaching the 
near-IR. It was found that dye 2.13l localized within the cytoplasm of mouse fibroblast 
cells. Due to the low energy of the emission, 2.13l is ideally suited for orthogonal imaging 
applications. This was achieved by using 4’6-diamidino-2-phenylindole (DAPI), which is 
a nuclear stain that emits in the blue region. Using this combination, the cytoplasm and 
nucleus of the mouse fibroblast cells could be imaged simultaneously and orthogonally.[72] 
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Figure 2.6. Confocal fluorescent micrographs of mouse fibroblast cells stained with BF2 
formazanate complex 2.13l and DAPI. Images (a) and (b) were visualized with excitation 
at 559 nm and emission collected between 625−725 nm. Images (c) and (d) are an overlay 
of images (a) and (b) with those obtained from excitation at 405 nm and emission collected 
between 425−475 nm. 
 
2.5 Conclusions 
In conclusion, we have demonstrated a straightforward synthetic route to a series of twelve 
formazanate boron difluoride complexes allowing for studies of their substituent-
dependent properties to be conducted. We have shown that the properties of these 
complexes, including their wavelengths of maximum absorption and emission, quantum 
yields, and electrochemical properties can be tuned by the introduction of electron-
donating (p-anisole) or electron-withdrawing (p-benzonitrile) aryl substituents at the 
formazanate ligand backbone. Changes in the properties of BF2 complexes of triaryl 
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formazanates were more dramatic when 1,5-substituents were varied compared to similar 
structural variations at the 3-position of the formazanate backbone, and were most dramatic 
when varying the 1,5-substituent on the 3-cyanoformazanate derivatives. Modest 
enhancements in emission intensity of triarylformazanate BF2 complexes were observed 
for asymmetrically-substituted complexes, which exhibited quantum yields close to 10%. 
3-cyanoformazanate BF2 complexes exhibited significantly higher quantum yields, 
reaching up to 77%. Finally, it was demonstrated that the 3-cyanoformazanate BF2 
complex with p-anisole N-aryl substituents was effective for use both as an 
electrochemiluminescent emitter, and for orthogonal cell imaging applications. 
 
2.6 Experimental 
2.6.1 General Considerations 
Reactions and manipulations were carried out under a nitrogen atmosphere using standard 
Schlenk techniques unless otherwise stated. Solvents were obtained from Caledon 
Laboratories, dried using an Innovative Technologies Inc. solvent puriﬁcation system, 
collected under vacuum, and stored under a nitrogen atmosphere over 4 Å molecular sieves. 
Reagents were purchased from Sigma-Aldrich or Alfa Aesar and used as received. 
Formazans 2.8a–l were synthesized according to previously published procedures, and the 
characterization data for 2.8a−f, 2.8j and 2.8l were consistent with the same reports.[47,55] 
NMR Spectra were recorded on a 400 MHz (1H: 399.8 MHz, 11B: 128.3 MHz, 19F: 376.1 
MHz) or 600 MHz (1H: 599.5 MHz, 13C: 150.8 MHz) Varian INOVA instrument or a 400 
MHz (13C: 100.6 MHz) Varian Mercury Instrument. 1H NMR spectra were referenced to 
residual CHCl3 (7.27 ppm) and 
13C NMR spectra were referenced to CDCl3 (77.2 ppm). 
11B spectra were referenced to BF3·OEt2 at 0 ppm, and 
19F spectra were referenced to CFCl3 
at 0 ppm. Mass spectrometry data was recorded in positive-ion mode using a high 
resolution Finnigan MAT 8400 spectrometer using electron impact ionization. UV-vis 
spectra were recorded using a Cary 300 Scan instrument. Four separate concentrations were 
run for each sample, and molar extinction coefficients were determined from the slope of 
a plot of absorbance against concentration. Infrared spectra were recorded on a KBr disk 
using a Bruker Vector 33 FT-IR spectrometer. Emission spectra were obtained using a 
Photon Technology International QM-4 SE spectrofluorometer. Excitation wavelengths 
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were chosen based on λmax from the respective UV-vis absorption spectrum in the same 
solvent. Quantum yields were estimated relative to ruthenium tris(bipyridine) 
hexafluorophosphate by previously described methods and corrected for wavelength 
dependent detector sensitivity (Figure A2.33).[57-58] Elemental analyses (C, H, N) were 
carried out by Laboratoire d’Analyse Élémentaire de l’Université de Montréal, Montréal, 
QC, Canada. 
2.6.2 Electrochemical Methods  
Cyclic voltammetry experiments were performed with a Bioanalytical Systems Inc. (BASi) 
Epsilon potentiostat and analyzed using BASi Epsilon software. Electrochemical cells 
consisted of a three-electrode setup including a glassy carbon working electrode, platinum 
wire counter electrode, and silver wire pseudo reference electrode. Experiments were run 
at scan rates of 250 mV s−1 in degassed acetonitrile solutions of the analyte (~1 mM) and 
supporting electrolyte (0.1 M [nBu4N][PF6]. Cyclic voltammograms were referenced 
against an internal standard (~1 mM ferrocene) and corrected for internal cell resistance 
using the BASi Epsilon software.  
2.6.3 X-ray Crystallography Details  
Single crystals of complexes 2.13d−f and 2.13j−l suitable for X-ray diﬀraction studies 
were grown by slow evaporation of a concentrated solution of each compound in CH2Cl2. 
The samples were mounted on a MiTeGen polyimide micromount with a small amount of 
Paratone N oil. All X-ray measurements were made on a Bruker Kappa Axis Apex2 
diffractometer at a temperature of 110 K. The data collection strategy included a number 
of ω and φ scans which collected data over a range of angles, 2θ. The frame integration 
was performed using SAINT.[73] The resulting raw data was scaled and absorption 
corrected using a multi-scan averaging of symmetry equivalent data using SADABS.[74] 
The structures were solved by direct methods using the XS program.[75] All non-hydrogen 
atoms were obtained from the initial solution. The hydrogen atoms were introduced at 
idealized positions and were allowed to refine isotropically. The structural model was fit 
to the data using full matrix least-squares based on F2. The calculated structure factors 
included corrections for anomalous dispersion from the usual tabulation. The structure was 
refined using the SHELXL-2014 program from SHELXTL.[76] For complex 2.13f, a 
fractional dichloromethane solvent was present which could not be modelled reliably, so it 
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was treated with the squeeze procedure in Platon.[77] See Table 2.5 for additional 
crystallographic data. 
 
Table 2.5. X-ray diffraction data collection and refinement details for complexes 2.13d−f 
and 2.13j−l. 
 2.13d 2.13e 2.13f 2.13j 2.13k 2.13l 
Chemical 
Formula 
C21H19BF2N4 C22H18BF2N5 C22H21BF2N4O C14H10BF2N5 C16H9BF2N7 C16H14BF2N5O2 
FW (g 
mol−1) 
376.21 401.22 406.24 297.08 348.11 357.13 
Crystal 
Habit 
Red plate 
Green 
rectangular 
Red needle Red plate Red plate Purple needle 
Crystal 
System 
Monoclinic Monoclinic Triclinic Triclinic Monoclinic Orthorhombic 
Space 
Group 
P21/n P21/c P1̅ P1̅ P21/c P212121 
T (K) 113(2) 110 110 200 200 200 
λ (Å) 0.71073 0.71073 0.71073 0.71073 0.71073 0.71073 
a (Å) 9.7298(10) 16.818(7) 10.362(6) 9.1735(14) 17.220(9) 7.897(5) 
b (Å) 18.713(2) 16.188(5) 28.120(17) 9.573(2) 6.729(4) 19.905(9) 
c (Å) 10.3804(12) 7.257(3) 28.16(2) 16.289(4) 14.760(7) 20.920(10) 
α (deg) 90 90 117.075(13) 96.419(11) 90 90 
β (deg) 97.825(6) 99.220(18) 96.626(17) 93.695(10) 114.342(13) 90 
γ (deg) 90 90 98.667(16) 105.880(13) 90 90 
V (Å3) 1872.4(4) 1950.0(13) 7062(8) 1360.5(5) 1558.2(14) 3288(3) 
Z 4 4 12 2 4 8 
ρ (g/cm3) 1.335 1.367 1.146 1.450 1.484 1.443 
μ (cm1) 0.094 0.097 0.083 0.0 0.112 0.113 
R1,a wR2b 
[I > 2σ] 
0.0711, 
0.1511 
0.0599, 
0.1676 
0.0669, 
0.1625 
0.0416, 
0.1062 
0.0421, 
0.1072 
0.0447, 
0.0747 
R1, wR2 
(all data) 
0.2110, 
0.2048 
0.0826, 
0.1835 
0.1407, 
0.1849 
0.0699, 
0.1231 
0.0623, 
0.1200 
0.0971, 
0.0885 
GOFc 0.977 1.035 1.122 1.029 0.969 1.008 
aR1 = (|Fo||Fc|)/Fo, bwR2 = [(w(Fo2Fc2)2)/(wFo4)]½, cGOF = [(w(Fo2-Fc2)2)/(No. of 
reflns. - No. of params.)]½ 
 
Representative procedure: triarylformazan 2.8g  
In air, 4-cyanophenyl hydrazine hydrochloride (1.50 g, 8.80 
mmol) was dissolved in EtOH (15 mL) containing NEt3 (1.60 g, 
2.21 mL, 15.8 mmol). p-Tolualdehyde (1.06 g, 1.04 mL, 8.80 
mmol) was then added and the solution was stirred for 10 min. 
After this time, a light yellow precipitate had formed. CH2Cl2 
(50 mL) and water (50 mL) were added to form a biphasic reaction mixture. Sodium 
carbonate (3.17 g, 29.9 mmol) and [nBu4N][Br] (0.28 g, 0.88 mmol) were added, and the 
mixture was cooled in an ice bath to 0 °C. In a separate flask, p-anisidine (1.11 g, 9.00 
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mmol) and concentrated HCl (3.6 mL, 43.2 mmol) were mixed in water (20 mL), and 
cooled in an ice bath. A cooled solution of sodium nitrite (0.69 g, 10 mmol) was added 
slowly to the aniline solution. This mixture was stirred at 0 °C for 30 min, after which time 
it was added dropwise to the biphasic reaction mixture described above over 10 min. The 
resulting solution was stirred for 18 h, gradually turned dark red over this time. The dark 
red organic fraction was then washed with deionized water (3 x 50 mL), dried over MgSO4, 
gravity filtered and concentrated in vacuo. The resulting residue was purified by flash 
chromatography (dichloromethane, neutral alumina) to yield formazan 2.8g as a dark red 
microcrystalline solid. Yield = 2.40 g, 74%. Melting point = 154–156 °C. 1H NMR (599.5 
MHz, CDCl3) δ 14.26 (s, 1H, NH), 7.96 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.93 (d, 3JHH = 9 
Hz, 2H, aryl CH), 7.60 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.40 (d,
 3JHH = 8 Hz, 2H, aryl CH), 
7.26 (d, 3JHH =8 Hz, 2H, aryl CH), 7.06 (d,
 3JHH = 9 Hz, 2H, aryl CH), 3.93 (s, 3H, OCH3), 
2.42 (s, 3H, CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 163.4, 147.5, 146.9, 143.0, 138.6, 
133.8, 133.7, 129.3, 126.7, 124.8, 119.7, 114.9, 114.7, 104.7, 55.9, 21.5. FT-IR (KBr): 
3420 (s), 3067 (m), 2918 (m), 2841 (m), 2219 (m), 1603 (s), 1509 (s), 1257 (s), 1231 (m), 
1143 (m) cm1. UV-vis (toluene): λmax = 489 nm (ε = 28,300 M1 cm1). Mass Spec. (EI, 
+ve mode): exact mass calculated for [C22H19N5O]
+: 369.1590; exact mass found: 
369.1598; difference: +2.3 ppm. Anal. Calcd. (%) for C22H19N5O: C, 71.53; H, 5.18; N, 
18.96. Found: C, 71.43; H, 5.00; N, 18.76. 
Formazan 2.8h  
From 12.6 mmol of p-tolyl hydrazine hydrochloride/aldehyde: 
Yield = 3.74 g, 80%. Melting point = 156–158 ºC. 1H NMR (599.5 
MHz, CDCl3) δ 14.37 (s, 1H, NH), 8.02 (d, 3JHH = 9 Hz, 2H, aryl 
CH), 7.82 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.60 (d,
 3JHH = 9 Hz, 2H, 
aryl CH), 7.38 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.35 (d,
 3JHH =8 Hz, 
2H, aryl CH), 6.98 (d, 3JHH = 8 Hz, 2H, aryl CH), 3.88 (s, 3H, OCH3), 2.47 (s, 3H, CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 160.2, 150.4, 147.5, 143.3, 142.6, 133.7, 130.3, 
129.1, 128.1, 122.6, 119.7, 114.9, 114.0, 104.9, 55.5, 21.8. FT-IR (KBr): 3421 (s), 3003 
(m), 2935 (m), 2840 (m), 2219 (s), 1603 (s), 1508 (s), 1248 (s), 1228 (s), 1170 (s) cm1. 
UV-vis (toluene): λmax = 501 nm (ε = 16,800 M1 cm1). Mass Spec. (EI, +ve mode): exact 
mass calculated for [C22H19N5O]
+: 369.1590; exact mass found: 369.1592; difference: +0.7 
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ppm. Anal. Calcd. (%) for C22H19N5O: C, 71.53; H, 5.18; N, 18.96. Found: C, 71.95; H, 
5.17; N, 18.23. 
Formazan 2.8i  
From 12.6 mmol of p-tolyl hydrazine hydrochloride/aldehyde: 
Yield = 3.34 g, 72%. Melting point = 179–181 ºC. 1H NMR (599.5 
MHz, CDCl3) δ 15.61 (s, 1H, NH), 8.19 (d, 3JHH = 8 Hz, 2H, aryl 
CH), 7.76 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.66 (d,
 3JHH = 8 Hz, 2H, 
aryl CH), 7.38 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.20 (d,
 3JHH =8 Hz, 
2H, aryl CH), 7.01 (d, 3JHH = 9 Hz, 2H, aryl CH), 3.90 (s, 3H, OCH3), 2.37 (s, 3H, CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 161.4, 144.6, 142.2, 142.2, 138.7, 135.6, 132.1, 
130.1, 125.6, 122.6, 119.5, 116.6, 114.7, 110.0, 55.7, 21.1. FT-IR (KBr): 3411 (s), 3003 
(m), 2918 (m) 2841 (m), 2222 (s), 1603 (s), 1499 (s), 1248 (s), 1189 (m), 1145 (m) cm1. 
UV-vis (toluene): λmax = 506 nm (ε = 22,400 M1 cm1). Mass Spec. (EI, +ve mode): exact 
mass calculated for [C22H19N5O]
+: 369.1590; exact mass found: 369.1602; difference: +3.3 
ppm. Anal. Calcd. (%) for C22H19N5O: C, 71.53; H, 5.18; N, 18.96. Found: C, 71.63; H, 
5.14; N, 18.78. 
Representative procedure: 3-cyanoformazan 2.8k  
In air, cyanoacetic acid (0.85 g, 0.010 mol) was dissolved in 
deionized water (75 mL) containing NaOH (4.00 g, 0.100 mol).  
This colourless solution was stirred for 45 min in an ice bath. 
Meanwhile, 4-aminobenzonitrile (2.36 g, 0.020 mol) was mixed with concentrated HCl (5 
mL, 0.060 mol) in deionized water (30 mL). This solution was cooled in an ice bath for 10 
min before a solution of sodium nitrite (1.48 g, 0.021 mmol) in deionized water (15 mL) 
was cooled in an ice bath, and then added slowly to the 4-aminobenzonitrile solution over 
a ten min period. This mixture was stirred in an ice bath for 30 min, and then added slowly 
to the basic cyanoacetic acid solution. A dark red/orange colour persisted almost 
immediately and a dark red/orange precipitate formed after a few min. The mixture was 
stirred in an ice bath for an additional 6 h before ethyl acetate (250 mL) was added and the 
organic layer was isolated, then washed with deionized water (3  100 mL) and dried over 
MgSO4, gravity filtered and concentrated in vacuo. The resulting residue was purified by 
flash chromatography (CH2Cl2, neutral alumina) to yield 3-cyanoformazan 2.8k as a dark 
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orange solid. Yield = 2.63 g, 88%. Melting point = 230–240 ºC (dec.). 1H NMR (599.5 
MHz, d6-DMSO) δ 13.19 (s, 1H, NH), 8.01 (m, 4H, AB spin system aryl CH) 7.87 (m, 4H, 
AB spin system, aryl CH). 13C NMR (100.6 MHz, d6-DMSO): δ 149.5, 133.8, 120.7, 118.6, 
112.0, 110.4, 96.0. FT-IR (KBr): 3461 (s), 2224 (m), 2112 (m), 1653 (s), 1540 (m), 1256 
(s), 1169 (s) cm1. UV-vis (toluene): λmax 423 nm (ε = 25,300 M1 cm1). Mass Spec. (EI, 
+ve mode): exact mass calculated for C16H9N7: 299.0919; exact mass found: 299.0929; 
difference: +3.2 ppm. Anal. Calcd. (%) for C16H9N7: C, 64.21; H, 3.03; N, 32.76. Found: 
C, 63.98; H, 2.79; N, 31.74. 
Representative procedure: formazanate BF2 complex 2.13a  
In air, formazan 2.8a (1.00 g, 2.76 mmol) was dissolved in dry toluene 
(100 mL). NEt3 (0.84 g, 1.2 mL, 8.3 mmol) was then added slowly and 
the solution was stirred for 10 min. BF3•OEt2 (1.96 g, 1.73 mL, 13.8 
mmol) was then added by syringe, and the solution was heated at 80 ºC 
for 18 h. The solution gradually turned from dark red to dark purple 
during this time. After cooling to 20 ºC, deionized water (10 mL) was added to quench any 
excess reactive boron-containing compounds. The purple toluene solution was then washed 
with deionized water (3 x 50 mL), dried over MgSO4, gravity filtered and concentrated in 
vacuo. The resulting residue was purified by flash chromatography (CH2Cl2, neutral 
alumina) to yield the BF2 complex as a dark purple microcrystalline solid. Yield = 0.69 g, 
60%. 1H NMR (599.5 MHz, CDCl3) δ 8.01 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.91 (d, 3JHH = 
7 Hz, 4H, aryl CH), 7.47 (m, 6H, aryl CH), 7.30 (d, 3JHH = 8 Hz, 2H, aryl CH), 2.44 (s, 3H, 
CH3). These data were consistent with those reported by Otten and coworkers.
14 
Formazanate BF2 complex 2.13b  
From 2.83 mmol of formazan: Yield = 0.18 g, 16%. Melting point 
= 169–171 ºC. 1H NMR (599.5 MHz, CDCl3) δ 8.06 (d, 3JHH = 9 
Hz, 4H, aryl CH), 7.96 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.80 (d,
 
3JHH = 9 Hz, 4H, aryl CH), 7.32 (d,
 3JHH = 8 Hz, 2H, aryl CH), 
2.45 (s, 3H, CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 146.7, 
140.7, 133.3, 129.9, 129.7, 125.8, 123.9 (t, 4JCF = 3 Hz), 118.0, 113.5, 110.2, 21.6. 
11B 
NMR (128.3 MHz, CDCl3): δ –0.7 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –141.8 
(q, 1JFB = 29 Hz).
 FT-IR (KBr): 2949 (m), 2916 (m), 2847 (m), 2218 (s), 1650 (s), 1559 
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(m), 1507 (m), 1458 (m) cm1. UV-vis (toluene): λmax = 548 nm (ε = 20,500 M1 cm1). 
Mass Spec. (EI, +ve mode): exact mass calculated for [C22H15N6BF2]
+: 412.1419; exact 
mass found: 412.1408; difference: –2.7 ppm. Anal. Calcd. (%) for C22H15N6BF2: C, 64.10; 
H, 3.67; N, 20.39. Found: C, 64.38; H, 3.50; N, 20.08. 
Formazanate BF2 complex 2.13c  
From 2.67 mmol of formazan: Yield = 0.83 g, 74%. Melting 
point = 186–188 ºC. 1H NMR (599.5 MHz, CDCl3) δ 7.98 (d, 
3JHH = 8 Hz, 2H, aryl CH), 7.86 (d,
 3JHH = 9 Hz, 4H, aryl CH), 
7.26 (d, 3JHH = 8 Hz, 2H, aryl CH), 6.96 (d,
 3JHH = 9 Hz, 4H, 
aryl CH), 3.87 (s, 6H, OCH3), 2.42 (s, 3H, CH3). 
13C{1H} NMR 
(100.6 MHz, CDCl3): δ 160.8, 139.1, 137.8, 137.7, 131.4, 129.5, 125.5, 125.0 (t, 4JCF = 3 
Hz), 114.4, 55.8, 21.5. 11B NMR (128.3 MHz, CDCl3): δ –0.7 (t, 1JBF = 29 Hz). 19F NMR 
(376.1 Hz, CDCl3): δ –145.7 (q, 1JFB = 29 Hz). FT-IR (KBr): 3025 (m), 2918 (m), 2794 
(m), 1653 (s), 1559 (m), 1508 (s), 1458 (m) cm1. UV-vis (toluene): λmax = 552 nm (ε = 
28,200 M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C22H21N4O2BF2]
+: 422.1726; exact mass found: 422.1745; difference: +4.6 ppm. Anal. 
Calcd. (%) for C22H21N4O2BF2: C, 62.58; H, 5.01; N, 13.27. Found: C, 62.52; H, 5.10; N, 
12.56. 
Formazanate BF2 complex 2.13d  
From 3.04 mmol of formazan: Yield = 0.98 g, 84%. Melting point = 
154–156 ºC. 1H NMR (599.5 MHz, CDCl3) δ 8.10 (d, 3JHH = 7 Hz, 
2H, aryl CH), 7.80 (d, 3JHH = 8 Hz, 4H, aryl CH), 7.46 (m, 2H, aryl 
CH), 7.27 (d, 3JHH = 8 Hz, 4H, aryl CH), 2.42 (s, 6H, CH3). 
13C{1H} 
NMR (100.6 MHz, CDCl3): δ 141.9, 140.3, 134.0, 130.4, 129.8, 129.2, 128.8, 125.6, 123.4 
(t, 4JCF = 3 Hz), 21.5. 
11B NMR (128.3 MHz, CDCl3): δ –0.5 (t, 1JBF = 29 Hz). 19F NMR 
(376.1 Hz, CDCl3): δ –144.6 (q, 1JFB = 29 Hz). FT-IR (KBr): 2961 (m), 2873 (m), 1580 (s), 
1500 (m), 1458 (m), 1267 (m) cm1. UV-vis (toluene): λmax = 524 nm (ε = 30,300 M1 
cm1). Mass Spec. (EI, +ve mode): exact mass calculated for [C21H19N4BF2]
+: 376.1671; 
exact mass found: 376.1671; difference: –0.3 ppm. Anal. Calcd. (%) for C21H19N4BF2: C, 
67.04; H, 5.09; N, 14.89. Found: C, 67.85; H, 5.35; N, 14.87. 
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Formazanate BF2 complex 2.13e  
From 2.83 mmol of formazan: Yield = 0.80 g, 70%. Melting point = 
190–192 ºC. 1H NMR (599.5 MHz, CDCl3) δ 8.23 (d, 3JHH = 8 Hz, 
2H, aryl CH), 7.69 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.58 (d,
 3JHH = 8 
Hz, 4H, aryl CH), 7.27 (d, 3JHH = 8 Hz, 4H, aryl CH), 2.41 (s, 6H, 
CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 141.6, 140.9, 138.3, 
132.6, 130.2, 129.9, 125.6, 123.3 (t, 4JCF = 2 Hz), 118.9, 112.2, 21.4. 
11B NMR (128.3 
MHz, CDCl3): δ 3.8 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –143.1 (q, 1JFB = 29 
Hz). FT-IR (KBr): 3026 (m), 2914 (m), 2870 (m), 2222 (m), 1654 (s), 1559 (m), 1507 (s), 
1458 (m) cm1. UV-vis (toluene): λmax = 525 nm (ε = 25,300 M1 cm1). Mass Spec. (EI, 
+ve mode): exact mass calculated for [C22H18N5BF2]
+: 401.1623; exact mass found: 
401.1610; difference: –3.2 ppm. Anal. Calcd. (%) for C22H18N5BF2: C, 65.86; H, 4.52; N, 
17.46. Found: C, 66.42; H, 4.63; N, 17.61. 
Formazanate BF2 complex 2.13f  
From 2.78 mmol of formazan: Yield = 0.81 g, 72%. Melting point = 
166–168 ºC. 1H NMR (599.5 MHz, CDCl3) δ 8.03 (d, 3JHH = 9 Hz, 
2H, aryl CH), 7.78 (d, 3JHH = 9 Hz, 4H, aryl CH), 7.26 (d,
 3JHH = 9 
Hz, 4H, aryl CH), 6.99 (d, 3JHH = 9 Hz, 2H, aryl CH), 3.88 (s, 3H, 
OCH3), 2.41 (s, 6H, CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 
160.6, 141.7, 141.7, 140.0, 129.7, 126.9, 126.5, 123.3 (t, 4JCF = 3 Hz), 114.1, 55.4, 21.4. 
11B NMR (128.3 MHz, CDCl3): δ –0.6 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –
145.8 (q, 1JFB = 29 Hz).
 FT-IR (KBr): 3035 (m), 3027 (m), 2997 (m), 2951 (m), 2916 (m), 
2831 (m), 1605 (s), 1504 (m), 1455 (m) cm1. UV-vis (toluene): λmax = 544 nm (ε = 25,800 
M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for [C22H21N4OBF2]
+: 
406.1776; exact mass found: 406.1788; difference: +2.9 ppm. Anal. Calcd. (%) for 
C22H21N4OBF2: C, 65.04; H, 5.21; N, 13.79. Found: C, 64.79; H, 5.22; N, 13.58. 
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Formazanate BF2 complex 2.13g  
From 2.70 mmol of formazan: Yield = 0.82 g, 73%. Melting 
point = 151–153 ºC. 1H NMR (599.5 MHz, CDCl3) δ 7.98 (m, 
6H, aryl CH), 7.72 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.29 (d,
 3JHH 
= 8 Hz, 2H, aryl CH), 7.01 (d, 3JHH = 9 Hz, 2H, aryl CH), 3.90 
(s, 3H, OCH3), 2.43 (s, 3H, CH3). 
13C{1H} NMR (100.6 MHz, 
CDCl3): δ 162.3, 147.4, 139.9, 137.7, 133.1, 130.7, 129.7, 125.7 (t, 4JCF = 3 Hz), 125.7, 
123.1 (t, 4JCF = 3 Hz), 118.6, 114.9, 114.8, 111.3, 55.9, 21.5. 
11B NMR (128.3 MHz, 
CDCl3): δ –0.6 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –142.9 (q, 1JFB = 29 Hz). 
FT-IR (KBr): 3004 (m), 2985 (m), 2910 (m), 2834 (m), 2222 (s), 1596 (s), 1505 (s), 1295 
(m), 1254 (s), 1170 (m) cm1. UV-vis (toluene): λmax = 561 nm (ε = 24,400 M1 cm1). Mass 
Spec. (EI, +ve mode): exact mass calculated for [C22H18N5OBF2]
+: 417.1572; exact mass 
found: 417.1609; difference: +8.7 ppm. Anal. Calcd. (%) for C22H18N5OBF2: C, 63.33; H, 
4.35; N, 16.79 Found: C, 63.40; H, 4.43; N, 15.99. 
Formazanate BF2 complex 2.13h  
From 2.70 mmol of formazan: Yield = 1.03 g, 92%. Melting point 
= 154–156 ºC. 1H NMR (599.5 MHz, CDCl3) δ 8.02 (d, 3JHH = 9 
Hz, 2H, aryl CH), 7.99 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.84 (d,
 3JHH 
= 8 Hz, 2H, aryl CH), 7.74 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.31 (d,
 
3JHH =8 Hz, 2H, aryl CH), 7.01 (d,
 3JHH = 9 Hz, 2H, aryl CH), 3.89 
(s, 3H, OCH3), 2.44 (s, 3H, CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 161.2, 147.4, 
142.2, 141.9, 133.2, 130.2, 127.3, 125.9, 123.9 (t, 4JCF = 2 Hz), 123.4 (t, 
4JCF = 3 Hz), 
118.6, 114.5, 111.8, 111.1, 55.7, 21.7. 11B NMR (128.3 MHz, CDCl3): δ –0.7 (t, 1JBF = 29 
Hz). 19F NMR (376.1 Hz, CDCl3): δ –145.7 (q, 1JFB = 29 Hz). FT-IR (KBr): 3035 (m), 3026 
(m), 2998 (m), 2931 (m), 2835 (m), 2227 (s), 1603 (s), 1509 (s), 130 (m), 1248 (s), 1170 
(m) cm1. UV-vis (toluene): λmax = 554 nm (ε = 21,500 M1 cm1). Mass Spec. (EI, +ve 
mode): exact mass calculated for [C22H18N5OBF2]
+: 417.1572; exact mass found: 
417.1579; difference: +1.5 ppm. Anal. Calcd. (%) for C22H18N5OBF2: C, 63.33; H, 4.35; 
N, 16.79. Found: C, 63.35; H, 4.47; N, 15.98. 
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Formazanate BF2 complex 2.13i  
From 2.70 mmol of formazan, Yield = 0.62 g, 55%. Melting point 
= 172–174 ºC. 1H NMR (599.5 MHz, CDCl3) δ 8.21 (d, 3JHH = 8 
Hz, 2H, aryl CH), 7.89 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.78 (d,
 3JHH 
= 8 Hz, 2H, aryl CH), 7.74 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.28 (d,
 
3JHH = 8 Hz, 2H, aryl CH), 6.99 (d,
 3JHH = 9 Hz, 2H, aryl CH), 
3.89 (s, 3H, OCH3), 2.43 (s, 3H, CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 161.5, 140.7, 
140.6, 138.5, 137.5, 132.7, 130.0, 125.7, 125.3 (t, 4JCF = 3 Hz), 125.3, 123.3 (t, 
4JCF = 3 
Hz), 119.0, 114.7, 112.3, 55.9, 21.5. 11B NMR (128.3 MHz, CDCl3): δ –0.6 (t, 1JBF = 29 
Hz). 19F NMR (376.1 Hz, CDCl3): δ –143.4 (q, 1JFB = 29 Hz). FT-IR (KBr): 3035 (m), 3001 
(m), 2997 (m), 2911 (m), 2835 (m), 2227 (m), 1599 (s), 1507 (s), 1318 (m), 1256 (s), 1168 
(s) cm1. UV-vis (toluene): λmax = 541 nm (ε = 25,100 M1 cm1). Mass Spec. (EI, +ve 
mode): exact mass calculated for [C22H18N5OBF2]
+: 417.1572; exact mass found: 
417.1583; difference: +2.5 ppm. Anal. Calcd. (%) for C22H18N5OBF2: C, 63.33; H, 4.35; 
N, 16.79. Found: C, 64.33; H, 4.43; N, 16.76. 
Formazanate BF2 complex 2.13j  
From 4.00 mmol of formazan. Yield = 1.03 g, 87%. Melting point = 107–
109 °C. 1H NMR (599.5 MHz, CDCl3) δ 7.91-7.88 (m, 4H, aryl CH), 
7.50-7.48 (m, 6H, aryl CH). 13C{1H} NMR (100.6 MHz, CDCl3): δ 
143.1, 131.6, 129.6, 123.2 (t, 4JCF = 3 Hz), 119.6, 114.1. 
11B NMR (128.3 MHz, CDCl3): 
δ –0.8 (t, 1JBF = 30 Hz). 19F NMR (376.1 Hz, CDCl3): δ –133.6 (q, 1JFB = 30 Hz). FT-IR 
(KBr): 3267 (s), 3116 (m), 3074 (m), 2962 (m), 2928 (m), 2236 (s), 1587 (m), 1381 (s), 
1348 (s), 1148 (s), 1037 (s) cm1. UV-vis (toluene): λmax 502 nm (ε = 30,400 M1 cm1). 
Mass Spec. (EI, +ve mode): exact mass calculated for C14H10N5BF2: 297.0997; exact mass 
found: 297.1003; difference: +1.0 ppm. Anal. Calcd. (%) for C14H10 N5BF2: C, 56.60; H, 
3.39; N, 23.57. Found: C, 56.63; H, 3.39; N, 23.46. 
Formazanate BF2 complex 2.13k  
From 1.85 mmol of formazan. Yield = 0.55 g, 85%. Melting point 
= 212 – 214 °C. 1H NMR (399.8 MHz, CDCl3) δ 8.09 (d, 4H, 
3JHH = 9 Hz, aryl CH), 7.85 (d, 4H, 
3JHH = 9 Hz, aryl CH). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ 145.5, 133.7, 123.8, 123.7 (t, 4JCF = 3 Hz), 117.4, 
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115.5, 113.1. 11B NMR (128.3 MHz, CDCl3): δ –0.9 (t, 1JBF = 31 Hz). 19F NMR (376.1 
MHz, CDCl3): δ –129.6 (q, 1JFB = 31 Hz). FT-IR (KBr): 3245 (s), 2958 (m), 2914 (m), 
2849 (m), 2254 (m), 2228 (m), 1559 (m), 1332 (s), 1261 (m), 1154 (m) cm1. UV-vis 
(toluene): λmax 515 nm (ε = 35,500 M1 cm1). Mass Spec. (EI, +ve mode): exact mass 
calculated for C16H8N7BF2: 347.0902; exact mass found: 347.0906; difference: +0.9 ppm. 
Anal. Calcd. (%) for C16H8N7BF2: C, 55.37; H, 2.32; N, 28.25. Found: C, 55.66; H, 2.45; 
N, 27.60. 
Formazanate BF2 complex 2.13l  
From 3.20 mmol of formazan. Yield = 1.04 g, 91%. Melting 
point = 113–115 °C. 1H NMR (599.5 MHz, CDCl3) δ 7.87 (d, 
4H, 3JHH = 9 Hz, aryl CH), 6.98 (d, 4H, 
3JHH = 9 Hz, aryl CH), 
3.89 (s, 6H, OCH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 162.3, 137.1, 137.1, 125.1 (t, 
4JCF = 3 Hz), 115.0, 114.7, 56.0. 
11B NMR (128.3 MHz, CDCl3): δ –0.7 (t, 1JBF = 31 Hz). 
19F NMR (376.1 MHz, CDCl3): δ –135.4 (q, 1JFB = 31 Hz). FT-IR (KBr): 3397 (s), 3267 
(s), 2954 (m), 2926 (m), 2856 (m), 2240 (m), 1599 (s), 1506 (m), 1260 (s), 1165 (s) cm1. 
UV-vis (toluene): λmax 572 nm (ε = 42,700 M1 cm1). Mass Spec. (EI, +ve mode): exact 
mass calculated for C16H14N5O2BF2: 357.1209; exact mass found: 357.1205; difference: –
1.0 ppm. Anal. Calcd. (%) for C16H14N5O2BF2: C, 53.81; H, 3.95; N, 19.61. Found: C, 
54.31; H, 3.98; N, 19.03. 
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Chapter 3 
3 The Effect of Extended π Conjugation on the Properties 
of BF2 Formazanate Dyes 
Adapted from:  
1. Barbon, S. M.; Price, J. T.; Yogarajah, U.; Gilroy, J. B. RSC Adv. 2015, 5, 
56316−56324.  
2. Barbon, S. M.; Staroverov, V. N.; Gilroy J. B. J. Org. Chem. 2015, 80, 5226−5235.  
 
3.1 Introduction 
It has long been known that extended π conjugation has a drastic effect on the electronic 
properties and spectroscopic features of molecules containing aromatic π-systems. Perhaps 
the simplest molecules that demonstrate this behavior are benzene, naphthalene, and 
anthracene. In this series, as the extent of π conjugation increases,  so does the wavelength 
of maximum absorption, going from ~260 nm for benzene, to ~310 nm for naphthalene 
and ~375 nm for anthracene.[1] The emission quantum yields of these compounds follow 
the same trend, increasing from 5% in benzene to 19% and 27% in naphthalene and 
anthracene, respectively.[1] As the structures of π-conjugated molecules become 
increasingly complex, so do their electronic properties and utility in a variety of 
applications. π-Conjugated molecules are frequently employed in photovoltaic cells,[2] as 
luminescent materials,[3] in field-effect transistors,[4] and as materials exhibiting 
aggregation-induced emission.[5] For many of these applications, materials with maximum 
absorption/emission wavelengths in the far-red/near-IR regions of the electromagnetic 
spectrum are required. 
Amongst the most common hybrid conjugated molecular materials are boron difluoride 
(BF2) complexes of N,N-, O,O- and N,O-chelating ligands.
[3,6-18] Boron dipyrromethenes 
(BODIPYs) are by far the most common of this class of complexes.[19-21],[22-35] BODIPY 
3.1, which was first reported by Daub and co-workers in 1998, showed absorption and 
emission maxima around 500 nm, with an emission quantum yield of 60%.[36] Ono et al. 
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synthesized compound 3.2, which is structurally very similar to 3.1, but includes a greater 
degree of π-conjugation. The addition of two fused phenyl rings increased the wavelength 
of maximum absorption and emission by close to 100 nm, and the quantum yield to 91%.[37] 
Similarly, Fu's group has applied this strategy to their naphthyridine BF2 complexes 3.3 
and 3.4, and observed that by extending the conjugation of the naphthyridine ligand by a 
pyridine moiety, the solid-state fluorescence quantum yield increased by 20%, and the 
wavelength of maximum absorption and emission was red-shifted by more than 20 nm.[38] 
Piers et al. have modified the structure of anilido-pyridine ligands to study the properties 
of the BF2 complexes of both the parent anilido-pyridine complex 3.5 and the modified 
BF2 complex 3.6, which has a higher degree of π-conjugation. This modification nearly 
doubled the emission quantum yield from 33% to 60% and red-shifted the absorption and 
emission maxima by ca. 50 nm.[39]  
Another common strategy involves combining two or more BF2 dye moieties into a single 
molecule.[15,40] By fusing together two BODIPY units with benzene rings and effectively 
extending π conjugation, for example, in dimers 3.7 and 3.8, λem red-shifts significantly to 
940 nm (7)[41] and 712 nm (3.8).[42] BODIPY units have also been linked via para-benzene 
spacers, e.g. 3.9, whereby the wavelength of maximum emission was red-shifted relative 
to unlinked BODIPYs.[43] 
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In an effort to assess the effect of extended π-conjugation on the properties of BF2 
formazanate dyes, and taking advantage of the ease of structural variation of the 
formazanate backbone, we have synthesized a series of formazans 3.11a−k and BF2 
complexes 3.10a−k (Scheme 3.1, Table 3.1). We have systematically introduced naphthyl 
(Np) substituents at the 1, 3, and 5 positions of the formazanate backbone, as well as 
synthesized the first examples of boron difluoride formazanate dimers exhibiting 
conjugated and cross-conjugated electronic structures, as we work towards functional 
molecular materials based on formazanate ligands with optical properties in the far-
red/near-IR.  
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Scheme 3.1. Synthesis of BF2 formazanate complexes 3.10a−k. 
Table 3.1. Substituents for formazans 3.11a−k and BF2 formazanate complexes 3.10a−k. 
 Ar1 Ar5 R3 
a Ph Ph Ph 
b Ph Ph Np 
c Ph Np Ph 
d Np Np Ph 
e[44] Ph Ph CN 
f Np Np CN 
g Ph Ph NO2 
h Np Np NO2 
i[45] Ph Ph p-tolyl 
j Ph Ph 
p-BF2 complex of 1,3,5-
phenyl formazanate 
k Ph Ph  
m-BF2 complex of 1,3,5-
phenyl formazanate 
 
3.2 Results and Discussion 
3.2.1 Synthesis 
Triarylformazans 3.11a−d, 3-cyanoformazans 3.11e−f, 3-nitroformazans 3.11g−h, and 
meta- and para-substituted benzene bridged bisformazans 3.11j−k, were synthesized by 
adapting previously published protocols.[46-50] Formazanate BF2 complexes 3.10a−k were 
prepared by refluxing the parent formazans in toluene in the presence of excess NEt3 and 
BF3•OEt2 (Scheme 3.1).[44,51] Analysis by 1H, 11B, 13C, and 19F NMR spectroscopy (Figures 
3.1, A3.1–A3.30), mass spectrometry and IR spectroscopy confirmed the proposed 
structures of formazans 3.11a−k and BF2 complexes 3.10a−k. The BF2 complexes showed 
characteristic 1:2:1 triplets in the 11B NMR spectra (e.g. 3.10j: −0.5 ppm; 3.10k: −0.5 ppm) 
and 1:1:1:1 quartets in the 19F NMR spectra (e.g. 3.10j: −144.1 ppm; 3.10k: −143.8 ppm) 
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(Figure 3.1, insets). The aryl regions of the 1H NMR spectra differ slightly from that of the 
respective formazans and the disappearance of the resonances above 15 ppm indicate the 
loss of the NH protons. The bidentate coordination mode observed for the formazanate 
ligands was consistent with other complexes of boron[44-45,51-52] and transition metals.[53-61] 
 
 
Figure 3.1. 1H NMR spectra of 3.10j (left) and 3.10k (right) in CDCl3. 
19F and 11B NMR 
spectra are shown as insets.  
 
3.2.2 Naphthyl-Substituted BF2 Formazanate Complexes 
By comparing 1,3,5-triphenyl-substituted BF2 complex 3.10a with naphthyl-substituted 
complexes 3.10b−d, the effect of π-conjugation on the properties of BF2 triarylformazanate 
complexes was explored. Molar absorptivities associated with π→π* transitions in 
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3.10a−d ranged from 20,900−26,800 M−1 cm−1 in toluene. The replacement of one phenyl 
substituent for a naphthyl substituent in 3.10b (Ar1 = Ar5 = Ph, R3 = Np) and 3.10c (Ar1 = 
R3 = Ph, Ar5 = Np) caused a red-shift of maximum absorption (λmax) in toluene, from 517 
nm for 3.10a to 529 nm for 3.10b and 535 nm for 3.10c. The replacement of a second 
phenyl substituent in 3.10d (Ar1 = Ar5 = Np, R3 = Ph) resulted in a further red shift in λmax 
to 556 nm (Figure 3.2a, Table 3.2). In order to verify that the observed absorption 
properties were not simply due to the presence of a naphthyl group, the UV-vis absorption 
spectrum of 2-naphthylamine was recorded (λmax = 345 nm, Figure A3.31). Interestingly, 
when comparing compound 3.10b and 3.10c, which both have one naphthyl and two 
phenyl substituents (3.10b: R3 = Np, 3.10c: R5 = Np), 3.10c has a slightly longer 
wavelength of maximum absorption (529 vs. 535 nm).  
All four compounds are weakly emissive, with maximum emission (λem) observed between 
626 and 681 nm (Figures 3.2b, A3.32, A3.33, Table 3.2). The trend observed for the 
wavelengths of maximum absorption is mirrored here, with the λem of 3.10b−d red-shifted 
with respect to 3.10a. Quantum yields for all four complexes are below 5%. However, the 
observed Stokes shifts (νST) were large (3.10a, νST = 109 nm, 3368 cm−1; 3.10b, νST = 124 
nm, 3590 cm−1; 3.10c, νST = 124 nm, 3517 cm−1; 3.10d, νST = 125 nm, 3301 cm−1). 
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Figure 3.2. UV-vis absorption (a) and emission spectra (b) of 3.10a (black, Ar1 = Ar5 = R3 
= Ph), 3.10b (blue, Ar1 = Ar5 = Ph, R3 = Np), 3.10c (red, Ar1 = R3 = Ph, Ar5 = Np) and 
3.10d (green, Ar1 = Ar5 = Np, R3 = Ph). UV-vis absorption and emission spectra were 
recorded for 10−5 M degassed toluene solutions. 
 
Complexes 3.10a−d are electrochemically active, exhibiting two reversible one-electron 
reduction waves corresponding to the reversible formation of ligand-centered radical 
anions and dianions, (Figure 3.3, Table 3.2) and irreversible oxidation waves (Figure 
A3.34). The reduction potentials observed for 3.10a−d, become less negative (easier to 
reduce) as naphthyl substituents are introduced (3.10a, −0.82 and −1.89 V; 3.10b, −0.81 
and −1.88 V; 3.10c, −0.80 and −1.85 V; and 3.10d, −0.78 and −1.78 V). This trend is 
consistent with naphthyl substituents having stabilized LUMOs due to enhanced π-
conjugation when compared to phenyl substituents. A single naphthyl substituent at the 
1,5-position has a more drastic effect than the same substituent at the 3 position, as 3.10c 
is easier to reduce than 3.10b by approximately 13 mV.  
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Figure 3.3. Cyclic voltammograms of 3.10a (black), 3.10b (blue), 3.10c (red) and 3.10d 
(green), recorded at 100 mV s−1 in 1 mM MeCN solutions containing 0.1 M [nBu4N][PF6] 
as supporting electrolyte. L = redox-active formazanate ligand.  
 
The data collected for compounds 3.10a−d allows for the conclusion that extended π-
conjugation has an effect on the properties of BF2 formazanate complexes. Systematically 
extending π-conjugation increases the emission quantum yields, red-shifts the wavelengths 
of maximum absorption and emission, and raises the reduction potentials of the resulting 
compounds. It is noteworthy that these data also demonstrate that extending the π-
conjugation at the 3 position of the formazanate backbone has a less pronounced effect 
than similar structural modification at the 1,5-positions, which is consistent with the 
absorption data (see Section 3.2.4 below). 
 
 
 
 
 
 
76 
 
 
 
Table 3.2. Solution characterization data for BF2 complexes 3.10a−h, j and k. 
 Solvent λmax 
(nm) 
ε (M−1 
cm−1) 
λem 
(nm) 
ΦFa 
(%) 
νST 
(nm) 
νST 
(cm−1) 
Ered1
b 
(V) 
Ered2
b 
(V) 
3.10a 
THF 509 22,500 627 1 118 3697 
−0.82 −1.89 toluene 517 23,800 626 < 1 109 3368 
CH2Cl2 509 23,400 630 1 121 3773 
3.10b 
THF 522 22,000 658 1 136 3960 
−0.81 −1.88 toluene 529 20,900 653 < 1 124 3590 
CH2Cl2 524 20,300 656 9 132 3840 
3.10c 
THF 529 25,000 655 < 1 126 3636 
−0.80 −1.85 toluene 535 26,800 659 2 124 3517 
CH2Cl2 530 27,500 656 3 126 3624 
3.10d 
THF 550 22,900 680 2 130 3476 
−0.78 −1.78 toluene 556 25,200 681 5 125 3301 
CH2Cl2 551 23,600 682 < 1 131 3486 
3.10e[44] 
THF 489 25,400 585 5 96 3356 
−0.53 −1.68 toluene 502 30,400 586 15 84 2855 
CH2Cl2 491 34,600 584 9 93 3243 
3.10f 
THF 551 27,700 676 25 125 3356 
−0.49 −1.54 toluene 581 25,700 670 39 89 2286 
CH2Cl2 558 23,900 669 32 111 2973 
3.10g 
THF 487 21,000 585 3 98 3440 
−0.48 −1.61 toluene 505 26,000 590 5 85 2853 
CH2Cl2 488 29,200 587 3 99 3456 
3.10h 
THF 561 27,500 679 23 118 3098 
−0.45 −1.49 toluene 583 24,100 671 48 88 2250 
CH2Cl2 563 26,700 677 28 114 2991 
 THF 523 26,700 650 3 127 3736   
3.10j toluene 534 28,800 649 4 115 3318 −0.90 −1.78c 
 CH2Cl2 523 30,900 654 8 131 3830   
 THF 509 35,800 625 < 1 116 3646   
3.10k toluene 518 30,200 628 1 110 3381 −0.92 −1.82c 
 CH2Cl2 507 39,600 627 3 120 3775   
aQuantum yields were measured according to a published method using [Ru(bpy)3][PF6]2 
as a relative standard, and corrected for detector non-linearity (Figure A3.35).[62,63] bCyclic 
voltammetry experiments were conducted in MeCN (complexes 3.10a−3.10h) and CH2Cl2 
(3.10j, 3.10k) containing 1 mM analyte and 0.1 M [nBu4N][PF6] at a scan rate of 100 mV 
s−1. All voltammograms were referenced internally against the ferrocene/ferrocenium 
redox couple. cIrreversible reduction, cathodic peak potential reported. 
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3.2.3 3-Phenyl-, 3-Cyano-, and 3-Nitro-Substituted BF2 Formazanate 
Complexes 
The influence of cyano-, nitro-, and phenyl-substituents at the R3 position of the 
formazanate backbone on the properties of BF2 formazanate dyes was assessed through 
comparison of 1,5-diphenyl-substituted compounds 3.10a (R3 = Ph), 3.10e (R3 = CN), and 
3.10g (R3 = NO2). Single crystals of complex 3.10g were grown by slow evaporation of a 
concentrated CH2Cl2 solution (Figure 3.4). The solid-state structure of complex 3.10e has 
previously been published.[44] Attempts to crystallize complex 3.10a under a variety of 
conditions consistently resulted in weakly diffracting, multiply twinned crystals (likely due 
to the pseudo three-fold symmetry of 3.10a) unsuitable for X-ray diffraction studies. 
Therefore, complex 3.10i (Ar1 = Ar5 = Ph, R3 = p-tolyl), previously reported by the Otten 
group,[45] has been included for comparison as the structural metrics associated with the 
presence of a single p-tolyl substituent are not expected to differ significantly from those 
expected for complex 3.10a. All three BF2 complexes contain a four-coordinate boron 
centre in a distorted tetrahedron, which is slightly displaced from the plane of the 
formazanate backbone. It is also noteworthy that the formazanate backbone is delocalized 
in all three examples (Table 3.3) with CN and NN bonds in between typical single and 
double bonds for the respective atoms involved. Each complex possesses moderate degrees 
of twisting between the N-aryl substituents and the formazanate backbone (3.10e, 22.0° 
and 24.4°, 3.10g, 36.4° and 38.2° and 3.10i, 48.0° and 42.0°). Overall we can conclude that 
structurally, all three complexes are very similar, and the nature of the R3 substituent has 
little influence over the bond lengths and angles of the BF2 formazanate heterocycle (Table 
3.3). 
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Figure 3.4. a) Top view and b) side view of the solid-state structure of BF2 formazanate 
complex 3.10g. Thermal displacement ellipsoids are shown at 50% probability and 
hydrogen atoms have been omitted for clarity.  
 
Table 3.3. Selected bond lengths (Å) and angles (°) for 3.10e, 3.10g, 3.10i,[45] 3.10j and 
3.10k 
 3.10e 3.10ga 3.10ib,[45] 3.10j 3.10k 
N1-N2, N3-N4 
1.2900(15), 
1.2948(15) 
1.302(5), 
1.304(5) 
1.308(1), 
1.308(1) 
1.297(2), 
1.303(2) 
1.3026(18), 
1.3077(18) 
N5-N6, N7-N8 − − − 
1.305(2), 
1.302(2) 
1.3078(19), 
1.3130(19) 
C1-N2, C1-N4 
1.3408(17), 
1.3379(17) 
1.330(5), 
1.318(5) 
1.346(1), 
1.343(1) 
1.346(3), 
1.336(2) 
1.343(2), 
1.340(2) 
C20-N6,  
C20-N8 
− − − 
1.337(3), 
1.344(2) 
1.341(2), 
1.339(2) 
N1-B1, N3-B1 
1.5748(18), 
1.5771(17) 
1.576(6), 
1.563(6) 
1.559(2), 
1.552(2) 
1.562(3), 
1.556(3) 
1.559(2), 
1.553(2) 
N5-B2, N7-B2 − − − 
1.563(3),  
1.546(3) 
1.556(2), 
1.556(2) 
N2-C1-N4 129.33(12) 130.0(4) 124.2(1) 126.29(17) 126.24(15) 
N6-C20-N8 − − − 124.78(17) 124.37(15) 
C1-N2-N1,  
C1-N4-N3 
117.14(11), 
117.30(11) 
115.6(3), 
115.5(3) 
117.68(9), 
117.72(9) 
118.56(15), 
118.61(16) 
117.15(14), 
119.12(14) 
C20-N6-N5, 
C20-N8-N7 
− − − 
118.74(15), 
116.89(16) 
118.14(13), 
117.02(14) 
Boron 
displacementc 
0.192 0.456 0.500 0.159, 0.503 0.307, 0.577 
Dihedral 
anglesd 
18.7, 26.2 36.4, 38.2 48.0, 42.0 
25.05, 31.59, 
27.46, 49.88 
18.77, 38.96, 
40.44, 37.20 
Benzene bridge 
dihedral anglese 
− − − 10.46, 17.48 
8.79,  
12.04 
aThe second molecule in the unit cell of 3.10g has very similar structural metrics and is not 
reported here. bThe numbering convention for the structure previously reported by Otten 
and co-workers[45] has been modified for ease of comparison.  cDistance between B1 and 
N4 plane. 
dAngles between the plane defined by the N1 and N3 aryl substituents and the 
N4 plane. 
eAngles between the benzene bridge and the N4 plane. 
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As both cyano and nitro groups are strongly electron-withdrawing, complexes 3.10e (R3 = 
CN) and 3.10g (R3 = NO2) have similar spectroscopic and electrochemical properties, 
though they differ significantly when compared to complex 3.10a (R3 = Ar). All three 
complexes are strongly absorbing between 400 and 600 nm (π→π*), though their λmax 
range from 502 nm (3.10e) to 505 nm (3.10g) and 517 nm (3.10a) (Figures 3.5a, A3.36, 
A3.37, Table 3.2). Similarly, while all three phenyl-substituted complexes are fluorescent 
(Figure 3.5b, Table 3.2), the emission quantum yields vary dramatically (3.10a: λem = 626 
nm, ΦF = <1%, 3.10e: λem = 586 nm, ΦF = 15%, 3.10g: λem = 590 nm, ΦF = 5%). We assume 
that the difference in quantum yields is likely due to non-radiative decay pathways 
associated with the 3-phenyl substituent. While complex 3.10a has the lowest quantum 
yield, it has the highest Stokes shift (νST = 109 nm, or 3368 cm−1 in toluene), significantly 
higher than complexes 3.10e (νST = 84 nm, 2855 cm−1) and 3.10g (νST = 85 nm, 2853 cm−1). 
The electron-withdrawing nature of the R3 substituent has a significant effect on the 
electrochemical properties of BF2 formazanate complexes. Complex 3.10g (R
3 = NO2) is 
the easiest to reduce, with the first and second one-electron reductions occurring at −0.48 
V and −1.61 V vs. ferrocene/ferrocenium. Complex 3.10e (R3 = CN) is slightly more 
difficult to reduce at potentials of −0.53 V and −1.68 V. Finally, complex 3.10a (R3 = Ph), 
is substantially more difficult to reduce, with two one-electron reductions occurring at 
−0.82 V and −1.89 V (Figure A3.38, Table 3.2). As mentioned earlier, the properties of 
complexes bearing phenyl and naphthyl substituents at the 3-position of the formazanate 
backbone did not differ dramatically. We have also previously shown that the substitution 
of electron-donating and withdrawing groups introduced on aryl rings at the 3-position of 
the formazanate backbone did not significantly alter the properties of the resulting BF2 
complexes.[51] However, complexes 3.10a, 3.10e, and 3.10g clearly demonstrate that the 
same trend is not true for all substituents at the 3 position, as the properties of 3.10e (R3 = 
CN) and 3.10g (R3 = NO2) are drastically different than those of 3.10a (R
3 = Ph). This is 
likely due to the strong electron-withdrawing characteristics of the cyano and nitro 
substituents, and less related to the extent of π-conjugation in these complexes.  
By comparing naphthyl-substituted complexes 3.10d, 3.10f and 3.10h with phenyl-
substituted complexes 3.10a, 3.10e, and 3.10g, the effect of π-conjugation on the properties 
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of BF2 3-phenyl-, 3-cyano- and 3-nitro-formazanate complexes was studied. The 
wavelength of maximum absorption of naphthyl substituted complexes 3.10d (R3 = Ph), 
3.10f (R3 = CN) and 3.10h (R3 = NO2) were red-shifted (relative to the phenyl-substituted 
analogs 3.10a [R3 = Ph], 3.10e [R3 = CN] and 3.10g [R3 = NO2]), from 502 to 581 nm for 
complex 3.10f (R3 = CN), from 505 to 583 nm for complex 3.10h (R3 = NO2), and from 
517 to 556 nm for complex 3.10d (R3 = Ph) (Figure 3.5c, Table 3.2). While in all three 
cases the observed trend was the same, the magnitude of the red-shift upon replacement of 
two phenyl substituents with two naphthyl substituents was much greater for complexes 
with strongly electron withdrawing R3 substituents [Δλmax = 79 nm, 2709 cm−1 (R3 = CN); 
Δλmax = 78 nm, 2649 cm−1 (R3 = NO2); Δλmax = 39 nm, 1357 cm−1 (R3 = Ph)].  
The emission spectra of complexes 3.10d, 3.10f and 3.10h (Figure 3.5d, Table 3.2) were 
also red-shifted with respect to the phenyl-substituted analogs, with λem of 681 nm (3.10d), 
670 nm (3.10f) and 671 nm (3.10g) in toluene. The emission quantum yields of these three 
complexes were significantly higher than the quantum yields of the phenyl-substituted 
complexes. The addition of the naphthyl substituent increases the emission quantum yield 
for 3.10d to 5% (from < 1% in complex 3.10a), for 3.10f to 39% (from 15% in complex 
3.10e) and for 3.10h to 48% (from 5% in complex 3.10g). The Stokes shifts observed for 
the 3-cyano- and 3-nitro-substituted complexes were smaller than those of 3-phenyl 
substituted complexes. All complexes with R3 = cyano or nitro have Stokes shifts ranging 
from 84−89 nm in toluene (2250–2855 cm−1), while those with R3 = Ph, have generally 
larger Stokes shifts, from 109−125 nm in toluene (3368–3590 cm−1).  
The cyclic voltammograms of complexes 3.10d, 3.10f and 3.10h demonstrate that the more 
electron-deficient complexes 3.10f and 3.10h are significantly easier to reduce (by almost 
300 mV) than complex 3.10d (Figure 3.6, Table 3.2). In all three examples, the reduction 
potential of the naphthyl-substituted complexes was 30–45 mV higher than the phenyl-
substituted analogs. Complexes 3.10f, 3.10g and 3.10h also underwent irreversible 
oxidation within the electrochemical window of the solvent (CH3CN) (Figure A3.39). 
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Figure 3.5. UV-vis absorption spectra (a) and emission spectra (b) of 3.10a (black, Ar1 = 
Ar5 = R3 = Ph), 3.10e (red, Ar1 = Ar5 = Ph, R3 = CN) and 3.10g (blue, Ar1 = Ar5 = Ph, R3 
= NO2). UV-vis absorption spectra (c) and emission spectra (d) of 3.10d (green, Ar
1 = Ar5 
= Np, R3 = Ph), 3.10f (purple, Ar1 = Ar5 = Np, R3 = CN) and 3.10h (orange, Ar1 = Ar5 = 
Np, R3 = NO2). All UV-vis absorption and emission spectra were recorded for 10−
5 M 
degassed toluene solutions. 
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Figure 3.6. Cyclic voltammograms of 3.10d (green), 3.10f (purple) and 3.10h (orange) 
recorded at 100 mV s−1 in 1 mM acetonitrile solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte. 
 
3.2.4 Electronic Structure Calculations 
In an attempt to rationalize the trends observed, we calculated the highest occupied and 
lowest unoccupied molecular orbitals (HOMOs and LUMOs) of 3.10a, 3.10e, and 3.10g 
(Figure 3.7 and Table 3.4) with the Gaussian 09 program[64] using the M06 density 
functional[65] and the 6-311+G* basis set, in vacuum and in toluene solution. The Kohn–
Sham molecular orbitals of 3.10a, 3.10e and 3.10g were computed for the corresponding 
optimized molecular structures. The UltraFine integration grid was employed in all 
calculations. Solvation effects were treated implicitly using the polarizable continuum 
model (SCRF=PCM). All optimized structures of 3.10a, 3.10e and 3.10g have Cs symmetry 
and were confirmed by vibrational analysis to be minima on the potential energy surface, 
both in vacuum and in toluene solution (see Appendix A3 for further details). 
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Figure 3.7. HOMOs and LUMOs for BF2 complexes 3.10a (Ar
1 = Ar5 = R3 = Ph), 3.10e 
(Ar1 = Ar5 = Ph, R3 = CN) and 3.10g (Ar1 = Ar5 = Ph, R3 = NO2) calculated in toluene 
solution. 
 
Table 3.4. HOMO/LUMO energies for BF2 complexes 3.10a (Ar
1 = Ar5 = R3 = Ph), 3.10e 
(Ar1 = Ar5 = Ph, R3 = CN) and 3.10g (Ar1 = Ar5 = Ph, R3 = NO2) in vacuum and toluene 
solution calculated at the M06/6311+G* level of theory using the SCRF method. 
Compound HOMO (eV) LUMO (eV) 
HOMO-LUMO 
Gap (eV) 
HOMO-LUMO  
Gap (nm) 
Vacuum 
3.10a 6.38 3.25 3.13 397 
3.10e 7.12 3.79 3.34 372 
3.10g 7.24 3.85 3.39 366 
 
Toluene Solution 
3.10a 6.45 3.30 3.15 393 
3.10e 7.12 3.76 3.36 369 
3.10g 7.23 3.83 3.40 365 
 
The calculated LUMOs for complexes 3.10a, 3.10e and 3.10g are highly delocalized over 
the formazanate backbone and N-aryl substituents, but do not extend over the 3-
substituents. By contrast, the HOMOs are delocalized over both the N-aryl and 3-
substituents (Ph, CN and NO2). The electrochemical reduction of complexes 3.10a, 3.10e, 
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and 3.10g should primarily involve the LUMOs of each complex. Based solely on the shape 
of the calculated frontier orbitals, the reduction potentials for each compound should be 
similar. However, due to the differing electron-withdrawing characteristics of the 3-
subsituents, the experimentally determined reduction potentials varied significantly. The 
observed trend in the first and second reduction potentials (Ered1 and Ered2), which involve 
stepwise population of the LUMO, was consistent with the trend in computed LUMO 
energies (LUMO) in toluene solution: 3.10g (3.83 eV) < 3.10e (3.76 eV) < 3.10a (3.30 
eV). The finding that the LUMOs do not extend over the 3-substituent is also consistent 
with the fact that the reduction potentials observed for 1,5-diphenyl-substituted complexes 
3.10a (R3 = Ph) and 3.10b (R3 = Np) are similar. The small difference in these potentials 
may be attributed to the subtle difference in the electron-withdrawing nature of phenyl and 
naphthyl substituents. 
The absorption and emission properties of BF2 formazanate complexes 3.10a, 3.10e and 
3.10g varied significantly and involve both the HOMO and LUMO orbitals. The 
HOMO/LUMO for 3.10a (R3 = Ph) were significantly higher in energy than those found 
for complexes 3.10e and 3.10g (R3 = CN and NO2, respectively). This is a result of 
destabilization of the HOMO, due to the extended -conjugation associated with the 3-
phenyl substituent, which leads to a decrease in the HOMO/LUMO gap, red-shifting of its 
absorption and emission spectra relative to 3.10e and 3.10g. Although one cannot expect 
quantitative agreement between HOMO-LUMO gaps and lowest electronic excitation 
energies, we note that the observed trends in max and em are consistent with the trends in 
calculated HOMO-LUMO gaps in toluene [3.10a (393 nm) > 3.10e (369 nm)  3.10g (365 
nm)].  
3.2.5 Benzene-Bridged BF2 Formazanate Complexes 
Single crystals of dimers 3.10j and 3.10k suitable for X-ray diffraction studies were grown 
by slow evaporation of concentrated CH2Cl2 solution (Figure 3.8, Table 3.3). In both solid-
state structures, the formazanate-benzene-formazanate π frameworks are relatively planar 
with angles between the benzene bridge and formazanate planes of 10.46° and 17.48° in 
3.10j and 8.79° and 12.04° in 3.10k. This planarity renders these compounds the perfect 
platform for probing electronic communication through meta- and para- benzene spacers. 
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The N-phenyl substituents are moderately twisted in each structure with dihedral angles of 
25.05−49.88° (3.10j) and 18.77−40.44° (3.10k) relative to the nearest formazanate moiety. 
The twisting is most likely the result of crystal packing effects. We also note that the 
formazanate backbones are delocalized with all N-N, C-N and C-C bonds falling between 
the typical single and double bond lengths for the respective atoms involved. The C-C bond 
lengths in the benzene bridges of 3.10j and 3.10k are between 1.375(3) Å and 1.397(3) Å, 
and are similar to other aromatic C-C bonds. For both dimers 3.10j and 3.10k, one of the 
two BF2 formazanate moieties exists in a relatively planar conformation and the other in a 
‘dragonfly’ conformation where the boron atom is displaced from the formazanate plane 
by more than 0.5 Å. We have previously reported that these two conformations differ in 
energy by only a few kcal/mol.[44] 
 
Figure 3.8. a,c) Top view and b,d) side view of the solid-state structure of BF2 formazanate 
dimers 3.10j and 3.10k. Thermal displacement ellipsoids are shown at 50% probability and 
hydrogen atoms have been omitted for clarity. Only one of two very similar molecules in 
the asymmetric unit for 3.10j is shown.  
 
Qualitatively, meta-substituted bridged dimer 3.10k and triphenyl BF2 complex 3.10a have 
very similar absorption and emission spectra. In CH2Cl2, 3.10k has a wavelength of 
maximum absorption of 507 nm, which is very similar to that of 3.10a (Ar1 = R3 = Ar5 = 
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Ph, λmax = 509 nm). 3.10a is highly absorbing, with a molar absorptivity (ε) of 23,400 M−1 
cm−1, while 3.10k has molar absorptivity of nearly double that, at 39,600 M−1 cm−1 due to 
the presence of two boron difluoride formazanate moieties. In comparison, para-
substituted bridged complex 3.10j has a higher wavelength of maximum absorption of 523 
nm in CH2Cl2 and is strongly absorbing (ε = 30,900 M−1 cm−1) (Figure 3.9, Table 3.2).  
BF2 complexes 3.10j and 3.10k are weakly emissive, with wavelengths of maximum 
emission of 654 and 627 nm and modest emission quantum yields of 8% and 3%, 
respectively. Each compound exhibits a large Stokes shift, ranging from 120 to 131 nm 
(3773–3830 cm−1). It is noteworthy that the emission quantum yields increase for the 
dimers, relative to triphenyl ‘monomer’ 3.10a. It has been shown that the emission 
quantum yield of para-benzene bridged BODIPY dimers 3.9 is significantly reduced 
relative to phenyl-substituted monomer 3.7.[66] A major factor contributing to the decreased 
emission intensity in BODIPY dimer 3.9 is the small Stokes shifts observed for the 
monomeric units (νST = 25 nm, 906 cm−1), which leads to reabsorption of emitted photons 
by the fluorophore in close proximity within the dimer framework. In the case of dimers 
3.10j and 3.10k, the large Stokes shifts result in minimal overlap between absorption and 
emission bands and limit reabsorption of emitted photons by the dimer pairs.  
 
Figure 3.9. UV-vis absorption spectra (dashed) and emission spectra (solid) of a) 3.10j 
and b) 3.10k, recorded in 10−5 M degassed toluene solutions.  
 
Due to the poor solubility of compounds 3.10j and 3.10k in CH3CN, CH2Cl2 was used for 
the cyclic voltammetry studies. The cyclic voltammograms of compounds 3.10a, 3.10j and 
3.10k in CH2Cl2 are shown in Figure 3.10. BF2 formazanate dimers 3.10j and 3.10k each 
undergo reversible electrochemical reduction at Ered1 = −0.90 V (3.10j) and −0.92 V 
(3.10k) corresponding to the transfer of two electrons (Figure 3.10, Table 3.2). Both dimers 
undergo a second irreversible electrochemical reduction at a cathodic peak potential (Epc), 
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Epc,red2 = −1.78 V (3.10j) and −1.89 V (3.10k) also consistent with a two-electron transfer. 
The first reversible reduction of dimers 3.10j and 3.10k corresponds to the formation of 
the bis-radical anion form of the dimer, as depicted in Scheme 3.2. The second reduction 
of compounds 3.10j and 3.10k corresponds to the bis-radical anions being transformed into 
bis-dianions. Monomer 3.10a displayed similar electrochemical properties (Ered1 = −0.93 
V and Epc, red2 = −1.84 V in CH2Cl2), with each reduction corresponding to transfer of a 
single electron. We have previously shown that the electrochemical properties of 
monomeric BF2 formazanate complexes are sensitive to the presence of electron-
withdrawing and electron-donating carbon substituents.[44,51] We therefore attribute the 
relative ease of reduction (less negative potentials) associated with 3.10j to the electron 
withdrawing nature of the BF2 formazanate moieties, which is enhanced in the para-
substituted dimer.   
The second reduction waves for 3.10j, 3.10k and 3.10a were not reversible in CH2Cl2, 
despite the second reduction of monomer 3.10a being fully reversible in CH3CN. The 
anodic peak current associated with the second reduction wave increased as the scan rate 
increased (Figures A3.40−A3.42), indicating that the irreversibility may arise due to a 
competing chemical reaction, which oxidizes the bis-dianions to bis-radical anions. 
Initially, we considered the possibility that the electrogenerated bis-dianions could undergo 
a comproportionation (e.g., LBF2
2− + LBF2 → 2 LBF2
•−) reaction with neutral BF2 
complexes to generate two equivalents of bis-radical anions. However, based on the 
symmetry of the anodic and cathodic peak currents associated with the first reduction, we 
do not feel that this is the case. We conclude that the electrogenerated dianions are oxidized 
back to their radical anion forms within the electrochemical cell, although the identity of 
the oxidant remains elusive.  
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Figure 3.10. Cyclic voltammograms of 3.10j (grey), 3.10k (pink) and 3.10a (black) 
recorded at 100 mV s−1 in 1 mM CH2Cl2 solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte.  
 
Due to the broad appearance of the reduction peaks in the cyclic voltammograms of dimers 
3.10j and 3.10k relative to monomer 3.10a we believe each process involves two distinct 
one-electron reductions (one electron for each of the BF2 formazanate moieties). However, 
we were unable to resolve each wave, even when square wave or differential pulse 
voltammetry techniques were employed. All three complexes also undergo irreversible 
electrochemical oxidation within the solvent window (Figure A3.43).  
 
Scheme 3.2. Electrochemical/chemical reactions for 3.10j and 3.10k. 
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Closely related benzene-bridged diradicals 3.12a and 3.12b have been shown to undergo 
reversible electrochemical oxidation and reduction to their closed shell bis-cation and bis-
anion forms. In these systems, electrochemical reduction occurred in two well-resolved 
steps, which supports the interpretation of our results.  
 
3.3 Conclusion 
In conclusion, we have described the synthesis and characterization of eight BF2 
formazanate complexes and two BF2 formazanate dimers allowing us to systematically 
assess the effect of extended π-conjugation on the spectroscopic and electrochemical 
properties of BF2 formazanate complexes. In general, extending the π-conjugation of 
complexes by replacing phenyl substituents with naphthyl substituents increased 
fluorescence quantum yields, increased (less negative) reduction potentials and red-shifted 
the wavelengths of maximum absorption and emission. We have also demonstrated that 
the differences in properties between BF2 complexes of 3-aryl-, cyano- and nitro-
formazans relate primarily to the electron-withdrawing nature of the 3-substituents (NO2 > 
CN >> Ph). The complexes of 3-cyano and 3-nitro formazans have significantly increased 
emission quantum yields, and their properties are very sensitive to extension of their π-
systems. The electrochemical properties of the dimers were closely related to those of the 
triphenyl monomer. In contrast, the para-substituted dimer exhibited optical properties 
consistent with extended π conjugation, including a red-shift in the wavelength of 
maximum absorption and emission, and an increase in emission quantum yield. The meta-
substituted dimer displayed characteristics consistent with a cross-conjugated electronic 
structure and essentially behaved as two independent BF2 formazanate moieties.  
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3.4 Experimental Section 
3.4.1 General Considerations 
Reactions and manipulations were carried out under a nitrogen atmosphere using standard 
Schlenk techniques unless otherwise stated. Solvents were obtained from Caledon 
Laboratories, dried using an Innovative Technologies Inc. solvent purification system, 
collected under vacuum, and stored under a nitrogen atmosphere over 4 Å molecular sieves. 
The synthesis and characterization of formazans 3.11a,[48] 3.11e, 3.11g,[49] 3.11j and 
3.11k[50] and BF2 complex 3.10e
[44] have been reported previously. The details of the 
synthesis and characterization of formazans 3.11j and 3.11k were limited, and so we have 
therefore included full experimental details for these compounds. 
NMR Spectra were recorded on a 400 MHz (1H: 399.8 MHz, 11B: 128.3 MHz, 19F: 376.1 
MHz) or 600 MHz (1H: 599.5 MHz, 13C: 150.8 MHz) instrument. 1H NMR spectra were 
referenced to residual CHCl3 (7.26 ppm) or DMSO-d5 (2.50 ppm) and 
13C NMR spectra 
were referenced to CDCl3 (77.2 ppm), CD2Cl2 (53.8 ppm) or DMSO-d6 (39.5 ppm). 
11B 
spectra were referenced to BF3·OEt2 at 0 ppm, and 
19F spectra were referenced to CFCl3 at 
0 ppm. Mass spectrometry data were recorded in positive-ion mode using electron impact 
ionization and electrospray ionization. UV-vis absorption data were recorded using a Cary 
300 Scan instrument. Four separate concentrations were run for each sample and molar 
extinction coefficients were determined from the slope of a plot of absorbance against 
concentration. Infrared spectra were recorded on a KBr disk using a Bruker Vector 33 FT-
IR spectrometer. Emission spectra were obtained using a Photon Technology International 
QM-4 SE spectrofluorometer. Excitation wavelengths for the emission spectra were chosen 
based on λmax from the respective UV-vis absorption spectrum in the same solvent. 
Emission quantum yields were estimated relative to ruthenium tris(bipyridine) 
hexafluorophosphate by previously described methods and corrected for wavelength 
dependent detector sensitivity (Figure A3.35).[62-63]  
3.4.2 Electrochemical Methods  
Cyclic voltammetry experiments were performed with a Bioanalytical Systems Inc. (BASi) 
Epsilon potentiostat and analyzed using BASi Epsilon software. Electrochemical cells 
consisted of a three-electrode setup including a glassy carbon working electrode, platinum 
wire counter electrode, and silver wire pseudo reference electrode. Experiments were run 
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at various scan rates (100−2000 mV s−1) in degassed CH3CN or CH2Cl2 solutions of the 
analyte (~1 mM) and supporting electrolyte (0.1 M [nBu4N][PF6]). Cyclic voltammograms 
were referenced against an internal standard (~1 mM ferrocene) and corrected for internal 
cell resistance using the software.  
3.4.3 X-ray Crystallography Details  
Single crystals of complex 3.10g, 3.10j and 3.10k suitable for X-ray diﬀraction studies 
were grown by slow evaporation of a concentrated CH2Cl2 solutions. The samples were 
mounted on MiTeGen polyimide micromounts with a small amount of Paratone N oil. X-
ray measurements were made on a Nonius KappaCCD Apex2 (3.10j) or Bruker Kappa 
Axis Apex2 (3.10g, 3.10k) at a temperature of 110 K. The data collection strategy included 
a number of ω and φ scans which collected data over a range of angles, 2θ. The frame 
integration was performed using SAINT.[67] The resulting raw data was scaled and 
absorption corrected using a multi-scan averaging of symmetry equivalent data using 
SADABS.[68] The structures were solved by direct methods using the XS program 
(3.10g)[69] or dual space methodology using the SHELXT program (3.10j, 3.10k).[70] Non-
hydrogen atoms were obtained from the initial solution. The hydrogen atoms were 
introduced at idealized positions and were allowed to refine isotropically. The structural 
model was fit to the data using full matrix least-squares based on F2. The calculated 
structure factors included corrections for anomalous dispersion from the usual tabulation. 
The structure was refined using the SHELXL-2014 program from the SHELX suite of 
crystallographic software.[71] See Table 3.5 for additional crystallographic data. 
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Table 3.5. X-ray diffraction data collection and refinement details for BF2 complexes 
3.10g, 3.10j and 3.10k. 
 3.10g 3.10j 3.10k 
Chemical Formula C13.50H11BClF2N5O2 C24H18B1.50F3N6 C32H24B2F4N8 
FW (g mol−1) 359.53 463.66 618.21 
Crystal Habit Red Prism Red Prism Red Plate 
Crystal System Monoclinic Triclinic Monoclinic 
Space Group P21/n P1̅ C2/c 
T (K) 110 110 110 
λ (Å) 0.71073 1.54178 0.71073 
a (Å) 9.555(8) 11.492(2) 18.424(7) 
b (Å) 17.226(11) 14.163(3) 17.935(7) 
c (Å) 18.840(14) 15.253(3) 18.574(6) 
α (deg) 90 65.150(6) 90 
β (deg) 98.070(13) 69.157(9) 110.646(10) 
γ (deg) 90 82.705(8) 90 
V (Å3) 3070(4) 2104.6(7) 5743(4) 
Z 8 4 8 
ρ (g/cm3) 1.556 1.463 1.430 
μ (cm1) 0.290 0.905 0.106 
R1,
a wR2
b [I > 2σ] 0.0588, 0.1730 0.0427, 0.1064 0.0460, 0.0912 
R1, wR2 (all data) 0.0811, 0.1901 0.0604, 0.1181 0.0932, 0.1079 
GOFc 1.025 1.020 1.018 
aR1 = (|Fo||Fc|)/Fo, bwR2 = [(w(Fo2Fc2)2)/(wFo4)]½, c GOF = [(w(Fo2-Fc2)2)/(No. of 
reflns. - No. of params.)]½ 
 
Representative procedure for the preparation of formazans 3.11b and 3.11c:  
Formazan 3.11b 
In air, phenyl hydrazine (0.69 g, 0.63 mL, 6.4 mmol) was dissolved in 
EtOH (15 mL). 2-Naphthylaldehyde (1.00 g, 6.40 mmol) was then added 
and the solution was stirred for 10 min. After this time, a light yellow 
precipitate had formed. CH2Cl2 (50 mL) and water (50 mL) were added 
to form a biphasic reaction mixture. Na2CO3 (2.17 g, 20.5 mmol) and 
[nBu4N][Br] (0.21 g, 0.64 mmol) were added, and the mixture was cooled in an ice bath to 
0 °C. In a separate flask, aniline (0.60 g, 6.4 mmol) and concentrated HCl (1.6 mL) were 
mixed in water (15 mL), and cooled in an ice bath. A cooled solution of sodium nitrite 
(0.51 g, 7.4 mmol) in water (5 mL) was added slowly to the amine solution. This mixture 
was stirred at 0 °C for 30 min, after which time it was added dropwise to the biphasic 
reaction mixture described above over 10 min. The resulting solution was stirred for 18 h, 
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which gradually turned dark red over this time. The dark red organic fraction was then 
washed with deionized water (3 x 50 mL), dried over MgSO4, gravity filtered and 
concentrated in vacuo. The resulting residue was purified by flash chromatography 
(CH2Cl2, neutral alumina) to afford formazan 3.11b as a dark red microcrystalline solid. 
Yield = 1.11 g, 50%. Melting point = 124–126 °C. 1H NMR (599.5 MHz, CDCl3) δ 15.49 
(s, 1H, NH), 8.62 (s, 1H, aryl CH), 8.29–8.28 (m, 1H, aryl CH), 7.95–7.87 (m, 3H, aryl 
CH), 7.74 (d, 3JHH = 8 Hz, 4H, aryl CH), 7.52–7.48 (m, 6H, aryl CH), 7.33–7.30 (m, 2H, 
aryl CH). 13C{1H} NMR (100.6 MHz, CDCl3): δ 148.0, 141.1, 135.0, 133.7, 133.1, 129.5, 
128.6, 128.0, 127.7, 127.6, 126.1, 125.9, 124.7, 124.1, 118.9. FT-IR (KBr): 3267 (br, s), 
3055 (s), 026 (m), 2915 (m), 2846 (m), 1598 (s), 1501 (s), 1453 (m), 1348 (m), 1253 (s), 
1226 (s) cm1. UV-vis (toluene): λmax = 498 nm (ε = 10, 100 M1 cm1). Mass Spec. (EI, 
+ve mode): exact mass calculated for [C23H18N4]
+: 350.1532; exact mass found: 350.1537; 
difference: +1.6 ppm.  
Formazan 3.11c 
In air, from 6.98 mmol of hydrazine/aldehyde: Yield = 2.24 g, 92%. 
Melting point = 140–142 °C. 1H NMR (400.1 MHz, CDCl3) δ 15.56 
(s, 1H, NH), 8.21 (d, 3JHH = 7 Hz, 2H, aryl CH), 8.04 (s, 1H, aryl 
CH), 7.93–7.88 (m, 3H, aryl CH), 7.85–7.83 (m, 1H, aryl CH), 7.69 
(d, 3JHH = 8 Hz, 2H, aryl CH), 7.56–7.47 (m, 6H, aryl CH), 7.43–7.40 (m, 1H, aryl CH), 
7.31–7.28 (m, 1H, aryl CH). 13C{1H} NMR (100.6 MHz, CDCl3): δ 147.4, 146.4, 141.4, 
137.6, 134.0, 133.3, 129.6, 129.5, 128.5, 128.5, 128.1, 127.8, 127.1, 127.0, 126.5, 126.0, 
120.1, 118.5, 116.5.  FT-IR (KBr): 3242 (br, s), 3050 (m), 3021 (m), 2915 (m), 2847 (m), 
1597 (m), 1515 (m), 1494 (s), 1445 (m), 1348 (m), 1227 (s) cm1. UV-vis (toluene): λmax 
= 508 nm (ε = 16, 500 M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C23H18N4]
+: 350.1532; exact mass found: 350.1537; difference: +1.6 ppm.  
Formazan 3.11d 
In air, phenylpyruvic acid (0.51 g, 3.1 mmol) was dissolved in 
150 mL deionized water with NaOH (0.94 g, 23 mmol), and 
cooled in an ice bath for 30 min. In a separate flask, 2-
naphthylamine (1.00 g, 6.98 mmol) and concentrated HCl (1.7 
mL) were mixed in water (15 mL), and cooled in an ice bath for 10 min. A cooled solution 
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of sodium nitrite (0.55 g, 8.0 mmol) in water (5 mL) was added slowly to the amine 
solution. This mixture was stirred at 0 °C for 30 min, after which time it was added 
dropwise to the phenylpyruvic acid reaction mixture described above over a 10 min period. 
The resulting solution was stirred for 18 h, during which time a dark purple precipitate was 
formed. The dark purple solid was filtered off and purified by flash chromatography 
(CH2Cl2, neutral alumina) to afford formazan 3.11d as a dark purple microcrystalline solid. 
Yield = 1.03 g, 82%. Melting point = 152–154 °C. 1H NMR (599.5 MHz, CDCl3) δ 15.72 
(s, 1H, NH), 8.24 (d, 3JHH = 7 Hz, 2H, aryl CH), 8.12 (s, 2H, aryl CH), 7.97–7.91 (m, 6H, 
aryl CH), 7.87 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.56–7.47 (m, 6H, aryl CH), 7.42–7.38 (m, 
1H, aryl CH). 13C{1H} NMR (100.6 MHz, CDCl3): δ 145.8, 141.8, 137.6, 134.1, 133.1, 
129.7, 128.6, 128.4, 128.2, 127.9, 127.1, 126.3, 126.2, 119.1, 116.5. FT-IR (KBr): 3267 
(br, s), 3050 (s), 3034 (m), 2914 (m), 2847 (m), 1629 (m), 1596 (s), 1499 (s), 1438 (m), 
1358 (m), 1226 (s) cm1. UV-vis (toluene): λmax = 532 nm (ε = 10, 300 M1 cm1). Mass 
Spec. (EI, +ve mode): exact mass calculated for [C27H20N4]
+: 400.1688; exact mass found: 
400.1695; difference: +1.8 ppm.  
Formazan 3.11f 
In air, cyanoacetic acid (0.30 g, 3.5 mmol) was dissolved in 150 
mL deionized water with NaOH (1.40 g, 34.9 mmol), and cooled 
in an ice bath. In a separate flask, 2-naphthylamine (1.00 g, 6.98 
mmol) and concentrated HCl (1.7 mL) were mixed in water (15 mL), and cooled in an ice 
bath. A cooled solution of sodium nitrite (0.55 g, 8.0 mmol) in water (5 mL) was added 
slowly to the amine solution. This mixture was stirred at 0 °C for 30 min, after which time 
it was added dropwise to the cyanoacetic acid solution described above over a 10 min 
period. The resulting solution was stirred for 18 h, during which time a dark red precipitate 
was formed. The dark red solid was filtered off and purified by flash chromatography 
(CH2Cl2, neutral alumina) to afford formazan 3.11f as a dark red microcrystalline solid. 
Yield = 1.06 g, 86%. Melting point = 187–189 °C. 1H NMR (599.5 MHz, DMSO-d6) δ 
12.90 (s, 1H), 8.39 (s, 2H), 8.18−7.88 (m, 8H), 7.62−7.51 (m, 4H). 13C{1H} NMR (100.6 
MHz, DMSO-d6): δ 144.9, 133.3, 132.7, 129.5, 128.6, 127.9, 127.8, 127.2, 127.0, 126.7, 
116.5, 112.9. FT-IR (KBr): 3276 (br, m), 3053 (m), 2970 (m), 2219 (s), 1604 (s), 1531 (s), 
1367 (m), 1346 (m), 1267 (m) cm1. UV-vis (toluene): λmax = 472 nm (ε = 12, 900 M1 
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cm1). Mass Spec. (EI, +ve mode): exact mass calculated for [C22H15N5]
+: 349.1327; exact 
mass found: 349.1330; difference: +0.7 ppm.  
Formazan 3.11h 
In air, nitromethane (0.21 g, 0.19 mL, 3.5 mmol) was dissolved 
in 100 mL deionized water with NaOH (0.31 g, 7.7 mmol), and 
cooled in an ice bath. In a separate flask, 2-naphthylamine (1.00 
g, 6.98 mmol) and concentrated HCl (1.7 mL) were mixed in water (15 mL), and cooled in 
an ice bath. A cooled solution of sodium nitrite (0.55 g, 8.0 mmol) in water (5 mL) was 
added slowly to the amine solution. This mixture was stirred at 0 °C for 30 min, after which 
time it was added dropwise to the nitromethane solution described above over a 10 min 
period. The resulting solution was stirred for 18 h, during which time a dark red precipitate 
was formed. The dark red solid was filtered off and purified by flash chromatography 
(CH2Cl2, neutral alumina) to afford formazan 3.11h as a dark red microcrystalline solid. 
Yield = 0.35 g, 27%. Melting point = 179–181 °C. 1H NMR (599.5 MHz, CDCl3) δ 15.63 
(s, 1H), 8.18 (s, 2H), 8.00–7.96 (m, 6H), 7.90 (d, 3JHH = 7 Hz, 2H), 7.60–7.56 (m, 4H). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ 144.5, 134.3, 133.9, 130.6, 129.1, 128.5, 127.9, 
125.8, 122.0, 116.3, 110.4. FT-IR (KBr): 3242 (br, s), 3035 (m), 2915 (m), 2857 (m), 1589 
(m), 1547 (s), 1502 (m), 1342 (s), 1277 (s) cm1. UV-vis (toluene): λmax = 488 nm (ε = 12, 
500 M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for [C21H15N5O2]
+: 
369.1226; exact mass found: 369.1220; difference: −1.6 ppm. This compound decomposes 
over several hours in halogenated solvents.  
Representative procedure for the preparation of formazans 3.11j and 3.11k:  
Formazan Dimer 3.11j 
In air, phenyl hydrazine (5.08 g, 4.62 mL, 47.0 mmol) was dissolved in 
EtOH (30 mL), before terephthalaldehyde (1.50 g, 22.0 mmol) was 
added and the solution was stirred for 10 min. At this time, a light yellow 
precipitate had formed. DMF (100 mL) and pyridine (100 mL) were 
added and the mixture was cooled in an ice bath to 0 °C. In a separate 
flask, aniline (5.12 g, 5.02 mL, 55.0 mmol) and concentrated HCl (11.8 
mL) were mixed in water (30 mL) and cooled in an ice bath. A cooled 
solution of sodium nitrite (4.00 g, 58.0 mmol) in water (10 mL) was added slowly to the 
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amine solution. This mixture was stirred at 0 °C for 30 min, at which time it was added 
dropwise to the DMF/pyridine mixture described above over a 10 min period. The resulting 
solution was stirred for 18 h, during which time a dark red/brown precipitate formed. The 
dark red/brown solid was isolated by vacuum filtration, washed with water and MeOH and 
purified by flash chromatography (CH2Cl2, neutral alumina) to afford formazan 3.11j as a 
dark red/brown microcrystalline solid. Yield = 2.60 g, 23%. Melting point = 196–198 °C. 
1H NMR (599.5 MHz, CDCl3) δ 15.45 (s, 2H, NH), 8.24 (s, 4H, aryl CH), 7.73 (d, 3JHH = 
7 Hz, 8H, aryl CH), 7.48 (t, 3JHH = 7 Hz, 8H, aryl CH), 7.30 (t, 
3JHH = 7 Hz, 4H, aryl CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 148.2, 136.9, 129.7, 127.7, 126.1, 119.1. After 
10,000 scans on a 600 MHz NMR spectrometer, only 6 signals were observed due to the 
poor solubility of 3.11j in common organic solvents. FT-IR (KBr): 3267 (br, s), 3035 (m), 
3006 (m), 1598 (s), 1509 (s), 1455 (m), 1405 (m), 1351 (s), 1311 (w), 1221 (s) cm1. UV-
vis (toluene): λmax = 500 nm (ε = 28,900 M1 cm1). Mass Spec. (EI, +ve mode): exact mass 
calculated for [C32H26N8]
+: 522.2280; exact mass found: 522.2280; difference: −0.2 ppm. 
Formazan Dimer 3.11k 
In air, from 11.2 mmol aldehyde and 28.0 mmol hydrazine: Yield 
= 1.68 g, 36%. Melting point = 175–177 °C. 1H NMR (599.5 MHz, 
CDCl3) δ 15.44 (s, 2H, NH), 9.03 (s, 1H, aryl CH), 8.14 (d, 3JHH = 
8 Hz, 2H, aryl CH), 7.76 (d, 3JHH = 8 Hz, 8H, aryl CH), 7.52 (t, 
3JHH = 8 Hz, 1H, aryl CH), 7.50−7.47 (m, 8H, aryl CH), 7.31 (t, 
3JHH = 7 Hz, 4H, aryl CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 
148.2, 141.1, 137.6, 129.6, 128.8, 127.6, 125.1, 123.6, 119.0. FT-IR (KBr): 3272 (br, s), 
3026 (m), 3019 (m), 1598 (s), 1510 (s), 1455 (m), 1451 (m), 1343 (m), 1217 (s) cm1. UV-
vis (toluene): λmax = 496 nm (ε = 39,200 M1 cm1). Mass Spec. (EI, +ve mode): exact mass 
calculated for [C32H26N8]
+: 522.2280; exact mass found: 522.2285; difference: +0.8 ppm.  
Representative procedure for the preparation of BF2 complexes 3.10a-h:  
Formazanate BF2 Complex 3.10a  
Formazan 3.11a (0.50 g, 1.6 mmol) was dissolved in dry toluene (50 
mL). NEt3 (0.50 g, 0.68 mL, 4.9 mmol) was then added slowly, and the 
solution was stirred for 10 min. BF3•OEt2 (1.16 g, 1.01 mL, 8.15 mmol) 
was then added, and the solution was heated at 80 °C for 18 h. The 
97 
 
 
 
solution gradually turned from dark red to dark purple during this time. The reaction was 
then cooled to 20 °C, and deionized water (10 mL) was added to quench any excess reactive 
boron-containing compounds. The red/purple toluene solution was then washed with 
deionized water (3 x 50 mL), dried over MgSO4, gravity filtered, and concentrated in 
vacuo. The resulting residue was purified by flash chromatography (CH2Cl2, neutral 
alumina) to afford BF2 complex 3.10a as a dark purple microcrystalline solid. Yield = 0.38 
g, 67%. Melting point = 129–131 °C. 1H NMR (599.5 MHz, CDCl3) δ 8.12 (d, 3JHH = 7 
Hz, 2H), 7.92 (d, 3JHH = 7 Hz, 4H), 7.50−7.43 (m, 9H). 13C{1H} NMR (100.6 MHz, CDCl3) 
δ 143.9, 133.6, 129.7, 129.3, 129.1, 128.8, 125.5, 123.5 (t, 4JCF = 3 Hz). 11B NMR (128.3 
MHz, CDCl3): δ –0.6 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –144.6 (q, 1JFB = 
29 Hz). FT-IR (KBr): 3263 (m), 3035 (m), 2900 (m), 2889 (m), 1310 (m), 1290 (s), 1265 
(s), 1218 (m), 1168 (m), 1113 (s) cm1. UV-vis (toluene): λmax = 517 nm (ε = 23, 800 M1 
cm1). Mass Spec. (EI, +ve mode): exact mass calculated for [C19H15N4BF2]
+: 348.1358; 
exact mass found: 348.1374; difference: +4.7 ppm.  
Formazanate BF2 Complex 3.10b 
From 1.70 mmol of formazan 3.11b: Yield = 0.31 g, 46%. Melting point 
= 127–129 °C. 1H NMR (599.5 MHz, CDCl3) δ 8.56 (s, 1H), 8.27–8.25 
(m, 1H), 7.96–7.93 (m, 6H), 7.90–7.88 (m, 1H), 7.54–7.50 (m, 6H), 
7.48–7.45 (m, 2H). 13C{1H} NMR (100.6 MHz, CDCl3): δ 144.0, 134.0, 
133.6, 131.1, 129.9, 129.3, 128.8, 128.7, 128.0, 126.8, 126.7, 125.1, 
123.7 (t, 4JCF = 4 Hz), 123.1, 110.2. 
11B NMR (128.3 MHz, CDCl3): δ –0.5 (t, 1JBF = 29 
Hz). 19F NMR (376.1 Hz, CDCl3): δ –144.8 (q, 1JFB = 29 Hz). FT-IR (KBr): 3236 (m), 3055 
(m), 2915 (m), 2860 (m), 1313 (s), 1279 (s), 1220 (m), 1172 (m), 1106 (m), 1105 (m) cm1. 
UV-vis (toluene): λmax = 529 nm (ε = 20, 900 M1 cm1). Mass Spec. (EI, +ve mode): exact 
mass calculated for [C23H17N4BF2]
+: 398.1514; exact mass found: 398.1513; difference: 
−0.3 ppm.  
Formazanate BF2 Complex 3.10c 
From 1.50 mmol of formazan 3.11c: Yield = 0.44 g, 73%. Melting 
point = 106–108 °C. 1H NMR (599.5 MHz, CDCl3) δ 8.46 (s, 1H), 
8.18–8.16 (m, 2H), 8.07–8.05 (m, 1H), 7.97–7.92 (m, 4H), 7.88–
7.86 (m, 1H), 7.57–7.43 (m, 8H). 13C{1H} NMR (100.6 MHz, 
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CDCl3): δ 149.4, 144.1, 141.6, 133.8, 133.6, 133.2, 129.8, 129.5, 129.3, 129.3, 129.2, 
128.9, 127.9, 127.8, 127.2, 125.7, 123.6 (t, 4JCF = 2 Hz), 123.4 (t, 
4JCF = 4 Hz), 120.7.  
11B 
NMR (128.3 MHz, CDCl3): δ –0.4 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –143.9 
(q, 1JFB = 29 Hz).
 FT-IR (KBr): 3236 (m), 3059 (s), 2915 (m), 2845 (m), 1347 (m), 1341 
(m), 1294 (s), 1266 (s), 1218 (m), 1174 (m) cm1. UV-vis (toluene): λmax = 535 nm (ε = 26, 
800 M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for [C23H17N4BF2]
+: 
398.1514; exact mass found: 398.1512; difference: −0.6 ppm.  
Formazanate BF2 Complex 3.10d  
From 2.70 mmol of formazan 3.11d: Yield = 0.95 g, 78%. 
Melting point = 140–142 °C. 1H NMR (599.5 MHz, CDCl3) δ 
8.49 (s, 2H), 8.21 (d, 3JHH = 7 Hz, 2H), 8.10–8.08 (m, 2H), 7.97–
7.93 (m, 4H), 7.89–7.86 (m, 2H), 7.57–7.48 (m, 7H). 13C{1H} 
NMR (100.6 MHz, CDCl3): δ 141.6, 133.9, 133.5, 133.1, 129.4, 129.3, 129.3, 128.9, 127.9, 
127.7, 127.1, 125.7, 123.3 (t, 4JCF = 4 Hz), 120.6, 119.1. 
11B NMR (128.3 MHz, CDCl3): 
δ –0.2 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –143.3 (q, 1JFB = 29 Hz). FT-IR 
(KBr): 3276 (m), 3050 (s), 2915 (m), 2846 (m), 1626 (m), 1592 (m), 1507 (s), 1344 (s), 
1298 (s), 1265 (m) cm1. UV-vis (toluene): λmax = 556 nm (ε = 25, 200 M1 cm1). Mass 
Spec. (ESI, +ve mode): exact mass calculated for [C27H19N4BF2Na]
+: 471.1568; exact mass 
found: 471.1569; difference: +0.1 ppm.  
Formazanate BF2 Complex 3.10f  
From 2.30 mmol of formazan 3.11f: Yield = 0.74 g, 81%. 
Melting point = 118–120 °C. 1H NMR (599.5 MHz, CDCl3) δ 
8.51 (s, 2H), 8.03–8.01 (m, 2H), 7.98–7.93 (m, 4H), 7.89–7.87 
(m, 2H), 7.62–7.56 (m, 4H). 13C{1H} NMR (100.6 MHz, CDCl3): δ 141.0, 134.4, 133.1, 
130.1, 129.9, 129.0, 128.2, 127.8, 126.4, 124.2, 119.5 (t, 4JCF = 3 Hz), 114.5. 
11B NMR 
(128.3 MHz, CDCl3): δ –0.4 (t, 1JBF = 31 Hz). 19F NMR (376.1 Hz, CDCl3): δ –132.7 (q, 
1JFB = 31 Hz).
 FT-IR (KBr): 3235 (m), 3035 (m), 2895 (m), 2240 (s), 1350 (s), 1146 (m), 
1124 (m), 1028 (m) cm1. UV-vis (toluene): λmax = 581 nm (ε = 25, 700 M1 cm1). Mass 
Spec. (EI, +ve mode): exact mass calculated for [C22H14N5BF2]
+: 397.1310; exact mass 
found: 397.1311; difference: +0.2 ppm.  
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Formazanate BF2 Complex 3.10g 
From 2.90 mmol of formazan 3.11g: Yield = 0.27 g, 29%. Melting point 
= 108–110 °C. 1H NMR (399.8 MHz, CDCl3) δ 8.01–7.99 (m, 4H), 7.56–
7.52 (m, 6H). 13C{1H}NMR (100.6 MHz, CDCl3): δ 143.4, 132.2, 129.9, 
123.7 (t, 4JCF = 2 Hz). 
11B NMR (128.3 MHz, CDCl3): δ –0.7 (t, 1JBF = 
30 Hz). 19F NMR (376.1 Hz, CDCl3): δ –135.4 (q, 1JFB = 29 Hz). FT-IR (KBr): 3257 (m), 
3062 (m), 2915 (m), 2912 (m), 2844 (m), 1557 (s), 1417 (s), 1333 (s), 1327 (s), 1271 (m), 
1175 (m), 1151 (m) cm1. UV-vis (toluene): λmax = 505 nm (ε = 26, 000 M1 cm1). Mass 
Spec. (EI, +ve mode): exact mass calculated for [C13H10N5O2BF2]
+: 317.0896; exact mass 
found: 317.0901; difference: +1.7 ppm.  
Formazanate BF2 Complex 3.10h  
From 0.54 mmol of formazan 3.11h: Yield = 0.22 g, 99%. 
Melting point = 199–201 °C. 1H NMR (599.5 MHz, CDCl3) δ 
8.61 (s, 2H), 8.14 (d, 3JHH = 9 Hz, 2H), 8.01–7.97 (m, 4H), 7.90 
(d, 3JHH = 8 Hz, 2H), 7.65–7.58 (m, 4H). 13C{1H} NMR (100.6 MHz, CDCl3): δ 141.1, 
134.6, 133.1, 130.4, 130.3, 129.9, 129.2, 128.2, 127.8, 124.6 (t, 4JCF = 4 Hz), 119.5. 
11B 
NMR (128.3 MHz, CDCl3): δ –0.3 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –134.3 
(q, 1JFB = 29 Hz).
 FT-IR (KBr): 3270 (s), 3036 (m), 2888 (m), 1554 (s), 1538 (m), 1425 
(m), 1377 (m), 1317 (s), 1269 (w) cm1. UV-vis (toluene): λmax = 583 nm (ε = 24, 100 M1 
cm1). Mass Spec. (EI, +ve mode): exact mass calculated for [C21H14N5O2BF2]
+: 417.1209; 
exact mass found: 417.1208; difference: −0.2 ppm.  
Representative procedure for the preparation of formazanate BF2 complexes 3.10j 
and 3.10k:  
Formazanate BF2 Dimer 3.10j 
Formazan 3.11j (1.00 g, 1.91 mmol) was dissolved in dry toluene (100 
mL) and NEt3 (1.16 g, 1.60 mL, 11.4 mmol) was added slowly, before 
the solution was stirred for 10 min. BF3•OEt2 (2.72 g, 2.36 mL, 19.1 
mmol) was then added and the solution heated at 80 °C for 18 h. The 
solution gradually changed colour from dark red to dark purple during 
this time. The reaction was then cooled to 20 °C and deionized water (10 
mL) was added to quench any excess reactive boron-containing 
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compounds. The red/purple toluene fraction was then washed with deionized water (3 x 50 
mL), dried over MgSO4, gravity filtered and concentrated in vacuo. The resulting residue 
was purified by flash chromatography (CH2Cl2, neutral alumina) to afford BF2 complex 
3.10j as a dark purple microcrystalline solid. Yield = 0.94 g, 80%. Melting point = 192–
194 °C. 1H NMR (599.5 MHz, CDCl3) δ 8.23 (s, 4H, aryl CH), 7.94 (d, 3JHH = 7 Hz, 8H, 
aryl CH), 7.52−7.45 (m, 12H, aryl CH). 13C{1H} NMR (100.6 MHz, CDCl3): δ 148.7, 
143.9, 134.4, 129.9, 129.2, 125.8, 123.5. 11B NMR (128.3 MHz, CDCl3): δ –0.5 (t, 1JBF = 
29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –144.1 (q, 1JFB = 29 Hz). FT-IR (KBr): 3035 (m), 
3004 (m), 1582 (m), 1487 (m), 1429 (m), 1322 (s), 1309 (s), 1260 (s), 1216 (m), 1153 (m), 
1116 (s) cm1. UV-vis (toluene): λmax = 521 nm (ε = 28,800 M1 cm1). Mass Spec. (EI, 
+ve mode): exact mass calculated for [C32H24N8B2F4]
+: 618.2246; exact mass found: 
618.2257; difference: +1.8 ppm.  
Formazanate BF2 Dimer 3.10k 
From 1.91 mmol of formazan 3.11k: Yield = 0.88 g, 75%. Melting 
point = 208–210 °C. 1H NMR (599.5 MHz, CDCl3) δ 8.82 (s, 1H, 
aryl CH), 8.20 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.94 (d,
 3JHH = 8 Hz, 
8H, aryl CH), 7.60 (t, 3JHH = 8 Hz, 1H, aryl CH), 7.50−7.43 (m, 
12H, aryl CH). 13C{1H} NMR (100.6 MHz, CDCl3): δ 144.0, 
134.5, 130.0, 129.4, 129.3, 129.2, 126.3, 123.6, 122.8. 11B NMR 
(128.3 MHz, CDCl3): δ –0.5 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, 
CDCl3): δ –143.8 (q, 1JFB = 29 Hz). FT-IR (KBr): 3034 (m), 3007 (w), 1581 (m), 1457 (m), 
1454 (m), 1341 (m), 1301 (s), 1281 (s), 1216 (m), 1179 (m), 1106 (s) cm1. UV-vis 
(toluene): λmax = 518 nm (ε = 20,200 M1 cm1). Mass Spec. (EI, +ve mode): exact mass 
calculated for [C32H24N8B2F4]
+: 618.2246; exact mass found: 618.2228; difference: −2.9 
ppm.  
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Chapter 4 
4 BF2 Formazanate Complexes Modified by Copper-
Assisted Alkyne-Azide Cycloaddition – Molecular Materials 
and Polymers 
Adapted from:  
1. Barbon, S. M.; Gilroy, J. B.* Polym. Chem. 2016, 7, 3589−3598.  
2. Barbon, S. M.; Novoa, S.; Bender, D.; Groom, H.; Luyt, L. G.*; Gilroy, J. B.* Org. 
Chem. Front. 2017, 4, 178−190. 
 
4.1 Introduction 
Fluorophores are a very useful class of molecules as they provide a handle with which to 
visualize chemical phenomena at the molecular, macromolecular and bulk size     
regimes.[1-6] For this reason, the development of new classes of fluorophores has been the 
focus of a significant amount of research.[7-8] One of the major hurdles to be overcome in 
the field was the facile synthetic modification of fluorophores in order to utilize them for 
an expanded range of applications.[9-11] Significant impact was made in this area with the 
development of copper-assisted alkyne-azide cycloaddition (CuAAC) chemistry.[12-13] 
Since the original reports appeared, the number of alkyne and azide modified fluorophores 
such as those based on anthracene,[14-15] pyrene,[16-17] boron dipyrromethenes 
(BODIPYs),[18-20] rhodamine[21-22] and coumarin[23-24] has expanded dramatically (e.g., 
4.1−4.3). The onward CuAAC chemistry of these and other fluorophores has led to their 
use, for example, as protein labels,[25] in photosensitizers,[26] as molecular switches,[27] as 
probes of DNA hybridization,[28] in radiolabeling,[29] and in polymer synthesis.[30-31] 
CuAAC chemistry has been used to create a variety of fluorescence sensors for anions,[32] 
acids and bases,[33-34] nitroxide radicals,[35] hydroxyl radicals,[36] and various metal ions 
including mercury[37-38] and zinc.[39-40]  
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In addition to the production of sensors, CuAAC chemistry has also been utilized to modify 
fluorophores for biological imaging applications. This strategy has been used both to 
impart water solubility (e.g., 4.4),[41] and functionalities which interact with specific 
biological targets (e.g., 4.5).[42-45] More recently, this strategy has been extended to include 
copper-free, strain-promoted alkyne-azide cycloaddition chemistry with specific utility in 
biological systems.[46-47] 
 
CuAAC chemistry has also been used to incorporate fluorophores into polymers and 
dendrimers, imparting the solution processability and film-forming properties often 
associated with these materials.[48-52] The Jin group used CuAAC chemistry to synthesize 
an alternating copolymer of 9,9-dioctyl-fluorene and benzothiadiazole 4.6. This polymer 
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had interesting thin-film optical properties, including emission from both the fluorene and 
benzothiadiazole, and was also incorporated into dye-sensitized solar cells, with 
efficiencies of up to 2.8%.[53] Similarly, the Jang group showed that 2-isopropyl-2-
oxazoline was polymerized, and terminated with sodium azide, which could be reacted 
with an alkyne-terminated BODIPY to form Polymer 4.7. While it only contains one 
BODIPY unit, 4.7 was still strongly emissive at ca. 525 nm, and could be combined with 
other polymers appended with primary-coloured dyes to produce temperature-dependent 
emissive materials.[31] 
 
Herein we expand the scope of BF2 formazanate chemistry further by producing a variety 
of functional molecular and polymeric materials through the use of CuAAC chemistry that 
cannot be synthesized directly by other methods. 
4.2 Synthesis and Characterization of Molecular Materials 
4.2.1 Benzyl-Functionalized BF2 Complexes of 3-Cyanoformazanates 
In order to study the effect of triazole formation on the photophysical properties of BF2 
complexes of 3-cyanoformazanate ligands, mono- and bis-alkyne substituted formazans 
4.8 and 4.12 were converted to mono-alkyne-substituted complex 4.9 and bis-alkyne-
substituted complex 4.13 by adapting previously reported protocols (Scheme 4.1).[54] 
Mono-alkyne-substituted BF2 complex 4.9 is the first example of a BF2 complex derived 
from an asymmetric 3-cyanoformazan, which was isolated from a reaction mixture 
containing equimolar quantities of the parent aryldiazonium salts. Complex 4.9 was first 
characterized by single crystal X-ray diffraction (Figure 4.1), and happened to crystallize 
on a two-fold rotation axis. As a result, the alkyne and methoxy substituents were 
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disordered. However, the structure does confirm the expected connectivity and planarity 
throughout the molecule (torsion angle between N4 plane and aryl substituents: 7.2°). All 
other structural metrics were consistent with the solid-state structures of previously 
reported BF2 adducts of 3-cyanoformazanate ligands.
[54] 
Scheme 4.1   Synthesis of (a) mono- and (b) bis-CuAAC-functionalized BF2 complexes. 
 
Figure 4.1   Solid-state structure of 4.9. Anisotropic displacement ellipsoids are shown at 
50% probability and hydrogen atoms have been omitted for clarity. Selected bond lengths 
(Å): B1−N1 1.5759(15), N1−N2 1.3023(15), N2−C1 1.3351(13), O1−C11 1.418(5), 
C9−C10 1.191(7). Selected bond angles (°): B1−N1−N2 124.57(10), N1−N2−C1 
117.24(11).   
 
The alkyne-substituted complexes 4.9 and 4.13 underwent CuAAC with benzyl azide when 
combined in the presence of copper (I) iodide and N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine (PMDETA) in THF to form mono- and bis-benzyl-
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functionalized compounds 4.10 and 4.14 (Scheme 4.1). The successful conversion of 
alkyne-substituted complexes 4.9 and 4.13 to benzyl-functionalized complexes 4.10 and 
4.14 was confirmed by 1H, 11B, 13C and 19F NMR spectroscopy (Figures 4.2, A4.1−A4.17), 
UV-vis absorption/emission and IR spectroscopy, and high resolution mass spectrometry. 
In order to further expand the scope of the BF2 formazanate complexes, CuAAC chemistry 
was used to synthesize BF2 formazanate complexes with appended ferrocene substituents 
(4.11, 4.15) and water-solubilizing tetraethylene glycol substituents (4.16). Initial attempts 
to synthesize the water-soluble complex 4.16 were unsuccessful, likely due to the TEG 
chains outcompeting PMDETA for the ligation of copper(I) when all of the reagents were 
combined simultaneously. We circumvented this issue by stirring CuI and PMDETA in 
THF for 30 min before the TEG azide was added.   
 
 
Figure 4.2   1H NMR spectra of a) benzyl azide (blue), mono-alkyne-substituted complex 
4.9 (red) and mono-benzyl-functionalized complex 4.10 (black) and b) benzyl azide (blue), 
bis-alkyne-substituted complex 4.13 (red) and bis-benzyl-functionalized complex 4.14 
(black) in CDCl3. The asterisks denote residual solvent signals.  
The electrochemical properties of complexes 4.9, 4.10, 4.13 and 4.14 were studied using 
cyclic voltammetry in THF. Each voltammogram showed two reversible, one-electron 
reduction waves within the electrochemical window of the solvent. Considering the first 
reduction wave, which corresponds to the formation of a ligand-centered radical anion, bis-
alkyne-substituted complex 4.13 is significantly easier to reduce than mono-alkyne-
substituted complex 4.9 (−0.50 V and −0.67 V relative to the ferrocene/ferrocenium redox 
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couple, respectively) due to the presence of the electron donating methoxy substituent in 
4.9. The benzyl-functionalized complexes were more difficult to reduce than their alkyne-
substituted precursors [(4.10: −0.68 V; 4.14: −0.62 V), Figure 4.3, Table 4.1]. We have 
previously demonstrated that extending electronic conjugation in BF2 complexes of 3-
cyanoformazanate ligands results in complexes that are easier to reduce due to a lowering 
of the LUMO energy.[55] However, in the case of complexes 4.10 and 4.14, the more 
negative reduction potentials observed are likely due to the electron donating nature of the 
benzyl-substituted triazoles, which appear to be better electron donors than alkyne 
substituents. The second reduction waves, which correspond to the formation of ligand-
centered dianions, followed the same trend.  
 
Figure 4.3   Cyclic voltammograms of (a) mono-alkyne-substituted complex 4.9 (black) 
and mono-benzyl-functionalized complex 4.10 (blue) and (b) bis-alkyne-substituted 
complex 4.13 (red) and bis-benzyl-functionalized complex 4.14 (purple), recorded at 100 
mV s−1 in 1 mM THF solutions containing 0.1 M [nBu4N][PF6] as supporting electrolyte.  
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In both the UV-vis absorption and emission spectra, the wavelength of maximum 
absorption (λmax) and emission (λem) red-shift by approximately 10 nm when comparing 
mono-benzyl-functionalized complex 4.10 and mono-alkyne-substituted complex 4.9. As 
may be expected, a more drastic red-shift was observed when the spectra of bis-benzyl-
functionalized complex 4.14 and bis-alkyne-substituted complex 4.13 were compared. In 
this case, red-shifts of approximately 30 nm (absorption) and 40 nm (emission) were 
observed (Figure 4.4), due to a destabilization of the HOMO. 
 
Figure 4.4   UV-vis absorption spectra (solid line) and emission spectra (dashed line) of 
(a) 4.9, (b) 4.10, (c) 4.13 and (d) 4.14, recorded for 10−5 M toluene solutions. 
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Complexes 4.9, 4.10, 4.13 and 4.14 exhibit moderate fluorescence quantum yields in THF, 
CH2Cl2, and toluene (Table 4.1). Mono-alkyne-substituted complex 4.9 has a quantum 
yield of 30% in CH2Cl2, which is almost double that of bis-alkyne-substituted complex 
4.13 (ΦF = 18% in CH2Cl2), likely due to its asymmetric structure.[56] Mono-benzyl-
functionalized complex 4.10 has the same quantum yield as complex 4.9, while bis-benzyl-
functionalized complex 4.14 showed the most intense emission at a quantum yield of 46%. 
The Stokes shifts observed (79133 nm; 2,1433,394 cm1) for these complexes were 
typical of other BF2 complexes of 3-cyanoformazanates.
[54] 
 
Table 4.1. Optical and electronic properties of BF2 formazanate complexes 4.9−4.11 and 
4.13−4.16. 
 Solvent 
λmax 
(nm) 
 (M1 cm1) 
λem 
(nm) 
ΦF 
(%)a 
ST 
(nm) 
ST 
(cm−1) 
Eox1 
(V)b 
Ered1 
(V)b 
Ered2 
(V)b 
4.9 
CH2Cl2 552 30,400 647 30 95 2,660 − 
−0.67 −1.78 THF 550 32,500 650 27 100 2,797 − 
Toluene 569 26,800 648 36 79 2,143 − 
4.10 
CH2Cl2 560 31,000 660 30 100 2,706 − 
−0.68 −1.81 THF 560 33,700 672 25 112 2,976 − 
Toluene 579 37,400 661 37 82 2,143 − 
 CH2Cl2 562 28,600 − − − −    
4.11c THF 562 31,700 − − − − 0.20 −0.67 −1.80 
 Toluene 578 23,900 − − − −    
 CH2Cl2 530 32,700 635 18 105 3,120 −   
4.13 THF 529 29,600 638 19 109 3,230 − −0.50 −1.58 
 Toluene 547 41,700 637 36 90 2,583 −   
4.14 
CH2Cl2 558 39,600 679 46 121 3,194 − 
−0.62 −1.72 THF 563 34,100 696 34 133 3,394 − 
Toluene 577 33,700 680 72 103 2,625 − 
4.15c 
CH2Cl2 569 30,900 − − − −  
−0.56 −1.67 THF 569 26,100 − − − − 0.21 
Toluene 582 30,700 − − − −  
4.16 
CH2Cl2 542 16,500 680 53 138 3,744 − 
−0.58 −1.68 THF 563 11,900 697 20 134 3,415 − 
Toluene − − − − − − − 
aQuantum yields were measured according to published protocols using [Ru(bpy)3][PF6]2 
as a relative standard and corrected for wavelength-dependent detector sensitivity (Figure 
A4.18).[57-58] bCyclic voltammetry experiments were conducted in THF containing 1 mM 
analyte and 0.1 M [nBu4N][PF6] as supporting electrolyte at a scan rate of 100 mV s
−1. All 
voltammograms were referenced internally against the ferrocene/ferrocenium redox 
couple. cComplexes 4.11 and 4.15 were non-emissive in the range of organic solvents 
employed. 
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4.2.2 Ferrocene-Functionalized BF2 Complexes of 3-
Cyanoformazanates 
BF2 complexes of formazanate ligands generally exhibit very well-behaved reduction 
chemistry.[54-55,59-62] However, their oxidation is rarely observed within the electrochemical 
window of most organic solvents. Ferrocene can be reversibly oxidized, and so the 
electrochemical properties of compounds that contain both ferrocene and formazanate 
moieties may have unusual properties, including charge-transfer characteristics. Similar 
compounds based on different fluorophores have been previously used as viscosity 
probes,[63] redox-active fluorescent switches,[64-65] and ion pair recognition receptors.[66] 
The resulting complexes were dark purple/blue in colour (Figures A4.19, A4.20) and were 
non-emissive in solution, likely due to excited-state electron transfer from the BF2 
formazanate moiety to the ferrocene.[65,67-69]  
Cyclic voltammetry studies of complex 4.15 revealed two characteristic BF2 formazanate 
reduction waves (each corresponding to one electron) at potentials of −0.56 V and −1.67 
V, respectively. This complex was more difficult to reduce than symmetric complexes 4.13 
and 4.14, due to the electron-rich nature of ferrocene. An oxidation wave corresponding to 
two electrons was observed at a potential of 0.21 V, which corresponds to the one-electron 
oxidation of both ferrocene groups (Figure 4.5). The coincident appearance of the ferrocene 
waves in the cyclic voltammogram of 4.15 confirmed that there was little to no electronic 
communication between the ferrocene units via the BF2 formazanate spacer.  
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Figure 4.5   Cyclic voltammograms of mono-ferrocene-substituted BF2 complex 4.11 (red) 
and bis-ferrocene-substituted complex 4.15 (black) recorded at 100 mV s−1 in 1 mM THF 
solutions containing 0.1 M [nBu4N][PF6] as supporting electrolyte. 
 
In order to further explore the apparent fluorescence quenching associated with the 
presence of ferrocene in complexes 4.11 and 4.15, we systematically oxidized the ferrocene 
units and studied their absorption and emission properties in CH2Cl2 (Figure 4.6). NOBF4 
was chosen as an oxidant as the gaseous byproducts were assumed not to contribute to the 
spectra collected upon oxidation and the oxidation potential of ca. 1.0 V[70] relative to 
ferrocene/ferrocenium was not in a range that would oxidize the 3-cyanoformazanate 
ligand backbone. In CH2Cl2, the absorption maxima associated with the * transition 
of the BF2 formazanate backbone of complexes 4.11 and 4.15 underwent a blue-shift upon 
subsequent addition of NOBF4, spanning a range from 563 nm (0 equiv.) to 561 nm (1 
equiv.) in mono-ferrocene substituted complex 4.11, and 569 nm (0 equiv.) to 549 nm (2 
equiv.) in bis-ferrocene substituted complex 4.15. The blue-shift appears to arise due to the 
removal of electron density from the ferrocene moieties, rendering the complexes less 
electron rich overall. This effect has been observed previously for similar complexes, 
whereby the introduction of electron withdrawing groups blue-shifted absorption 
maxima.[54] Perhaps more significant, was the observation that upon conversion of 
ferrocene to ferrocenium, the solutions of 4.11 and 4.15 that had been treated with NOBF4 
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became emissive. The emission intensity gradually increased with the subsequent addition 
of oxidizing agent until a maximum intensity (F = 7% for complex 4.11 and 14% for 
complex 4.15) was reached when 1 or 2 equiv. of NOBF4 had been added, while em was 
unchanged. These observations corroborate our hypothesis that the emission of these 
complexes was quenched as a result of excited-state electron transfer from the formazanate 
backbone to ferrocene. 
 
Figure 4.6   Emission spectra of solutions of ferrocene-substituted complexes (a) 4.11 and 
(b) 4.15 treated with 0 equiv. (black), 0.5 equiv. (blue), 1.0 equiv. (red), 1.5 equiv. (green) 
and 2.0 equiv. (purple) of NOBF4, recorded in degassed CH2Cl2 at a concentration of 10
−5 
M. The arrows indicate the trends upon addition of NOBF4. 
 
4.2.3 Tetraethylene Glycol-Functionalized BF2 Complexes of 3-
Cyanoformazanates 
Complex 4.16, which was targeted over a mono-tetraethylene glycol substituted complex, 
in an effort to maximize hydrophilicity, is soluble in both polar organic solvents and water. 
Interestingly, the optical properties were highly dependent on the polarity of the solvent 
used. In relatively non-polar solvents such as CH2Cl2 and THF, 4.16 was moderately 
fluorescent (ΦF: 53% and 20%, respectively). However, the fluorescence intensity dropped 
off significantly in more polar solvents (ΦF: 5% in H2O), and there was also a blue-shift in 
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the wavelength of maximum emission (Table 4.2, Figure 4.7), which is often observed for 
fluorescent dyes in highly polar solvents.[71-75] 
Table 4.2. Absorption and emission properties of complex 4.16 in different solvents. 
Solvent 
λmax 
(nm) 
ε 
(M−1 cm−1) 
λem 
(nm) 
ΦF 
(%) 
νST 
(nm) 
νST (cm−1) 
CH2Cl2 542 16,500 680 53 138 3,744 
THF 563 11,900 697 20 134 3,415 
MeOH 521 19,900 681 6 160 4,510 
MeCN 524 18,200 697 10 173 4,737 
DMSO 526 17,600 716 <1 190 5,045 
H2O 527 15,100 698 5 171 4,649 
aQuantum yields were measured according to published protocols using [Ru(bpy)3][PF6]2 
as a relative standard and corrected for wavelength-dependent detector sensitivity (Figure 
A4.18).[57-58] 
 
Figure 4.7   UV-vis absorption (solid line) and emission (dashed line) spectra of TEG-
functionalized complex 4.16 in CH2Cl2 (black) and H2O (red), recorded for degassed 
solutions at a concentration of 10−5 M.  
 
While the emission intensity of 4.16 was relatively low in water, many other fluorophores 
with low quantum yields have shown promise as cell-imaging agents, especially dyes 
which emit in the red to near-IR region.[76-80] With these factors in mind, complex 4.16 was 
introduced into mouse fibroblast cells and its utility as an imaging agent studied using 
fluorescence confocal microscopy.  
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Figure 4.8   Confocal fluorescence micrographs of mouse fibroblast cells stained with 
TEG-functionalized complex 4.16 and DAPI. Images (a) and (c) were visualized with 
excitation at 579 nm and emission collected between 620−720 nm. Images (b) and (d) are 
an overlay of images (a) and (c) with those obtained from excitation at 405 nm and emission 
collected between 425−475 nm. 
 
Complex 4.16 was successfully incorporated into the cells, as evidenced by the 
fluorescence micrographs shown in Figure 4.8. Specifically, complex 4.16 was distributed 
throughout the cell structure and clearly penetrated the cell nucleus. The dark spots 
visualized in Figure 4.8c are believed to be DNA-free nucleoli, and appear to be the only 
features of the cells that were not stained by 4.16. Despite the widespread incorporation of 
complex 4.16 throughout the cell, Figures 4.8b and 4.8d demonstrate our ability to 
differentiate between cytoplasm and nucleus when 4',6-diamidino-2-phenylindole (DAPI), 
119 
 
 
 
a selective nuclear stain, was employed concurrently. These results differed significantly 
when compared to previous studies involving BF2 complexes of 3-cyanoformazanates 
bearing p-anisole substituents.[60] The hydrophobic nature of the anisole-based dye resulted 
in selective staining of the cell cytoplasm and required the use of DMSO to achieve cellular 
uptake.[60] While we have not produced a site-specific imaging agent as part of this study, 
we have demonstrated our ability to create hydrophilic analogs of the parent complexes 
and shown that, in doing so, we can drastically alter their cellular uptake. This work sets 
the stage for future iterations whereby site-specific staining will be achieved through the 
introduction of hydrophilic, tailor-made peptide chains. 
4.3 π-Conjugated Polymers of BF2 Formazanates 
The use of CuAAC chemistry to incorporate BF2 formazanate complexes into π-conjugated 
polymers was also intriguing, as we demonstrated that extending the π conjugation of BF2 
formazanates (e.g., by replacing phenyl with naphthyl substituents), results in red-shifted 
wavelengths of maximum absorption and emission and increased emission quantum yields. 
Due to the limited solubility of BF2 formazanate complexes with 3-cyano substituents, BF2 
complexes 4.9 and 4.13 were not ideally suited for the envisioned polymer studies. To 
circumvent this issue, similar mono-alkyne 4.17 and bis alkyne 4.18 complexes with 3-
phenyl substituents were synthesized. These complexes can react with mono-azide 4.19 
and bis-azide 4.20 fluorene compounds to create π-conjugated polymers and model 
complexes. 
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Bis-alkyne substituted BF2 complex 4.18 and bis-azide substituted fluorene 4.20 were used 
to synthesize polymer 4.21 through copper-catalyzed alkyne-azide cycloaddition chemistry 
(see Scheme 4.2), and the same methods were used to synthesize model complexes 
4.24−4.26. The model compounds and polymer were fully characterized by 1H, 11B, 
13C{1H} and 19F NMR spectroscopy, UV-vis absorption and emission and IR spectroscopy 
(Figures A4.21−A4.36). 
 
Scheme 4.2 Synthesis of polymer 4.21 by copper-catalyzed alkyne-azide cycloaddition 
chemistry.  
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Polymerization reactions (Scheme 4.2) were monitored for 7 days by removing an aliquot 
after 24, 48, 72 and 168 h, and it was determined by gel permeation chromatography (GPC) 
that the molecular weight reached a maximum after 2 days (Figures 4.9, A4.37). 
Decreasing the catalyst loading from 5% to 2% resulted in a decreased number average 
molecular weight (Mn) from 17,000 g mol
−1 [Dispersity (Ɖ = 2.14)] to 6,000 g mol−1 (Ɖ = 
2.13). Optimized conditions were chosen to maximize polymer molecular weight, while 
minimizing reaction time, and thus a catalyst loading of 5% and reaction time of 48 h was 
selected as the conditions to be used for all further polymerizations.  
 
Figure 4.9 Number average molecular weight of 4.21 as a function of time. The black line 
has been added as a guide for the eye. 
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In the case of the polymer, the successful incorporation of both the BF2 formazanate and 
diheyxl fluorene repeating units was confirmed using NMR spectroscopy. We noted the 
disappearance of the terminal alkyne proton resonance (3.25 ppm), as well as the 
appearance of a singlet at 8.38 ppm, consistent with the presence of the triazole ring (Figure 
4.10). The boron and fluorine signals in the 11B and 19F NMR spectra were retained (11B 
NMR δ = −0.5 ppm, 19F NMR δ = −143.4 ppm), indicating that the structure of the BF2 
formazanate complex had been maintained throughout the polymerization process. The 
molecular weight distribution of a representative sample of 4.21 after 2 days was 
determined by gel permeation chromatography (GPC), yielding a polymer with Mn = 
17,000 g mol−1 and Đ = 2.14. 
 
Figure 4.10 1H NMR spectra of bis alkyne BF2 complex 4.18 (red), bis azide fluorene 4.20 
(blue) and polymer 4.21 (black) in CDCl3. The asterisks denote residual solvent signals.  
 
Thermal gravimetric analysis (TGA) showed that 4.21 degraded gradually up to a 
temperature of 255 °C, at which time it had lost 3% of its mass. Above 255 °C, the polymer 
degraded quickly to 55% of its original mass at 505 °C. Above 505 °C, slower degradation 
occurs to a final 43% of the initial mass at 1,000 °C (Figure A4.38). There was no 
observable glass transition (Tg) within the stability window (0 to 200 °C) determined for 
4.21 (Figure A4.39). Furthermore, there was also no observable melt transition in the 
differential scanning calorimetry (DSC) trace and powder X-ray diffraction studies and 
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scanning electron microscopy of a thin film of the polymer were consistent with the 
amorphous character of the polymer (Figures A4.40, A4.41).  
The polymer and each of the model compounds showed strong absorbance in the 200−350 
nm and the 500−600 nm regions of the electromagnetic spectrum in DMF (Table 4.3). First, 
we consider the low-energy wavelength of maximum absorption (λmax), which has been 
previously attributed to a BF2 formazanate π→π* transition with HOMO→LUMO 
character (Figure 4.11).[55] This transition in the polymer (λmax = 557 nm) is red-shifted by 
approximately 50 nm when compared to BF2 formazanate model compound 4.23 (λmax = 
505 nm). Furthermore, when we studied the same transition in fluorene-BF2-fluorene 
model compound 4.24 (λmax = 557 nm), it matched well with that of the polymer. In both 
polymer 4.21 and fluorene-BF2-fluorene model 4.24, each BF2 unit is bound to two triazole 
rings, potentially extending the degree of π conjugation. We also note that the same 
absorption in fluorene-BF2 model 4.25 (λmax = 533 nm), which has just one triazole bound 
to the BF2 moiety, was red-shifted by just 28 nm. Based on these results, we concluded that 
the introduction of each triazole ring shifted the formazanate λmax by approximately 30 nm. 
The similarity between polymer 4.21 and the model compounds also suggested that the 
properties of the polymer are not dictated by long range π conjugation along the polymer 
backbone. 
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Figure 4.11 a) UV-vis absorption spectra of 4.21 (purple), 4.23 (black), 4.24 (green) and 
4.25 (red), recorded for 10−5 M DMF solutions. b) Normalized UV-vis absorption spectra 
from 400−750 nm for comparison.  
 
Next, we considered the high-energy absorption maxima for these compounds (Figure 
4.12). This region is complex, as both hexyl fluorene (4.22) and the BF2 formazanate 
complex (4.23) absorb between 200–350 nm. When considering the 9,9-di-n-hexylfluorene 
contributions, we observed a similar trend to that of the absorption of the BF2 formazanate 
unit. The high-energy absorption band of polymer 4.21 (λmax = 327 nm) was red-shifted by 
23 nm, when compared to 4.22 (λmax = 304 nm). Again, we attributed the red-shift to 
extended π conjugation relating to the presence of the triazole rings bound to 9,9-di-n-
hexylfluorene. BF2-fluorene model compound 4.25 has a high energy wavelength of 
maximum absorption (λmax = 317 nm) which falls almost exactly half way between the 
wavelength of maximum absorption of 4.22 and polymer 4.21, further corroborating our 
conclusion that the observed trends in electronic properties arise due to the presence of the 
triazole rings and not extended π conjugation of the polymer backbone. The observed 
trends are consistent with similar compounds synthesized by alkyne-azide cycloaddition 
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chemistry.[25,48,81] We also note that the absorption profile is unchanged with variation in 
the molecular weight of polymer 4.21 (Figure A4.42). The thin-film absorption spectra of 
4.21 and all model compounds were red-shifted with respect to the solution-based spectra 
by ca. 20 nm, but were qualitatively similar, indicating the formation of J-aggregates 
(Figure A4.43). The estimated band gap (Eg) of 1.67 eV (Table 4.4), indicates that, despite 
the lack of long range π conjugation in polymer 4.21, it may find use as a light harvesting 
material in organic electronics. 
 
Figure 4.12 a) UV-vis absorption spectra of 4.21 (purple), 4.22 (grey), 4.25 (red) and 4.26 
(blue), recorded for 10−5 M DMF solutions. b) Normalized UV-vis absorption spectra for 
280−400 nm region for comparison. 
Each of the model compounds are weakly emissive in solution, with fluorescence quantum 
yields (ΦF) of < 3% in DMF (Table 4.3) and Stokes shifts (νST) ranging from 123−143 nm 
(3590−3880 cm−1). Polymer 4.21 exhibits two emission maxima when excited at 327 nm. 
The first is a broad, bimodal signal, with a wavelength of maximum emission (λem) at       
352 nm. The second maxima at 669 nm was consistent with the emissive behavior of BF2 
formazanates (Figure A4.44).[56] The fact that the intense emission normally associated 
with hexyl fluorene has been quenched leads us to believe that either a photoinduced 
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electron transfer (PET) mechanism or Förster resonance energy transfer (FRET) 
mechanism may be implicated for these systems. However, as the high energy 
absorption/emission bands for hexyl fluorene and the BF2 formazanate complexes overlap, 
we were unable to probe this behavior in detail. The emission profile of the polymer was 
also unchanged with variation in the molecular weight of the polymer. The emission 
spectra for the model compounds were qualitatively similar to the polymer, with the high 
energy emission maxima generally decreasing in intensity when the ratio of BF2 
formazanate to hexyl fluorene units was increased (Table 1). All of the compounds reported 
in this study were non-emissive in the solid state.  
Table 4.3 Summary of absorption/emission and electrochemical properties of 4.21−4.26 
in DMF and as thin films.  
 λmax, DMF 
(nm) 
λmax, film 
(nm) 
λem, DMF 
(nm) 
ΦF, DMF 
(%)a 
νST, DMF 
(nm) 
νST, DMF 
(cm−1) 
Ered1c 
(V) 
Ered2c 
(V) 
4.21 
327 - 352 
1.2 
55 4400 
−0.73 −1.76b 
557 586 696 139 3590 
4.22 304 - 317 41.5 13 1350 - - 
4.23 
306 - 338 
0.2 
32 3090 
−0.80 −2.00 
505 525 628 123 3880 
4.24 
314 - 382 
2.2 
68 5670 
−0.75 −1.86 
557 583 700 143 3670 
4.25 
317 - 352 
2.3 
35 3140 
−0.77 −1.84 
533 554 669 136 3810 
4.26 
326 - 383 
2.0 
57 4560 
−0.78 −1.93 
533 559 670 137 3840 
aQuantum yields were measured using ruthenium tris(bipyridine) hexafluorophosphate as 
a relative standard and corrected for wavelength-dependent detector sensitivity (Figure 
A4.18).[57-58] bOnset of irreversible reduction, cathodic peak potential quoted. cCyclic 
voltammetry experiments were conducted in DMF containing 1 mM analyte and 0.1 M 
[nBu4N][PF6] as supporting electrolyte at a scan rate of 250 mV s
−1. All voltammograms 
were referenced internally against the ferrocene/ferrocenium redox couple.  
 
The electrochemical properties of polymer 4.21 and each of the model compounds are 
dominated by the BF2 formazanate fragments, as 9,9-di-n-hexylfluorene is not redox-active 
within the electrochemical window of DMF (Figure A4.45). Model compounds gave rise 
to two reversible one-electron reduction waves per BF2 unit in their cyclic voltammograms 
(Figures A4.45−4.49). As stated earlier, the first reduction corresponds to the formation of 
a ligand-centered radical anion, and the second to a ligand-centered dianion.[54,82-83] 
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Polymer 4.21 displayed broadened electrochemical features, including a chemically-
reversible one-electron reduction at Ered1 = −0.73 V vs. the ferrocene/ferrocenium redox 
couple, and a second one-electron irreversible reduction at an onset potential, Epc = −1.76 
V (Figure 4.13). We also consistently observed the presence of a small irreversible 
oxidation event over multiple experiments at an onset of Epa = 0.35 V. The first reduction 
potentials (Ered1) of the compounds and polymer follow a logical trend with the number of 
triazoles present in the compound (Table 4.3). The model compound with no triazoles 
present (4.23) is the most difficult to reduce, at Ered1 = −0.80 V. Adding one triazole, in 
model compounds 4.25 and 4.26 makes the BF2 formazanate slightly easier to reduce (Ered1 
= −0.77 V and −0.78 V, respectively). Finally, compound 4.24 with two triazoles is the 
easiest model compound to reduce, with a first reduction potential of −0.75 V, very similar 
to that of polymer 4.21 (Ered1 = −0.73 V). The energies of the lowest occupied molecular 
orbital (ELUMO) for each species were estimated from the onset of the first reduction, and 
ranged from −4.79 to −4.81 eV (Table 4.4).   
Table 4.4 Optical and electrochemical band gaps and HOMO/LUMO energies of 4.21, 
4.23−4.26. 
 Eg (nm)a Eg (eV)a ELUMO (eV)b EHOMO (eV)c 
4.21 744 1.67 −4.81 −6.48 
4.23 660 1.88 −4.74 −6.62 
4.24 736 1.68 −4.77 −6.45 
4.25 703 1.76 −4.75 −6.51 
4.26 700 1.77 −4.76 −6.53 
aEstimated from the onset of absorption in the thin-film UV-vis spectra. bEstimated from 
the onset of the first electrochemical reduction, with the ferrocene/ferrocenium oxidation 
set at a potential of 5.39 eV.[84] cEstimated from the ELUMO level and the optical band gap. 
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Figure 4.13 Cyclic voltammogram of polymer 4.21 recorded at 250 mV s−1 in a 1 mM 
DMF solution containing 0.1 M [nBu4N][PF6] as supporting electrolyte.  
 
4.4 Conclusions 
As a result of this work, we have demonstrated the effect of triazole formation on the 
spectroscopic and electrochemical properties of BF2 complexes of formazanate ligands. 
Complexes functionalized with benzyl groups showed that the formation of triazole rings 
resulted in red-shifted wavelengths of maximum absorption and emission, as well as 
increased fluorescence quantum yields. Triazole formation also resulted in BF2 complexes 
that were more difficult to reduce electrochemically. We also demonstrated how CuAAC 
chemistry could be used to expand the scope of BF2 formazanate chemistry. The 
attachment of ferrocene into the BF2 formazanate scaffold via CuAAC resulted in the 
formation of a non-emissive complex with rich electrochemistry. Specifically, an oxidation 
wave corresponding to one electron per ferrocene group, and two reduction waves (one 
electron each) originating from the formazanate backbone were observed by cyclic 
voltammetry. Furthermore we showed that the stepwise conversion of ferrocene to 
ferrocenium was accompanied by an increase in emission intensity, confirming our 
hypothesis that quenching arose due to excited-state electron transfer from the formazanate 
backbone to ferrocene.  Additionally, CuAAC chemistry was used to append water-
solubilizing TEG chains to a BF2 formazanate complex. The resulting complex was used 
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to image mouse fibroblast cells, and demonstrated our ability to control cellular uptake via 
the modification of hydrophobicity/hydrophilicity. Finally, we successfully synthesized the 
first π-conjugated polymer based on BF2 formazanate complexes. Comparison of model 
complexes with that of the polymer indicated that π conjugation does not extend beyond 
the triazole groups formed by alkyne-azide cycloaddition. Based on the thin-film UV-vis 
absorption spectra we estimate an optical band gap of 1.67 eV for the polymer, highlighting 
the potential application of this material in organic light-harvesting devices. 
4.5 Experimental section 
4.5.1 General Considerations 
Reactions and manipulations were carried out under a nitrogen atmosphere using standard 
Schlenk techniques unless otherwise stated. Solvents were obtained from Caledon 
Laboratories, dried using an Innovative Technologies Inc. solvent puriﬁcation system, 
collected under vacuum and stored under a nitrogen atmosphere over 4 Å molecular sieves. 
Reagents were purchased from Sigma-Aldrich or Alfa Aesar and used as received. TEG-
N3,
[85] Fc-N3,
[86] 4.20,[51] 4.22,[87] and 4.23[55] were prepared according to literature 
procedures.  
NMR spectra were recorded on 400 MHz (1H: 399.8 MHz, 11B: 128.3 MHz, 19F: 376.1 
MHz) or 600 MHz (1H: 599.5 MHz, 13C: 150.8 MHz) Varian INOVA instruments. 1H 
NMR spectra were referenced to residual CHCl3 (7.26 ppm) or DMSO-d6 (2.50 ppm) and 
13C NMR spectra were referenced to CDCl3 (77.2 ppm) or DMSO-d6 (39.5 ppm). 
11B 
spectra were referenced to BF3·OEt2 at 0 ppm and 
19F spectra were referenced to CFCl3 at 
0 ppm. Mass spectrometry data were recorded in positive-ion mode using a high-resolution 
Finnigan MAT 8400 spectrometer using electron impact ionization or a Micromass LCT 
electrospray time-of-flight mass spectrometer. UV-vis absorption spectra were recorded 
using Cary 300 or Cary 5000 instruments. Four separate concentrations were run for each 
sample and molar extinction coefficients were determined from the slope of a plot of 
absorbance against concentration. Thin-film absorption spectra were recorded for films 
prepared by spin coating onto glass from a 15 mg mL−1 solution in chlorobenzene at room 
temperature. FT-IR spectra were recorded on a KBr disk or using an attenuated total 
reflectance (ATR) attachment using a Bruker Vector 33 FT-IR spectrometer. Emission 
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spectra were obtained using a Photon Technology International QM-4 SE 
spectrofluorometer. Excitation wavelengths were chosen based on λmax from the respective 
UV-vis absorption spectrum in the same solvent. Emission quantum yields were estimated 
relative to [Ru(bpy)3][PF6]2 and corrected for wavelength dependent detector sensitivity 
(Figure A4.18).[57] Powder samples of 4.21 were analyzed using an Inel CPS powder 
diffractometer with a Cu Kα source of λ = 1.5406 Å. 
4.5.2 Electrochemical Methods  
Cyclic voltammetry experiments were performed with a Bioanalytical Systems Inc. (BASi) 
Epsilon potentiostat and analyzed using BASi Epsilon software. Electrochemical cells 
consisted of a three-electrode setup including a glassy carbon working electrode, platinum 
wire counter electrode and silver wire pseudo reference electrode. Experiments were run 
at scan rates of 100 or 250 mV s−1 in degassed THF or DMF solutions of the analyte (~1 
mM) and supporting electrolyte (0.1 M [nBu4N][PF6]). Cyclic voltammograms were 
referenced against an internal standard (~1 mM ferrocene) and corrected for internal cell 
resistance using the BASi Epsilon software.  
4.5.3 Gel Permeation Chromatography (GPC)  
GPC experiments were conducted in chromatography-grade DMF at concentrations of 5 
mg mL−1 using a Waters 2695 separations module equipped with a Waters 2414 differential 
refractometer and two PLgel 5 m mixed-D (300 × 7.5 mm) columns from Polymer 
Laboratories connected in series. The calibration was performed using polystyrene 
standards. 
4.5.4 Thermal Analysis 
Thermal degradation studies were performed using a TA Instruments Q50 TGA. A sample 
of polymer 4.21 was placed in a platinum pan and heated at a rate of 10 °C min−1 from 
room temperature to 1,000 °C under a flow of nitrogen (100 mL min−1). Differential 
Scanning Calorimetry studies were performed on a TA Instruments DSC Q2000. A sample 
of polymer 4.21 was placed in an aluminum Tzero pan and heated from 20 °C to 200 °C at 
10 °C min−1 under a flow of nitrogen (50 mL min−1) and cooled down to 20 °C at                    
10 °C min−1, before the sample underwent two additional heating/cooling cycles.  
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4.5.5 Scanning Electron Microscopy 
Thin films of polymer 4.21 were prepared by spin coating (150 rpm, 10 s, then 2000 rpm, 
30 s) a 15 mg mL‒1 solution of 4.21 in chlorobenzene at room temperature onto silicon 
wafers. The surface morphology was assessed directly by scanning electron microscopy 
(SEM) at 2 keV beam energy using the LEO/Zeisss 1530 instrument at the Western 
Nanofabrication Facility. 
4.5.6 X-ray Crystallography Details  
Single crystals of mono-alkyne-substituted complex 4.9 suitable for X-ray diffraction 
studies were grown by slow evaporation of a concentrated CH2Cl2 solution. The sample 
was mounted on a MiTeGen polyimide micromount with a small amount of Paratone N oil. 
X-ray measurements were made on a Bruker Kappa Axis Apex2 diffractometer at a 
temperature of 110 K. The data collection strategy included a number of ω and φ scans 
which collected data over a range of angles, 2θ. The frame integration was performed using 
SAINT.[88] The resulting raw data was scaled and absorption corrected using a multi-scan 
averaging of symmetry equivalent data using SADABS.[89] The structure was solved by 
using a dual space methodology using the SHELXT program.[90] All non-hydrogen atoms 
were obtained from the initial solution. The hydrogen atoms were introduced at idealized 
positions and were allowed to refine isotropically. The structural model was fit to the data 
using full matrix least-squares based on F2. The calculated structure factors included 
corrections for anomalous dispersion from the usual tabulation. The structure was refined 
using the SHELXL-2014 program from the SHELXT suite of crystallographic software.[91] 
See Table 4.5 for additional crystallographic data. 
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Table 4.5   X-ray diffraction data collection and refinement details for mono-alkyne-
substituted complex 4.9. 
 4.9 
Chemical Formula C17H12BF2N5O 
FW (g mol−1) 351.13 
Crystal Habit Purple Prism 
Crystal System monoclinic 
Space Group C2/c 
T (K) 110 
λ (Å) 0.71073 
a (Å) 10.248(6) 
b (Å) 14.634(7) 
c (Å) 11.146(5) 
α (deg) 90 
β (deg) 107.352(18) 
γ (deg) 90 
V (Å3) 1595.5(14) 
Z 4 
ρ (g/cm3) 1.462 
μ (cm1) 0.111 
R1,
a wR2
b [I > 2σ] 0.0428, 0.0963 
R1, wR2 (all data) 0.0770, 0.1107 
GOFc 1.038 
aR1 = (|Fo||Fc|)/Fo, bwR2 = [(w(Fo2Fc2)2)/(wFo4)]½, cGOF = [(w(Fo2-Fc2)2)/(No. of 
reflns. - No. of params.)]½ 
 
4.5.7 Cell Imaging Studies 
Mouse fibroblast C3H/10T1/2 cells (ATCC) were released from the tissue culture flask 
and seeded onto cover slips in a 12-well tissue culture plate at approximately 50 000 cells 
per well. The cells were incubated overnight in Dulbecco’s modified Eagle’s medium 
(DMEM, Sigma-Aldrich) containing 10% fetal bovine serum (FBS, Sigma-Aldrich) with 
penicillin streptomycin at 37 °C in a 5% CO2 atmosphere. Cell media was aspirated and 
the cells were washed once with serum free media and twice with phosphate buffer saline 
(PBS, Sigma-Aldrich). Water-soluble complex 4.16 (8 mg) was dissolved into 5 mL 
DMEM (serum free), filter sterilized with a 0.2 μm filter and diluted to 100 μM with serum 
free DMEM. The dye stock was incubated at 37 °C for 1 h with the cells. The cells were 
washed twice with PBS, fixed with 4% paraformaldehyde and mounted onto slides 
containing Pro-Long Antifade mounting medium with DAPI (ThermoFisher Scientific). 
Fluorescence microscopy images were obtained using an Olympus FluoView FV 1000 
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confocal microscope. Images based on the fluorescence of DAPI were obtained using 2% 
laser strength, with excitation at 405 nm and emission collected between 425 and 475 nm. 
Images based on the fluorescence of complex 4.16 were obtained using 10% laser strength, 
with excitation at 579 nm and emission collected between 620 and 720 nm.  
Formazan 4.8 
In air, cyanoacetic acid (1.00 g, 11.7 mmol) and NaOH (4.70 
g, 117 mmol) were mixed with deionized H2O (60 mL) and 
the solution was stirred in an ice bath for 20 min. Meanwhile, 
in a separate flask, 4-ethynylaniline (1.10 g, 9.36 mmol) was 
mixed with 12 M HCl (2.3 mL, 28 mmol) in deionized H2O (2.3 mL). The solution was 
cooled in an ice bath for 15 min before a cooled solution of sodium nitrite (0.75 g, 10 
mmol) in deionized H2O (7 mL) was added dropwise. The resulting reaction mixture, 
which contained the corresponding diazonium salt, was stirred in an ice bath for an 
additional 20 min. In the meantime, in a separate flask, p-anisidine (1.4 g, 12 mmol) was 
mixed with 12 M HCl (2.9 mL, 35 mmol) in deionized H2O (2.9 mL). The solution was 
cooled in an ice bath for 15 min before a cooled solution of sodium nitrite (0.93 g, 13 
mmol) in deionized H2O (8 mL) was added dropwise. The resulting reaction mixture, 
which contained diazonium salt, was stirred in an ice bath for an additional 20 min. The 
diazonium salt solutions were then mixed together and stirred in an ice bath for 10 min. 
The diazonium-containing solution was then added dropwise to the cyanoacetic acid 
solution. The solution turned dark red after approximately 2 min. After complete addition, 
the mixture was stirred in an ice bath for an additional 60 min before it was neutralized 
with 1M HCl. The resulting red-brown solid was filtered off and purified by flash 
chromatography using a gradient strategy (starting at 1:1 n-hexanes:CH2Cl2 and ending 
with 2:8 n-hexanes:CH2Cl2) where the second coloured fraction contained the desired 
product. Removal of the solvent in vacuo afforded mono-alkyne-substituted formazan 4.8 
as a dark red microcrystalline solid. Yield = 0.89 g, 25%. M.p 212213 oC. 1H NMR (400.1 
MHz, DMSO-d6): δ 12.49 (br s, 1H, NH), 8.08 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.54 (d, 4H, 
aryl CH), 7.18 (d, 3JHH = 9 Hz, 2H, aryl CH), 4.19 (s, 1H, alkyne CH), 3.91 (s, 3H, 
OCH3).
13C{1H} NMR (100.6 MHz, DMSO-d6): δ 163.2, 145.9, 142.5, 132.8, 126.9, 126.2, 
116.6, 115.5, 114.8, 112.6, 83.3, 80.5, 55.7. FT-IR(ATR): 3308 (m), 3230 (m), 2942 (s), 
134 
 
 
 
2837 (s), 2224 (m), 2099 (m), 1605 (m), 1579 (m), 1514 (s), 1249 (s), 1183 (s), 1164 (s), 
1140 (s), 1110 (m), 1028 (m) cm–1. UV-Vis (CH2Cl2): λmax 444 nm (ε = 26,400 M1 cm1). 
Mass Spec. (EI, +ve mode): exact mass calculated for [C17H13N5O]
+: 303.1120; exact mass 
found: 303.1111; difference: –3.0 ppm.  
Formazanate BF2 complex 4.9 
Formazan 4.8 (0.40 g, 1.3 mmol) was dissolved in dry toluene 
(75 mL). NEt3 (0.40 g, 0.55 mL, 3.9 mmol) was then added 
slowly, and the solution was stirred for 10 min before BF3•OEt2 
(0.94 g, 0.81 mL, 6.6 mmol) was added and the solution was 
heated to 80 oC with stirring for 16 h. The solution became dark purple during this time 
and after cooling to 22 C, deionized H2O (10 mL) was added to quench any excess boron-
containing compounds. The toluene solution was then washed with deionized H2O (3  20 
mL), dried over MgSO4, gravity filtered, and concentrated in vacuo. The resulting 
compound was purified by flash chromatography (THF, neutral alumina) to afford mono-
alkyne-substituted complex 4.9 as a dark-purple solid. Yield = 0.31 g, 68%. M.p 199201 
oC. 1H NMR (399.8 MHz, CDCl3): δ 7.96 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.85 (d, 3JHH = 9 
Hz, 2H, aryl CH), 7.59 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.00 (d, 
3JHH = 9 Hz, 2H, aryl CH), 
3.91 (s, 3H, OCH3), 3.27 (s, 1H, alkyne CH). 
13C{1H} NMR (150.7 MHz, CDCl3): δ 163.0, 
142.9, 136.8, 133.0, 125.3, 124.5, 122.5, 115.0, 114.0, 82.5, 80.7, 55.8. 11B NMR (128.3 
MHz, CDCl3): δ –0.7 (t, 1JBF = 31 Hz). 19F NMR (376.1 MHz, CDCl3): δ –133.7 (q, 1JFB = 
31 Hz). FT-IR (ATR): 3282 (m), 2928 (s), 2840 (s), 2240 (m), 1593 (s), 1505 (m), 1407 
(s), 1343 (s), 1328 (s), 1307 (s), 1262 (s), 1166 (s), 1138 (s) cm–1. UV-Vis (CH2Cl2): λmax 
552 nm (ε = 30,400 M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C17H12BF2N5O]
+:  351.1103; exact mass found: 351.1108; difference: +1.4 ppm. 
Complex 4.10 
A solution of PMDETA (0.002 g, 0.003 mL, 0.01 
mmol) in dry THF (2 mL) was degassed via 3 freeze-
pump-thaw cycles before CuI (0.003 g, 0.014 mmol) 
was added and the resulting mixture was stirred for 15 
min at 22 C. Benzyl azide (0.04 g, 0.04 mL, 0.3 mmol) and mono-alkyne-substituted 
complex 7 (0.1 g, 0.3 mmol) were then added and the reaction mixture was stirred at 22 C 
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for 16 h. Upon cooling, the THF solution was then purified by flash chromatography (THF, 
neutral alumina) and recrystallized from MeOH to afford mono-benzyl-functionalized 
complex 4.10 as a dark-purple microcrystalline solid. Yield = 0.14 g, 51%. M.p 188189 
oC. 1H NMR (400.1 MHz, CDCl3): δ 7.957.93 (m, 6H, aryl CH), 7.75 (s, 1H, =CH), 
7.427.40 (m, 3H, aryl CH), 7.347.32 (m, 2H, aryl CH), 7.00 (d, 3JHH = 9 Hz, 2H, aryl 
CH) 5.60 (s, 2H, CH2), 3.90 (s, 3H, CH2). 
13C{1H} NMR (150.7 MHz, CDCl3): δ 162.7, 
146.6, 142.6, 136.8, 134.4, 132.9, 129.2, 128.9, 128.1, 126.4, 125.2, 123.3, 120.5, 114.9, 
114.3, 55.8, 54.3.  11B NMR (128.3 MHz, CDCl3): δ –0.7 (t, 1JBF = 29 Hz). 19F NMR (376.1 
MHz, CDCl3): δ –134.2 (q, 1JFB = 29 Hz). FT-IR(ATR): 3123 (m), 2849 (m), 2250 (m), 
1603 (s), 1509 (m), 1460 (m), 1375 (s), 1344 (s), 1326 (s), 1308 (s) cm–1. UV-Vis (CH2Cl2): 
λmax 560 nm (ε = 31,000 M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C24H19BF2N8O]
+: 484.1743; exact mass found: 484.1759; difference: +3.3 ppm. 
Complex 4.11 
A solution of PMDETA (0.0018 g, 0.0022 mL, 0.011 
mmol) in THF (3 mL) was degassed via 3 freeze-pump-
thaw cycles before CuI (0.0020 g, 0.011 mmol) was 
added and the resulting mixture was stirred for 30 min. 
Ferrocenyl azide (0.024 g, 0.11 mmol) and mono-alkyne-substituted complex 4.9 (0.037 g, 
0.11 mmol) were then added and the reaction mixture was stirred at 50 °C for 18 h. The 
resulting dark purple solution was filtered through a plug of celite and purified by flash 
chromatography (CH2Cl2, silica gel) to afford ferrocene-functionalized complex 4.11 as a 
dark purple powder. Yield = 0.044 g, 72%. Melting point not observed (Melting point > 
250 oC). 1H NMR (400.1 MHz, CDCl3): δ 8.06 (s, 1H, triazole CH), 8.02–7.95 (m, 6H, aryl 
CH), 7.01–7.00 (m, 2H, aryl CH), 4.90 (s, 2H, ferrocene CH), 4.32 (s, 2H, ferrocene CH), 
4.26 (s, 6H, ferrocene CH), 3.91 (s, 3H, OCH3). 
13C{1H} NMR (150.7 MHz, CDCl3): δ 
162.9, 146.3, 142.9, 137.0, 132.9, 126.7, 125.4, 123.6, 120.0, 115.1, 114.4, 93.6, 70.4, 67.1, 
62.4, 62.3, 56.0.  11B NMR (128.3 MHz, CDCl3): δ –0.7 (t, 1JBF = 30 Hz). 19F NMR (376.1 
MHz, CDCl3): δ –134.1 (q, 1JFB = 30 Hz). FT-IR(ATR): 3092 (w), 2926 (m), 2842 (m), 
2241 (m), 1597 (s), 1505 (m), 1342 (m), 1261 (s), 1167 (s), 1029 (m), 965 (m), 832 (m), 
733 (s) cm–1. UV-Vis (CH2Cl2): λmax 562 nm (ε = 28,600 M1 cm1). Mass Spec. (EI, +ve 
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mode): exact mass calculated for [C27H21BF2FeN8O]
+: 578.1249; exact mass found: 
578.1261; difference: +2.1 ppm. 
Formazan 4.12 
In air, cyanoacetic acid (0.47 g, 5.5 mmol) was dissolved in 
deionized H2O (75 mL) containing NaOH (2.20 g, 55 mmol).  
This colourless solution was stirred for 45 min in an ice bath. 
Meanwhile, 4-ethynylaniline (1.30 g, 12 mmol) was mixed 
with concentrated HCl (2.85 mL) in deionized H2O (30 mL). This solution was cooled in 
an ice bath for 10 min before a solution of sodium nitrite (1.01 g, 15 mmol) in deionized 
H2O (15 mL) was cooled in an ice bath, and then added slowly to the 4-ethynylaniline 
solution over a 10 min period. This mixture was stirred in an ice bath for 30 min, and then 
added slowly to the basic cyanoacetic acid solution. A dark red/orange colour persisted 
almost immediately, and a dark red/orange precipitate formed after a few min. The mixture 
was stirred in an ice bath for an additional 16 h before ethyl acetate (250 mL) was added 
and the organic layer was isolated, washed with deionized H2O (3  100 mL), dried over 
MgSO4, gravity filtered and concentrated in vacuo. The resulting residue was purified by 
flash chromatography (CH2Cl2, neutral alumina) to afford bis-alkyne-substituted formazan 
4.12 as a dark red solid. Yield = 1.55 g, 94%. Melting point not observed (>250 °C). 1H 
NMR (599.5 MHz, CDCl3) δ 12.60 (s, 1H, NH), 7.60 (s, 8H, aryl CH), 3.24 (s, 2H, alkyne 
CH). 13C{1H} NMR (100.6 MHz, DMSO-d6): δ 146.8, 133.0, 126.9, 121.7, 120.2, 112.5, 
83.2, 82.8. FT-IR (KBr): 3397 (br, s), 3261 (m), 2915 (m), 2850 (m), 2221 (s), 1653 (s), 
1540 (m), 1268 (m), 1193 (m), 1142 (m) cm1. UV-vis (CH2Cl2): λmax = 434 nm (ε = 22,800 
M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for [C18H11N5]
+: 297.1014; 
exact mass found: 297.1018; difference: +1.3 ppm.  
Formazanate BF2 complex 4.13 
Formazan 4.12 (1.00 g, 3.40 mmol) was dissolved in dry toluene 
(100 mL). NEt3 (1.03 g, 1.42 mL, 10.2 mmol) was then added 
slowly and the solution was stirred for 10 min before BF3•OEt2 
(2.39 g, 2.08 mL, 16.8 mmol) was added and the solution was 
heated with stirring at 80 ºC for 18 h. The solution gradually turned from dark red to dark 
purple during this time. After cooling to 22 ºC, deionized H2O (10 mL) was added to 
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quench any excess reactive boron-containing compounds. The purple toluene solution was 
then washed with deionized H2O (3  50 mL), dried over MgSO4, gravity filtered and 
concentrated in vacuo. The resulting residue was purified by flash chromatography 
(CH2Cl2, neutral alumina) to afford bis-alkyne-substituted complex 4.13 as a dark purple 
microcrystalline solid. Yield = 0.82 g, 70%. Melting point = 218 °C (decomp.). 1H NMR 
(599.5 MHz, CDCl3) δ 7.91 (d, 3JHH = 9 Hz, 4H, aryl CH), 7.61 (d, 3JHH = 9 Hz, 4H, aryl 
CH), 3.32 (s, 2H, alkyne CH). 13C{1H} NMR (100.6 MHz, CDCl3): δ 143.0, 133.4, 126.0, 
123.2, 113.8, 82.6, 81.8. 11B NMR (128.3 MHz, CDCl3): δ –0.8 (t, 1JBF = 31 Hz). 19F NMR 
(376.1 Hz, CDCl3): δ –132.0 (q, 1JFB = 31 Hz). FT-IR (KBr): 3290 (s), 3189 (m), 3108 (m), 
3092 (m), 2244 (s), 1589 (s), 1391 (m), 1331 (s), 1187 (m), 1147 (s), 1033 (m), 958 (m), 
838 (s) cm1. UV-vis (CH2Cl2): λmax = 530 nm (ε = 32,700 M1 cm1). Mass Spec. (EI, +ve 
mode): exact mass calculated for [C18H10N5BF2]
+: 345.0997; exact mass found: 345.0999; 
difference: +0.6 ppm.  
Complex 4.14 
A solution PMDETA (0.0075 g, 0.0091 mL, 
0.044 mmol) in THF (3 mL) was degassed via 3 
freeze-pump-thaw cycles before CuI (0.0083 g, 
0.044 mmol) was added and the resulting 
mixture was stirred for 30 min. Benzyl azide (0.174 g, 1.30 mmol) and bis-alkyne-
substituted complex 4.13 (0.150 g, 0.44 mmol) were then added and the reaction mixture 
was stirred at 50 °C for 18 h. Upon cooling, the resulting dark purple solution was filtered 
through a plug of celite and purified by flash chromatography (CH2Cl2, silica gel) to afford 
bis-benzyl-functionalized complex 4.14 as a dark-purple solid. Yield = 0.21 g, 77%. 
Melting point not observed (>250 °C). 1H NMR (599.5 MHz, CDCl3) δ 7.997.94 (m, 8H, 
aryl CH), 7.76 (s, 2H, triazole CH), 7.437.38 (m, 6H, aryl CH), 7.347.33 (m, 4H, aryl 
CH), 5.60 (s, 4H, benzyl CH2). 
13C{1H} NMR (150.7 MHz, CDCl3): δ 146.7, 142.8, 134.4, 
133.8, 129.4, 129.2, 128.3, 126.7, 123.8, 120.7, 114.2, 54.6. 11B NMR (128.3 MHz, 
CDCl3): δ –0.7 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –133.1 (q, 1JFB = 29 Hz). 
FT-IR (KBr): 3109 (m), 3100 (s), 3035 (m), 2915 (m), 2246 (s), 1608 (s), 1497 (m), 1456 
(s), 1326 (s), 1226 (m), 1074 (s), 1027 (s), 976 (m), 826 (m) cm1. UV-vis (CH2Cl2): λmax 
138 
 
 
 
= 558 nm (ε = 39,600 M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C32H25N11BF2]
+: 612.2356; exact mass found: 612.2362; difference: +1.0 ppm.  
Complex 4.15 
A solution of PMDETA (0.0019 g, 0.0023 mL, 
0.011 mmol) in THF (4 mL) was degassed via 
3 freeze-pump-thaw cycles before CuI (0.0021 
g, 0.011 mmol) was added and the resulting 
mixture was stirred for 30 min. Ferrocenyl azide (0.050 g, 0.22 mmol) and bis-alkyne-
substituted complex 4.13 (0.038 g, 0.11 mmol) were then added and the reaction mixture 
was stirred at 50 °C for 18 h. The resulting dark purple solution was filtered through a plug 
of celite and purified by flash chromatography (CH2Cl2, silica gel) to afford ferrocene-
functionalized complex 4.15 as a dark purple powder. Yield = 0.08 g, 90%. Melting point 
not observed (>250 °C). 1H NMR (599.5 MHz, CDCl3) δ 8.08 (s, 2H, triazole CH), 8.05 
(s, 8H, aryl CH), 4.91 (m, 4H, ferrocene CH), 4.344.33 (m, 4H, ferrocene CH), 4.284.26 
(m, 10H, ferrocene CH). Due to the poor solubility of 4.15, and despite a saturated solution 
in THF-d8 being subjected to 10,000 scans (8 h) on a 600 MHz spectrometer, a publication 
quality 13C{1H} NMR spectrum was not obtained. 11B NMR (128.3 MHz, CDCl3): δ –0.6 
(t, 1JBF = 28 Hz). 
19F NMR (376.1 Hz, CDCl3): δ –132.8 (q, 1JFB = 28 Hz). FT-IR (KBr): 
3131 (w), 3092 (m), 2929 (m), 2246 (m), 1605 (s), 1381 (m), 1341 (s), 1226 (m), 1181 (s), 
1027 (m), 966 (s), 816 (s) cm1. UV-vis (CH2Cl2): λmax = 569 nm (ε = 30,900 M1 cm1). 
Mass Spec. (ESI, +ve mode): exact mass calculated for [C38H29N11BF2Fe2]
+: 800.1367; 
exact mass found: 800.1380; difference: +1.6 ppm.  
Complex 4.16 
A solution of PMDETA (0.0075 g, 0.0091 
mL, 0.044 mmol) in THF (3 mL) was 
degassed via 3 freeze-pump-thaw cycles 
before CuI (0.0083 g, 0.044 mmol) was 
added and the resulting solution was stirred for 30 min. TEG-azide (0.29 g, 1.30 mmol) 
and bis-alkyne-substituted complex 4.13 (0.15 g, 0.44 mmol) were then added and the 
reaction mixture was stirred at 50 °C for 18 h. The resulting dark purple solution was 
filtered through a plug of celite and purified by precipitation of a concentrated THF 
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solution into n-hexanes thrice to yield a dark purple solid. Yield = 0.24 g, 71%. 1H NMR 
(599.5 MHz, CDCl3) δ 8.20 (s, 2H, triazole CH), 8.00 (s, 8H, aryl CH), 4.634.61 (m, 4H, 
ethylene glycol CH2), 3.933.90 (m, 4H, ethylene glycol CH2), 3.713.57 (m, 24H, 
ethylene glycol CH2). 
13C{1H} NMR (150.7 MHz, CDCl3): 145.9, 142.4, 134.0, 126.5, 
123.6, 122.6, 114.1, 72.4, 70.5, 70.4, 70.3, 70.1, 69.4, 61.5, 50.5 ppm. 11B NMR (128.3 
MHz, CDCl3): δ –0.7 (t, 1JBF = 29 Hz). 19F NMR (376.1 Hz, CDCl3): δ –133.1 (q, 1JFB = 
29 Hz). FT-IR (KBr): 3132 (br), 3317 (w), 2915 (m), 2868 (m), 2242 (w), 1604 (s), 1527 
(w), 1461 (m), 1360 (m), 1333 (s), 1227 (m), 1179 (s), 1121 (s), 1069 (s), 1029 (s), 967 
(s), 845 (m), 765 (w) cm-1. UV-vis (CH2Cl2): λmax = 542 nm (ε = 16,500 M1 cm1). UV-
vis (H2O): λmax = 527 nm (ε = 15,100 M1 cm1). Mass Spec. (ESI, +ve mode): exact mass 
calculated for [C34H45N11O8BF2]
+: 784.3514; exact mass found: 784.3540; difference: +3.3 
ppm.  
2-Azido-9,9-dihexyl fluorene 4.19 
2-Bromo-9,9-di-n-hexylfluorene (2.50 g, 6.05 mmol) was dissolved in 
dry THF (125 mL) and cooled to −78 °C. n-BuLi (5.5 mL of a 2.5 M 
solution in hexanes, 14 mmol) was added slowly via a dropping funnel over a 20 min 
period. Upon addition, the solution turned a bright yellow color, and was stirred for 90 min 
at −78 °C. Tosyl azide (2.72 g, 13.8 mmol) was dissolved in 25 mL dry THF and added 
slowly to the 9,9-di-n-hexylfluorene solution, causing it to change to a dark orange/brown 
color. The reaction was warmed to room temperature and stirred for an additional 18 h. 
Deionized H2O (10 mL) was then added to quench any excess n-BuLi, and the organics 
were extracted into CH2Cl2, dried over MgSO4, gravity filtered and concentrated in vacuo. 
The resulting residue was purified by flash chromatography (petroleum ether, silica) to 
yield a light yellow oil. Yield = 0.58 g, 26%. 1H NMR (599.5 MHz, CDCl3) δ 7.67−7.64 
(m, 2H, aryl CH), 7.33−7.27 (m, 3H, aryl CH), 7.01−6.98 (m, 2H, aryl CH), 1.99−1.89 (m, 
4H, alkyl CH), 1.14−1.03 (m, 12H, alkyl CH), 0.77 (t, 3JHH = 7 Hz, 6H, alkyl CH), 
0.62−0.57 (m, 4H, alkyl CH). 13C{1H} NMR (100.6 MHz, CDCl3): δ 153.1, 150.6, 140.5, 
138.9, 138.6, 127.2, 127.1, 123.0, 120.9, 119.6, 117.9, 113.8, 55.4, 40.6, 31.7, 29.9, 23.9, 
22.8, 14.2. FT-IR (KBr): 2938 (m), 2926 (s), 2856 (m), 2102 (s), 1559 (m), 1456 (m), 1375 
(w), 1291 (m), 1123 (w), 1084 (w), 817 (m), 736 (m) cm−1. UV-vis (CH2Cl2): λmax = 276 
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nm (ε = 23,800 M−1 cm−1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C25H33N3]
+: 375.2674; exact mass found: 375.2669; difference: −1.3 ppm. 
1-p-ethynylphenyl-3-5-phenyl formazan 
In air, phenylhydrazine (0.9 g, 0.8 mL, 9 mmol) was dissolved in 
ethanol (10 mL) before benzaldehyde (0.9 g, 0.9 mL, 9 mmol) was 
added and the solution stirred for 10 min. After this time, a light 
yellow precipitate had formed and CH2Cl2 (75 mL) and deionized 
H2O (75 mL) were added to form a biphasic reaction mixture. Na2CO3 (2.88 g, 27.2 mmol) 
and [nBu4N][Br] (0.27 g, 0.85 mmol) were added, and the mixture was cooled with stirring 
for 30 min in an ice bath to 0 °C. In a separate flask, 4-ethynylaniline (1.00 g, 8.50 mmol) 
and concentrated HCl (2.2 mL, 26 mmol) were mixed in deionized H2O (15 mL) and cooled 
in an ice bath. A cooled solution of sodium nitrite (0.67 g, 9.7 mmol) in deionized H2O (5 
mL) was added slowly to the amine solution over a 5 min period. This mixture was then 
stirred at 0 °C for 30 min, after which time it was added dropwise to the biphasic reaction 
mixture described above over a 10 min period. The resulting solution was stirred for 18 h, 
gradually turning dark red over this time. The dark red organic fraction was then washed 
with deionized H2O (3 × 50 mL), dried over MgSO4, gravity filtered and concentrated in 
vacuo. The resulting residue was purified by flash chromatography (CH2Cl2, neutral 
alumina) to afford a dark red microcrystalline solid. Yield = 1.56 g, 57%. Melting point = 
181–183 °C. 1H NMR (599.5 MHz, CDCl3) δ 15.34 (s, 1H, NH), 8.13 (d, 3JHH = 7 Hz, 2H, 
aryl CH), 7.79 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.55 (s, 4H, aryl CH), 7.52−7.46 (m, 8H, aryl 
CH), 7.43−7.35 (m, 2H, aryl CH), 3.15 (s, 1H, alkyne CH). 13C{1H} NMR (100.6 MHz, 
CDCl3): δ 149.6, 146.5, 141.7, 137.3, 133.6, 129.6, 129.4, 128.6, 128.0, 126.1, 120.3, 
119.4, 117.4, 83.8, 78.1. FT-IR (KBr): 3280 (s), 3064 (m), 3033 (w), 2915 (m), 2849 (w), 
1506 (s), 1436 (m), 1348 (m), 1313 (m), 1227 (m), 1162 (m), 1017 (m), 826 (m), 762 (s) 
cm−1. UV-vis (CH2Cl2): λmax = 306 nm (ε = 39,400 M−1 cm−1), 491 nm (ε = 24,000 M−1 
cm−1). Mass Spec. (EI, +ve mode): exact mass calculated for [C21H16N4]
+: 324.1375; exact 
mass found: 324.1373; difference: −0.6 ppm. 
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1-p-ethynylphenyl-3,5-phenyl formazanate BF2 complex 4.17 
Mono-alkyne substituted formazan (2.00 g, 6.17 mmol) was 
dissolved in dry toluene (200 mL).  NEt3 (1.9 g, 2.6 mL, 18 mmol) 
was then added slowly and the solution was stirred for 10 min. 
BF3·OEt2 (4.3 g, 3.8 mL, 30 mmol) was then added, and the solution 
was heated at 80 ºC for 18 h. The solution gradually turned from dark red to dark purple 
during this time. After cooling to 20 ºC, deionized H2O (10 mL) was added to quench any 
excess reactive boron-containing compounds. The purple toluene solution was then washed 
with deionized H2O (3 × 50 mL), dried over MgSO4, gravity filtered and concentrated in 
vacuo. The resulting residue was purified by flash chromatography (CH2Cl2, neutral 
alumina) to yield a dark purple microcrystalline solid. Yield = 1.87 g, 83%. Melting point 
= 166−168 °C. 1H NMR (399.8 MHz, CDCl3) δ 8.12 (d, 3JHH = 7 Hz, 2H, aryl CH), 
7.94−7.89 (m, 4H, aryl CH), 7.60 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.53−7.43 (m, 6H, aryl 
CH), 3.24 (s, 1H, alkyne CH) ppm. 13C NMR (100.6 MHz, CDCl3): δ 144.0, 133.5, 133.0, 
130.2, 129.6, 129.3, 128.9, 125.7, 123.6, 123.5, 123.2, 83.0, 80.1 ppm. 11B NMR (128.3 
MHz, CDCl3): δ −0.6 (t, 1JBF = 29 Hz) ppm. 19F NMR (376.1 MHz, CDCl3) δ −143.6 (q, 
1JBF = 29 Hz) ppm. FT-IR (KBr): 3066 (w), 3033 (w), 2917 (m), 2848 (m), 1507 (m), 1456 
(m), 1348 (m), 1232 (s), 1148 (m), 1042 (m), 1017 (m), 764 (m) cm−1. UV-vis (CH2Cl2): 
λmax = 312 nm (ε = 27,400 M−1 cm−1), 526 nm (ε = 28,300 M−1 cm−1). Mass Spec. (EI, +ve 
mode): exact mass calculated for [C21H15N4BF2]
+: 372.1358; exact mass found: 372.1355; 
difference: −0.8 ppm. 
1,5-p-ethynylphenyl-3-phenyl formazan 
In air, phenyl pyruvic acid (1.40 g, 8.53 mmol) was dissolved in 
100 mL deionized H2O containing NaOH (2.55 g, 6.38 mmol), 
and cooled in an ice bath. In a separate flask, 4-ethynyl aniline 
(2.00 g, 17.0 mmol) and concentrated hydrochloric acid (4.3 
mL) were mixed in deionized H2O (15 mL) and cooled in an ice bath to 0 C. A cooled 
solution of sodium nitrite (1.35 g, 20.0 mmol) in H2O (5 mL) was then added slowly to the 
amine solution over a 5 min period. This mixture was stirred at 0 °C for 30 min, after which 
time it was added dropwise to the biphasic reaction mixture described above over a 10 min 
period. A dark red/purple precipitate formed almost immediately. The resulting mixture 
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was stirred for an additional 18 h. The dark red/purple precipitate was then collected by 
filtration and washed with deionized H2O (3 × 50 mL). The resulting residue was purified 
by flash chromatography (CH2Cl2, neutral alumina) to afford a dark red microcrystalline 
solid. Yield = 1.70 g, 57%. Melting point = 157–159 °C. 1H NMR (599.5 MHz, CDCl3) δ 
15.28 (s, 1H, NH), 8.07−8.06 (m, 2H, aryl CH), 7.58−7.54 (m, 8H, aryl CH), 7.44−7.42 
(m, 2H, aryl CH), 7.37−7.35 (m, 1H, aryl CH), 3.20 (s, 2H, alkyne CH).  13C{1H} NMR 
(100.6 MHz, CDCl3): δ 147.8, 141.8, 137.0, 133.4, 128.5, 128.1, 126.1, 121.2, 118.8, 83.6, 
78.8. FT-IR (KBr): 3276 (s), 3056 (w), 3033 (m), 2921 (m), 2852 (m), 1506 (s), 1345 (m), 
1310 (w), 1224 (s), 1188 (m), 1162 (m), 1042 (m), 1018 (m), 832 (m), 768 (m) cm−1. UV-
vis (CH2Cl2): λmax = 276 nm (ε = 51,200 M−1 cm−1), 511 nm (ε = 20,500 M−1 cm−1). Mass 
Spec. (EI, +ve mode): exact mass calculated for [C23H16N4]
+: 348.1375; exact mass found: 
348.1380; difference: +1.4 ppm. 
1,5-p-ethynylphenyl-3-phenyl formazanate BF2 complex 
Bis-alkyne substituted formazan (0.70 g, 2.0 mmol) was 
dissolved in dry toluene (70 mL). NEt3 (0.61 g, 0.84 mL, 6.0 
mmol) was then added slowly and the solution was stirred for 10 
min. BF3·OEt2 (1.4 g, 1.2 mL, 10. mmol) was then added, and 
the solution was heated at 80 ºC for 18 h. The solution gradually turned from dark red to 
dark purple during this time. After cooling to 20 ºC, deionized H2O (10 mL) was added to 
quench any excess reactive boron-containing compounds. The purple toluene solution was 
then washed with deionized H2O (3 × 50 mL), dried over MgSO4, gravity filtered and 
concentrated in vacuo. The resulting residue was purified by flash chromatography 
(CH2Cl2, neutral alumina) to yield a dark purple microcrystalline solid. Yield = 0.51 g, 
65%. Melting point = 162−164 °C. 1H NMR (399.8 MHz, CDCl3) δ 8.11−8.09 (m, 2H, aryl 
CH), 7.91 (d, 3JHH
 = 8 Hz, 4H, aryl CH), 7.61−7.58 (m, 4H, aryl CH), 7.52−7.45 (m, 3H, 
aryl CH), 3.25 (s, 2H, alkyne CH) ppm. 13C NMR (100.6 MHz, CDCl3): δ 143.9, 133.4, 
133.1, 129.7, 129.0, 125.7, 123.9, 123.3, 118.8, 83.0, 80.4 ppm. 11B NMR (128.3 MHz, 
CDCl3): δ −0.6 (t, 1JBF = 29 Hz) ppm. 19F NMR (376.1 MHz, CDCl3) δ −142.9 (q, 1JBF = 
29 Hz) ppm. FT-IR (KBr): 3065 (w), 3035 (w), 2938 (m), 2922 (m), 2857 (m), 1508 (s), 
1456 (m), 1347 (m), 1301 (s), 1267 (s), 1222 (m), 1175 (m), 1119 (m), 1025 (m), 967 (s) 
cm−1. UV-vis (CH2Cl2): λmax = 317 nm (ε = 24,000 M−1 cm−1), 541 nm (ε = 27,700 M−1 
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cm−1). Mass Spec. (EI, +ve mode): exact mass calculated for [C23H15N4BF2]
+: 396.1358; 
exact mass found: 396.1360; difference: +0.5 ppm.   
Polymer 4.21 
In a typical procedure, 4.18 (0.13 g, 0.34 
mmol) was mixed with 4.20 (0.14 g, 0.34 
mmol) in dry THF (3 mL). Cu(PPh3)3Br 
(0.02 g, 0.02 mmol) was then added and the 
mixture was purged with N2 for 15 min. The 
reaction mixture was heated with stirring at 60 °C for 48 h before it was cooled to room 
temperature and filtered through a pad of neutral alumina. The resulting solution was added 
to cold hexanes to precipitate 4.21 as a dark purple solid. The precipitation was repeated 
two additional times before the solid was isolated by centrifugation and dried in vacuo. 
Yield = 0.26 g, 94%. 1H NMR (399.8 MHz, CDCl3) δ 8.38−8.30 (m, 2H, triazole CH), 
8.18−8.07 (m, 5H, aryl CH), 7.94−7.80 (m, 5H, aryl CH), 7.70−7.47 (m, 9H, aryl CH), 
2.13−1.82 (m, 6H, alkyl CH), 1.13−0.97 (m, 10H, alkyl CH), 0.80−0.69 (m, 8H, alkyl CH), 
0.49 (br s, 2H, alkyl CH) ppm. 11B NMR (128.3 MHz, CDCl3): δ −0.5 (br s) ppm. 19F NMR 
(376.1 MHz, CDCl3) δ −143.4 (br s) ppm. FT-IR (KBr): 3057 (m), 2936 (m), 2924 (s), 
2852 (s), 1473 (m), 1436 (m), 1346 (m), 1299 (m), 1268 (m), 1222 (m), 1176 (m), 1119 
(m), 1007 (m), 963 (m), 842 (m), 720 (m) cm−1. UV-vis (DMF): λmax 330 nm (ε = 45, 700 
M−1 cm−1), 559 nm (ε = 25, 700 M−1 cm−1). GPC (DMF, conventional calibration vs. PS 
standards): Mn = 17,000 g mol
−1, Mw = 32,750 g mol
−1, Đ = 2.14. 
Study of Change in Molecular Weight vs. Time for 4.21 
In a typical procedure, 4.18 (0.119 g, 0.30 mmol) was mixed with 4.20 (0.125 g, 0.30 
mmol) in dry THF (3 mL). Cu(PPh3)3Br (0.014 g, 0.015 mmol) was then added, and the 
mixture was purged with N2 for 15 min. The reaction mixture was heated with stirring at 
60 °C. Aliquots (0.5 mL) were removed from the reactions at 12, 24, 48, 72 and 168 h. 
Each aliquot was filtered through a pad of neutral alumina. The resulting solution was 
added to cold hexanes to precipitate 4.21 as a dark purple solid. The precipitation was 
repeated two additional times. The degree of polymerization was determined by GPC 
analysis in DMF (conventional calibration vs. polystyrene).  
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Complex 4.24 
4.18 (0.10 g, 0.25 mmol) was 
mixed with 4.19 (0.19 g, 0.50 
mmol) in dry THF (4 mL).  
Cu(PPh3)3Br (0.02 g, 0.03 mmol) 
was then added and the mixture 
was purged with N2 gas for 15 
min. The reaction mixture was heated with stirring at 60 °C for 18 h before it was cooled 
to room temperature and filtered through a pad of neutral alumina. The resulting purple 
solution was concentrated in vacuo and the residue was purified by flash chromatography 
(CH2Cl2, silica gel) to afford 4.24 as a dark purple solid. Yield = 0.21 g, 71%. Melting 
point = 77−79 °C. 1H NMR (399.8 MHz, CDCl3) δ 8.36 (s, 2H, triazole CH), 8.18 (d, 3JHH 
= 8 Hz, 2H, aryl CH), 8.11−8.07 (m, 8H, aryl CH), 7.85−7.82 (m, 4H, aryl CH), 7.76−7.73 
(m, 4H, aryl CH), 7.54−7.46 (m, 3H, aryl CH), 7.40−7.37 (m, 6H, aryl CH), 2.06−2.03 (m, 
8H, alkyl CH), 1.13−1.02 (m, 24H, alkyl CH), 0.76 (t, 3JHH = 7 Hz, 12H, alkyl CH), 
0.68−0.63 (m, 8H, alkyl CH) ppm. 13C NMR (100.6 MHz, CDCl3): δ 152.8, 151.0, 147.2, 
143.8, 142.1, 139.7, 135.9, 133.6, 131.8, 129.5, 129.5, 128.9, 128.0, 127.2, 126.5, 125.6, 
124.0, 123.1, 120.7, 120.2, 119.4, 118.5, 115.4, 55.7, 40.4, 31.5, 29.7, 23.8, 22.6, 14.0 ppm. 
11B NMR (128.3 MHz, CDCl3): δ −0.5 (t, 1JBF = 29 Hz) ppm. 19F NMR (376.1 MHz, 
CDCl3) δ −143.6 (q, 1JBF = 29 Hz) ppm. FT-IR (KBr): 3141 (m), 3035 (m), 2938 (m), 2924 
(s), 2852 (m), 1457 (s), 1299 (s), 1268 (s), 1227 (m), 1180 (m), 1122 (w), 1028 (m), 963 
(s), 843 (m), 737 (m) cm−1. UV-vis (CH2Cl2): λmax 315 nm (ε = 61,600 M−1 cm−1), 556 nm 
(ε = 31,100 M−1 cm−1). Mass Spec. (ESI, +ve mode): exact mass calculated for 
[C73H81N10BF2·Na]
+: 1169.6604; exact mass found: 1169.6616; difference: −1.0 ppm.   
Complex 4.25 
4.17 (0.20 g, 0.54 mmol) was mixed with 4.19 (0.20 
g, 0.54 mmol) in dry THF (6 mL). Cu(PPh3)3Br (0.02 
g, 0.03 mmol) was then added and the mixture was 
purged with N2 gas for 15 min. The reaction mixture 
was heated with stirring at 60 °C for 18 h before it 
was cooled to room temperature and filtered through 
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a small pad of neutral alumina. The resulting purple solution was concentrated in vacuo 
and the residue was purified by flash chromatography (2:1 CH2Cl2:hexanes, neutral 
alumina) to afford 4.25 as a dark purple solid. Yield = 0.35 g, 87%. Melting point = 63−65 
°C. 1H NMR (399.8 MHz, CDCl3) δ 8.33 (s, 1H, triazole CH), 8.16−8.14 (m, 2H, aryl CH), 
8.09−8.04 (m, 4H, aryl CH), 7.95−7.93 (m, 2H, aryl CH), 7.85−7.74 (m, 4H, aryl CH), 
7.52−7.45 (m, 6H, aryl CH), 7.38−7.37 (m, 3H, aryl CH), 2.06−2.01 (m, 4H, alkyl CH), 
1.13−1.02 (m, 12H, alkyl CH), 0.77−0.74 (m, 6H, alkyl CH), 0.66−0.61 (m, 4H, alkyl CH) 
ppm. 13C NMR (100.6 MHz, CDCl3): δ 152.9, 151.1, 149.3, 147.2, 144.0, 143.8, 142.1, 
139.7, 135.9, 133.7, 131.8, 129.9, 129.5, 129.2, 128.9, 128.0, 127.2, 126.5, 125.6, 124.0, 
123.6, 123.1, 120.7, 120.2, 119.4, 118.6, 115.4, 55.8, 40.5, 31.6, 29.7, 23.9, 22.7, 14.1 ppm. 
11B NMR (128.3 MHz, CDCl3): δ −0.5 (t, 1JBF = 29 Hz) ppm. 19F NMR (376.1 MHz, 
CDCl3) δ −144.1 (q, 1JBF = 29 Hz) ppm. FT-IR (KBr): 3062 (m), 2935 (m), 2924 (m), 2851 
(m), 1456 (m), 1348 (w), 1296 (m), 1268 (m), 1222 (w), 1119 (m), 964 (m), 764 (m) cm−1. 
UV-vis (CH2Cl2): λmax 315 nm (ε = 54,900 M−1 cm−1), 532 nm (ε = 31,100 M−1 cm−1). Mass 
Spec. (EI, +ve mode): exact mass calculated for [C46H48N7BF2]
+: 747.4032; exact mass 
found: 747.4027; difference: −0.7 ppm.   
Complex 4.26 
4.17 (0.15 g, 0.40 mmol) was 
mixed with 4.20 (0.08 g, 0.2 
mmol) in dry THF (3 mL). 
Cu(PPh3)3Br (0.02 g, 0.02 
mmol) was then added and 
the mixture was purged with N2 gas for 15 min. The reaction mixture was heated with 
stirring at 60 °C for 18 h before it was cooled to room temperature and filtered through a 
pad of neutral alumina. The resulting purple solution was concentrated in vacuo and the 
residue was purified by flash chromatography (2:1 CH2Cl2:hexanes, neutral alumina) to 
afford 4.26 as a dark purple solid. Yield = 0.20 g, 86%. Melting point = 118−120 °C. 1H 
NMR (399.8 MHz, CDCl3) δ 8.36 (s, 2H, triazole CH), 8.16−8.14 (m, 4H, aryl CH), 
8.10−8.05 (m, 8H, aryl CH), 7.96−7.87 (m, 8H, aryl CH), 7.82−7.80 (m, 2H, aryl CH), 
7.53−7.44 (m, 12H, aryl CH), 2.15−2.10 (m, 4H, alkyl CH), 1.14−1.03 (m, 12H, alkyl CH), 
0.77−0.74 (m, 6H, alkyl CH), 0.70−0.66 (m, 4H, alkyl CH) ppm. 13C NMR (100.6 MHz, 
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CDCl3): δ 153.2, 149.2, 147.4, 144.0, 143.9, 140.6, 136.6, 133.7, 131.6, 130.0, 129.5, 
129.3, 128.9, 126.6, 125.7, 124.1, 123.6, 121.3, 119.7, 118.5, 115.4, 56.4, 40.5, 31.6, 29.7, 
24.0, 22.7, 14.1 ppm. 11B NMR (128.3 MHz, CDCl3): δ −0.5 (t, 1JBF = 28 Hz) ppm. 19F 
NMR (376.1 MHz, CDCl3) δ −143.7 (q, 1JBF = 28 Hz) ppm. FT-IR (KBr): 3065 (m), 3048 
(m), 2951 (m), 2925 (s), 2852 (m), 1477 (m), 1419 (m), 1350 (m), 1296 (s), 1267 (s), 1222 
(m), 1119 (m), 1007 (m), 964 (s), 845 (m), 763 (s) cm−1. UV-vis (CH2Cl2): λmax 325 nm (ε 
= 73, 200 M−1 cm−1) 535 nm (ε = 51,200 M−1 cm−1). Mass Spec. (ESI, +ve mode): exact 
mass calculated for [C67H62N14BF2·Na]
+: 1183.5302; exact mass found: 1183.5309; 
difference: −0.6 ppm.   
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Chapter 5 
5 Structurally Diverse Boron-Nitrogen Heterocycles from 
an N2O23− Formazanate Ligand 
Adapted from:  
1. Barbon, S. M.; Staroverov, V. N.; Gilroy, J. B.* Angew. Chem. Int. Ed., 2017, DOI: 
10.1002/anie.201704285. 
 
5.1 Introduction 
Boron-nitrogen heterocycles are of significant interest to a wide range of disciplines on 
account of their unusual structure, bonding, and properties.[1-3] The most common 
compounds with such heterocycles, azaborines, find applications in organic electronics and 
chemical hydrogen storage.[4-6] Other boron-nitrogen heterocycles, exemplified by 
compounds 5.1−5.6, are noted for their unexpected reactivity and, in many cases, unique 
redox properties.[7-18] 
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Each of compounds 5.1−5.3 contains boron-nitrogen bonds in unusual heterocyclic 
frameworks that were formed in an unanticipated reaction from the corresponding boron-
containing precursor.[19-21] Piers’ B2N2 triphenylene analogue 5.4 can be reduced by one 
electron to form a stable radical anion,[22] and Russell’s polycyclic borazine 5.5 undergoes 
one-electron oxidation to form a stable radical cation.[23] The Jäkle group has demonstrated 
that ferrocene boron complex 5.6 can be converted to the planar borenium cation via 
abstraction of the chloride.[24]  
Boron difluoride complexes of formazanate ligands have many interesting and useful 
properties, including high molar absorptivities and a capacity for reversible stepwise 
reduction. In this work, we set out to study the properties of similar complexes derived 
from trianionic, potentially tetradentate formazanate ligands. 
 
5.2 Results and Discussion 
The parent formazan 5.7 was synthesized according to a published method.[25] Upon 
reaction of 5.7 with BF3•OEt2 in the presence of NEt3, the expected product 5.8 was not 
detected; instead, the reaction mixture was found to contain five new compounds 
(5.9−5.13) along with formazan 5.7, which could be separated by column chromatography 
in 60−70% yield (Figure A5.1). Careful analysis of the 1H, 11B, 13C and 19F NMR spectra, 
as well as single-crystal X-ray diffraction analysis enabled us to identify all six compounds 
present (Scheme 5.1, Figures A5.2−A5.11). The complex reaction mixture obtained was in 
striking contrast to the clean conversion of formazan 5.14 to boron complex 5.15 in 92% 
yield under identical conditions (Scheme 5.2, Figures A5.12−A5.16). 
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Scheme 5.1. Products formed from the reaction of formazan 5.7 with BF3•OEt2 and NEt3. 
The Gibbs free energies (ΔG°) were computed for the formation of each compound under 
conditions simulating those employed in the actual synthesis, and are expressed in kJ mol−1 
of the corresponding formazan. The dashed arrow indicates interconversion in solution. 
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Scheme 5.2. Products formed from the reaction of formazan 5.14 with BF3•OEt2 and NEt3. 
The Gibbs free energy (ΔG°) was computed for the formation of 5.15 under conditions 
simulating those employed, and are expressed in kJ mol−1 of formazan 5.14.  
 
To rationalize these observations, we used density-functional methods to calculate the 
changes in standard thermodynamic state functions for the reaction pathways leading from 
5.7 to 5.8−5.13 and from 5.14 to 5.15 under the experimental reaction conditions (80 °C, 
1 atm, toluene solution). The calculations were performed with the Gaussian 09 program[26] 
using the hybrid version of the Perdew-Burke-Ernzerhof density functional[27]  
(PBE1PBE), the 6-311+G(d,p) basis set, and implicit solvation methods. According to this 
level of theory (Table A5.1), the formation of tetradentate boron complex 5.8 from 5.7 is 
thermodynamically unfavourable (ΔG° = 75.7 kJ mol−1), whereas the formation of 
tetradentate complex 5.15 from 5.14 is favourable (ΔG° = −19.4 kJ mol−1). It appears that 
the 5-membered chelates of 5.8 are too strained to form, so less strained compounds are 
produced instead. Compound 5.13, which appears to form via 5.12, was predicted to be the 
most favoured product of this reaction (ΔG° = −68.6 kJ mol−1), in agreement with 
experiment. 
Through variation of reaction conditions, we were able to optimize the yields of each of 
the five new compounds produced (Table 5.1). When elevated temperatures or longer 
reaction times were employed, the ratio of 5.13 (the thermodynamic product) to 5.9 and 
5.10 was increased. When greater excess amounts of BF3•OEt2 and NEt3 were used, 
products 5.9 and 5.10 were observed in higher yields. 
 
 
 
 
156 
 
 
 
Table 5.1. Varied conditions and the resulting distribution (as a percent of the total reaction 
mixture) of the different products. 
Equiv. 
NEt3 
Equiv. 
BF3•OEt
2 
Reaction 
Time (h) 
Temp. 
(°C) 
Conc. of 7  
(mg mL−1) 
Distribution of Productsa 
9 10 11 7 12 13 
3 5 16  80 10 24 7 11 27 3 28 
1 1 16  80 10 − − 8 92 − − 
6 10 16  80 10 3 29 2 63 − 3 
3 5 8 80 10 6 1 22 68 1 2 
3 5 32 80 10 6 2 17 6 1 68 
3 5 16 50 10 4 3 21 66 − 6 
3 5 16 110 10 21 11 7 15 − 46 
3 5 16 80 5 1 2 21 28 3 45 
3 5 16 80 20 4 11 26 18 4 37 
aOverall isolated yields were typically 60−70%. 
The six compounds present in the reaction mixture were separated by column 
chromatography (CH2Cl2, silica gel). The first two that eluted (Rf = 0.82, 0.76) yielded very 
similar NMR spectra without 19F NMR resonances. We were able to identify these two 
compounds using X-ray crystallography as dimers 5.9 and 5.10 (Figure 5.1a, b). Both 
structures contain a ten-membered ring (-B-O-C-C-N-B-O-C-C-N-), where B−O bonds 
bridge the monomeric units. The difference between the two structures is the orientation of 
the ten-membered ring. The ten-membered ring exists in a pseudo-chair conformation in 
compound 5.9, and in a pseudo-boat conformation in compound 5.10 (see insets, Figure 
5.1a, b). We did not observe interconversion between these two products in solution, even 
upon prolonged heating.  
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Figure 5.1. Solid-state structures of (a) 5.9 and (b) 5.10. Thermal displacement ellipsoids 
are shown at the 50% probability level, and phenyl substituents have been made wireframe 
for clarity. Hydrogen atoms have also been removed for clarity. Insets in panels show only 
the atoms in the respective ten-membered rings.  
 
The pseudo-boat ring conformation leads to a π-stacking interaction between aryl 
substituents and the formazanate backbone in the solid-state phase of 5.10, which is not 
observed in 5.9. In solution, it causes broadening of the low-energy absorption of 5.10 and 
the appearance of a shoulder at 597 nm that is not present in the absorption profile of 5.9 
(Figures 5.4, A5.17, Table 5.2). The cyclic voltammograms of compounds 5.9 and 5.10 
included three reduction waves (Figure 5.2, Table 5.2). Both compounds exhibit two 
reversible one-electron reduction waves (5.9: Ered1 = −760 mV, Ered2 = −1010 mV; 5.10: 
Ered1 = −720 mV, Ered2 = −1020 mV), and a third irreversible two-electron reduction (5.9: 
Epc = −1730 mV; 5.10: Epc = −1770 mV). The reversible waves correspond to the stepwise 
reduction of the formazanate backbones to mono- and bis-radical anions and the 
irreversible wave to the formation of bis-dianions. The difference between the reversible 
reduction potentials (ΔEred) was 250 mV for 5.9 and 290 mV for 5.10. 
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Figure 5.2. Cyclic voltammograms of 5.9 (black) and 5.10 (blue) recorded at 100 mV s−1 
in 1 mM CH2Cl2 solutions containing 0.1 M [nBu4N][PF6] as supporting electrolyte. 
 
Compound 5.10 proved easier to isolate than its structural isomer 5.9, so it was chosen for 
further reactivity studies. Reduction with one and two equivalents of cobaltocene yielded 
compounds 5.10•− and 5.10••2−, both of which produced broad isotropic signals in their EPR 
spectra at g = 2.0038, confirming their paramagnetic nature (Figure A5.18). Both reduced 
species were characterized by single-crystal X-ray analysis (Figure 5.3, Table 5.3). The 
average N−N bond length in the neutral dimer 5.10 was 1.314(3) Å, which is typical of an 
N−N bond with a bond order of ~1.5. In compound 5.10•−, the average N−N bond length 
for N1 to N4 is 1.360(3) Å, suggesting the presence of a borataverdazyl radical in which 
the additional electron occupies an orbital with antibonding N−N character.[28-30] The 
average N−N bond length for N5 to N8 is 1.315(3) Å, typical of a formazanate adduct.[28] 
These metrics confirm that chemical reduction occurs in a stepwise fashion, and that the 
radical anion is localized on one formazanate ligand. In the doubly reduced species 5.10••2−, 
the average N−N bond length was 1.366(3) Å, which corresponds to N−N single bonds as 
expected for borataverdazyl radicals.[30]  
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Figure 5.3. Solid-state structures of (a) 10•− and (b) 10••2−. Thermal ellipsoids are shown 
at the 50% probability level, and phenyl substituents have been made wireframe for clarity. 
Hydrogen atoms have also been removed for clarity. 
 
These conclusions were corroborated by UV-vis absorption spectroscopy in acetonitrile 
(Figure 5.4, Table 5.2). Neutral dimer 5.10 has a λmax at 569 nm, and a molar absorptivity 
of 20 500 M−1 cm−1. Singly reduced 5.10•− absorbs strongly at 568 nm, as well as 687 and 
477 nm, which is typical of verdazyl species,[30] and shows that 5.10•− is made up of 
independent borataverdazyl and formazanate units. Doubly reduced species 5.10••2− 
absorbs minimally at 568 nm, but exhibits two absorption peaks typical of verdazyl species 
with λmax of 687 nm (ε = 8 200 M−1 cm−1) and 477 nm (ε = 39 200 M−1 cm−1).[31] 
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Figure 5.4. UV-vis absorption spectra of complexes 5.10 (blue), 5.10•− (red) and 10••2− 
(black) in CH3CN.  
 
We were unable to grow single crystals of the third compound to elute (Rf = 0.61). 
However, using 1H, 11B, 13C and 19F NMR spectroscopy and mass spectrometry, we were 
able to identify this product as 5.11. This product is dark blue, can be reversibly reduced 
twice (Figures A5.19, A5.20, Table 5.2), and slowly converts to formazan 5.7 in solution. 
The fourth compound that eluted from the column (Rf = 0.39) was formazan 5.7. This 
compound is present due to incomplete reactivity, or the hydrolysis of unstable, 
unidentified species formed during the reaction. 
The final two compounds that eluted from the column (Rf = 0.31, 0.22) were identified as 
compounds 5.12 and 5.13. Interestingly, 5.13 showed two doublets in its 11B NMR 
spectrum due to the coupling of each boron atom with a single fluorine atom (1JBF = 33, 42 
Hz). Single-crystal X-ray analysis showed that compound 5.13 was not a dimer, but 
contained two boron atoms bonded to one formazanate ligand, where the cyano group had 
been hydrolyzed.[32] Complex 5.12 is similar to 5.13, aside from a free OH group, and a 
BF2 unit (Figure 5.5). In solution, compound 5.12 converts to 5.13 over the course of a few 
hours.  
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Figure 5.5. Solid-state structures of (a) 5.12 and (b) 5.13 with thermal displacement 
ellipsoids shown at the 50% probability level. Hydrogens, aside from the hydrogens on N5 
in both 5.12 and 5.13 and on O1 in 5.12 have been removed for clarity. 
 
The λmax of 5.12 is blue-shifted by 17 nm in CH2Cl2 with respect to 5.13 (Figure A5.21, 
A5.22). Compound 5.13 yielded a single reversible one-electron reduction in its cyclic 
voltammogram (Figure A5.23), prompting us to perform chemical reduction using one 
equivalent of cobaltocene. The solution changed from pink-purple to dark blue-purple 
(Scheme 3). Attempts to crystallize the resulting compounds were unsuccessful, so a salt 
metathesis reaction was performed with [nBu4N][Br] in order to exchange the 
cobaltocenium cation for the more solubilizing tetra-n-butyl ammonium cation. The colour 
of the solution was unchanged throughout this process. Single-crystal X-ray diffraction 
revealed the resulting product to be anion 5.16−. Upon reduction, the NH bond in 5.13 
appears to cleave homolytically, resulting in the formation of 5.16− and H2 (Figure 5.6). 
The proposed structure was confirmed by 1H, 13C NMR spectroscopy, mass spectrometry 
and IR spectroscopy (see Figure A5.24, A5.25). Aside from the loss of the N-bonded 
proton, the connectivity in 5.16− is identical to that of 5.13. The B1-N5 bond has shortened 
(5.13: 1.516(3) Å; 5.16−: 1.442(5) Å) and the C2-N5 bond has lengthened (5.13: 1.304(3) 
Å; 5.16−: 1.327(4) Å, Table 5.3). The angles around B1 and N5 change with the presence 
of the lone pair. For example, the N1-B1-N5 angle widens by ~3.5°, while the B1-N5-C2 
angle contracts by ~3.6°. The same angles around B2 change less drastically (N3-B2-O2 
angle contracts by 1.1°, and the B2-O3-C2 angle contracts by 2.0°). 5.16− is highly 
absorbing (ε = 18 000 M−1 cm−1), with a low-energy λmax of 589 nm that was red-shifted 
by 12 nm with respect to neutral 5.13 (Figures A5.22, A5.26). 
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Scheme 5.3. Chemical reduction of 5.13 to 5.16− with cobaltocene. 
 
 
Figure 5.6. Solid-state structure of 5.16− with thermal displacement ellipsoids shown at 
the 50% probability level. Hydrogens and the nBu4N cation have been removed for clarity. 
 
The calculated highest occupied molecular orbitals (HOMO) of 5.13 and 5.16− are 
delocalized over the entire molecules (Figure 5.7). The lowest unoccupied molecular 
orbitals (LUMO) were delocalized over the formazanate nitrogen atoms and the N-aryl 
substituents. Time-dependent PBE1PBE/6-311+G(d,p) calculations of 5.13 and 5.16− in 
CH2Cl2 solution showed the HOMO and LUMO to be the dominant orbital pair involved 
in the lowest energy transition in both molecules, and approximately reproduced the shift 
in λmax from 5.13 to 5.16− (Δλcalc = 8 nm, Δλobs = 12 nm, Table A5.2). 
Table 5.2. Optical and electronic properties of complexes 5.9−5.13 and their reduction 
products. 
Compound Solvent λmax 
(nm) 
ε  
(M−1 cm−1) 
Ered1
 
(mV) 
Ered2 
(mV) 
Ered3
 
(mV) 
Eox1 
(mV) 
5.9 CH2Cl2 535 28 100 −760 −1010 −1730a 1060a 
5.10 CH2Cl2 569 20 500 −720 −1020 −1770a 1020a 
5.11 CH2Cl2 577 13 500 −720 −1630 − 606a 
5.12 CH2Cl2 560 27 600 − − − − 
5.13 CH2Cl2 577 35 900 −770 −1130a − 839a 
5.10•− CH3CN 477 15 500 − − − − 
5.10••2− CH3CN 477 39 200 − − − − 
5.16− CH2Cl2 589 18 000 − − − − 
aOnset of irreversible reduction or oxidation. 
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Figure 5.7. HOMOs and LUMOs for 5.13 and 5.16− calculated at the PBE1PBE/6-
311+G(d,p) level. 
 
Table 5.3. Selected bond lengths (Å) and angles (°) for solid-state structures of various 
products. 
 5.9 5.10 5.10•− 5.10••2− 5.12 5.13 5.16− 
N1-N2  1.2896(16) 1.297(3) 1.353(3) 1.357(3) 1.2997(19) 1.288(2) 1.297(4) 
N3-N4  1.3206(16) 1.330(3) 1.366(3) 1.375(3) 1.280(2) 1.284(2) 1.287(4) 
N5-N6  − 1.299(3) 1.329(3) 1.371(3) − − − 
N7-N8  − 1.332(3) 1.301(3) 1.359(3) − − − 
B1-N1  1.5743(19) 1.572(4) 1.541(4) 1.540(3) 1.596(2) 1.573(3) 1.583(5) 
B1-N5  − − − − 1.532(2) 1.516(3) 1.442(5) 
C2-N5  − − − − 1.295(2) 1.304(3) 1.327(4) 
N1-B1-N5  − − − − 107.37(13) 104.45(17) 107.9(3) 
B1-N5-C2  − − − − 126.62(14) 120.36(18) 116.8(3) 
N3-B2-O2  − − − − 101.53(14) 101.62(17) 100.5(3) 
B2-O3-C2  − − − − 116.48(14) 118.97(17) 117.0(3) 
 
5.3 Conclusions 
In conclusion, we have reported the synthesis of five new boron-nitrogen heterocycles 
5.9−5.13 by one straightforward reaction, starting from an N2O23− formazanate ligand. The 
observed product distribution appears to be strain-driven as evidenced by the fact that 
similar heterocycles were not formed when the reactant 5.7 was replaced by a homologous 
compound 5.14. Each of compounds 5.9−5.13 exhibited interesting optical and 
electrochemical properties. In particular, compound 5.10 was reduced to stable mono- and 
bis- radical anions, with electronically-isolated formazanate units. Compound 5.13, 
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containing an unprecedented boron-nitrogen core, was reduced to a radical anion which 
rapidly lost one equivalent of H• to form a stable anion.  
 
5.4 Experimental Section 
5.4.1 General Considerations 
Reactions and manipulations were carried out under a nitrogen atmosphere using standard 
Schlenk techniques unless otherwise stated. Solvents were obtained from Caledon 
Laboratories, dried using an Innovative Technologies Inc. solvent puriﬁcation system, 
collected under vacuum and stored under a nitrogen atmosphere over 4 Å molecular sieves. 
Reagents were purchased from Sigma-Aldrich or Alfa Aesar and used as received. 
Formazan 5.7 was prepared according to a literature procedure.[25] 
NMR spectra were recorded on 400 MHz (1H: 399.8 MHz, 11B: 128.3 MHz, 19F: 
376.1 MHz) or 600 MHz (1H: 599.5 MHz, 13C: 150.8 MHz) Varian INOVA instruments. 
1H NMR spectra were referenced to residual CHCl3 (7.26 ppm), CHDCl2 (5.32 ppm) or 
DMSO-d5 (2.50 ppm) and 
13C{1H} NMR spectra were referenced to CDCl3 (77.2 ppm), 
CD2Cl2 (53.8 ppm), or DMSO-d6 (39.5 ppm). 
11B spectra were referenced to BF3·OEt2 at 
0 ppm and 19F spectra were referenced to CFCl3 at 0 ppm. Mass spectrometry data were 
recorded in positive-ion mode using a high-resolution Finnigan MAT 8200 spectrometer 
using electron impact ionization. UV-vis absorption spectra were recorded using a Cary 
5000 instrument. Four separate concentrations were run for each sample and molar 
extinction coefficients were determined from the slope of a plot of absorbance against 
concentration. FT-IR spectra were recorded using an attenuated total reflectance (ATR) 
attachment using a Bruker Vector 33 FT-IR spectrometer. Elemental analyses (C, H, N) 
were carried out by Laboratoire d’Analyse Élémentaire de l’Université de Montréal, 
Montréal, QC, Canada or Canadian Microanalytical Services Ltd., Delta, BC, Canada. 
5.4.2 Purity of New Compounds 
The purity of diamagnetic compounds described in this study was demonstrated by 
providing very clean 1H, 11B, 13C{1H}, and 19F NMR spectra and high resolution mass 
spectrometry data. For paramagnetic compounds 5.10•− and 5.10••2−, carbon analysis was 
consistently low, while H and N analysis matched well across several independent batches. 
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This is likely due to the presence of boron, which often hampers C analysis.[33-34] However, 
these data are provided to illustrate the best values obtained to date. 
5.4.3 Electrochemical Methods  
Cyclic voltammetry experiments were performed with a Bioanalytical Systems Inc. (BASi) 
Epsilon potentiostat and analyzed using BASi Epsilon software. Electrochemical cells 
consisted of a three-electrode setup including a glassy carbon working electrode, platinum 
wire counter electrode and silver wire pseudo reference electrode. Experiments were run 
at scan rates of 100 mV s−1 in degassed THF solutions of the analyte (~1 mM) and 
supporting electrolyte (0.1 M [nBu4N][PF6]). Cyclic voltammograms were referenced 
against an internal standard (~1 mM ferrocene) and corrected for internal cell resistance 
using the BASi Epsilon software.  
5.4.4 X-ray Crystallography Details  
Single crystals suitable for X-ray diffraction were grown from slow evaporation of CH2Cl2 
(5.10, 5.12, 5.13, 5.15, 5.10•−), or CHCl3 (5.9), or diffusion of hexanes into a concentrated 
THF solution (5.10••2−). To grow single crystals of 5.16−, the compound was first stirred 
for 30 min with [nBu4N][Br] in CH2Cl2. The resulting solution was then filtered and 
concentrated in vacuo. Finally, crystals appeared upon diffusion of hexanes into a 
concentrated THF solution. Samples were mounted on a MiTeGen polyimide micromount 
with a small amount of Paratone N oil. X-ray measurements were made on a Bruker Kappa 
Axis Apex2 diffractometer (5.9, 5.12, 5.13, 5.15, 5.10•−, 5.102− and 5.16−) or Nonius 
KappaCCD Apex2 diffractometer (5.10) at a temperature of 110 K. Initial indexing 
indicated that the sample crystal for 5.12 was non-merohedrally twinned. The twin law was 
determined to be: 
−1.00038 −0.00037 −0.00061 
0.00057 −0.99976 0.00063 
0.92946 0.44676 1.00014 
which represents a −179.9° rotation about [0 0 −1]. The twin fraction was included in the 
refinement as an adjustable parameter (vide infra). 
The data collection strategy included a number of ω and φ scans which collected data over 
a range of angles, 2θ. The frame integration was performed using SAINT.[35] The resulting 
raw data were scaled and absorption corrected using a multi-scan averaging of symmetry 
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equivalent data using SADABS (5.9, 5.10, 5.13, 5.15, 5.10•−, 5.102−, 5.16−),[36] or 
TWINABS (5.12)[37]. The structures were solved by using a dual space methodology using 
the SHELXT program.[38]  All non-hydrogen atoms were obtained from the initial solution. 
The hydrogen atoms were introduced at idealized positions and were allowed to refine 
isotropically (5.9, 5.10, 5.12, 5.13, 5.15), or allowed to ride on the parent atom (5.10•−, 
5.102−), or treated in a mixed fashion (5.16−). The twin fraction of 5.12 refined to a value 
of 0.07489. The structural model was fit to the data using full matrix least-squares based 
on F2. The calculated structure factors included corrections for anomalous dispersion from 
the usual tabulation. The difference map of 5.10••2− showed regions of electron density that 
could not be accurately modeled to something that makes chemical sense. Thus the 
PLATON SQUEEZE program[39] was used, and analysis was continued on this data.  The 
structure was refined using the SHELXL-2014 program from the SHELXT suite of 
crystallographic software.[40] See Table 5.4 for additional crystallographic data. 
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Table 5.4. X-ray diffraction data collection and refinement details for compounds 5.9, 
5.10, 5.12, 5.13, 5.15, 5.10•−, 5.10••2−, and 5.16−. 
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General Experimental for Complexes 5.9-5.13 
Formazan 5.7 (0.33 g, 1.2 mmol) was dissolved in dry toluene (40 mL). NEt3 (0.36 g, 0.49 
mL, 3.5 mmol) was then added slowly and the solution stirred for 10 min before BF3•OEt2 
(0.83 g, 0.72 mL, 5.8 mmol) was added and the solution was heated with stirring at 80 ºC 
for 18 h. The solution immediately turned dark blue/purple. After cooling to 22 ºC, the 
reaction mixture was poured into a separatory funnel containing deionized H2O (100 mL). 
The purple toluene solution was then washed with deionized H2O (3  100 mL), dried over 
MgSO4, gravity filtered and concentrated in vacuo. The resulting residue contained a 
mixture of compounds 5.7 and 5.9−5.13. These compounds were separated (5.9: Rf = 0.82; 
5.10: Rf = 0.76; 5.11: Rf = 0.61; 5.7: Rf = 0.39; 5.12: Rf = 0.31; 5.13: Rf = 0.22) by column 
chromatography (CH2Cl2, silica). Additional column chromatography (10:1 
Toluene:EtOAc, silica) was required to separate compounds 5.9 and 5.10, and 5.12 and 
5.13. See Table S3 for compound distributions under a variety of experimental conditions. 
Dimer 5.9 
Melting point = 244246 °C. 1H NMR (400.1 MHz, CDCl3): δ 7.80 
(d, 3JHH = 9 Hz, 2H, aryl CH), 7.397.34 (m, 4H, aryl CH), 
7.137.11 (m, 2H, aryl CH), 7.057.00 (m, 4H, aryl CH), 6.94 (d, 
3JHH = 8 Hz, 2H, aryl CH) 6.606.58 (m, 2H, aryl CH). 13C{1H} 
NMR (150.7 MHz, CDCl3): δ 155.7, 148.0, 138.1, 135.9, 132.6, 
131.9, 130.3, 129.2, 128.4, 125.0, 124.1, 122.7, 115.7, 114.6. 11B NMR (128.3 MHz, 
CDCl3): δ 1.0 (s). FT-IR (ATR): 2235 (m), 1590 (m), 1483 (m), 1382 (m), 1309 (s), 1252 
(s), 1079 (s), 1046 (s), 988 (m), 960 (m) cm–1. UV-vis (CH2Cl2): λmax 535 nm (ε = 28,100 
M1 cm1), 440 nm (ε = 12,600 M−1 cm−1), 296 nm (ε = 21,500 M−1 cm−1). Mass Spec. (EI, 
+ve mode): exact mass calculated for [C28H16B2N10O4]
+: 578.1542; exact mass found: 
578.1531; difference: 1.9 ppm. 
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Dimer 5.10 
Melting point not observed (>250 °C). 1H NMR (400.1 MHz, 
CDCl3): δ 7.88−7.85. (m, 2H, aryl CH),  7.567.52 (m, 2H, aryl 
CH), 7.367.32 (m, 2H, aryl CH), 7.23 (d, 3JHH = 8 Hz, 2H, aryl 
CH), 7.177.12 (m, 6H, aryl CH), 6.84−6.81 (m, 2H, aryl CH). 
13C{1H} NMR (150.7 MHz, CDCl3): δ 156.6, 147.5, 136.4, 136.3, 
132.6, 132.1, 131.0, 126.4, 125.1, 122.9, 122.3, 117.1, 116.4, 112.9.  11B NMR (128.3 
MHz, CDCl3): δ 1.1 (s). FT-IR (ATR): 2923 (m), 2853 (w), 2243 (m), 1592 (m), 1481 (m), 
1323 (s), 1247 (s), 1148 (m), 1084 (s), 995 (m), 971 (m) cm–1. UV-vis (CH2Cl2): λmax 605 
nm (ε = 19,400 M−1 cm−1), 569 nm (ε = 20,500 M1 cm1), 415 nm (8,800 M−1 cm−1), 319 
nm (19,700 M−1 cm−1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C28H16B2N10O4]
+: 578.1542; exact mass found: 578.1547; difference: +0.9 ppm. 
Compound 5.11 
Melting point = 165166 oC. 1H NMR (400.1 MHz, CDCl3): δ 9.56 (s, 
1H, OH), 8.14 (d, 3JHH = 9 Hz, 1H,  aryl CH), 7.82 (d, 
3JHH = 9 Hz, 1H, 
aryl CH), 7.53 (m, 1H, aryl CH), 7.357.34 (m, 1H, aryl CH), 7.207.16 
(m, 2H, aryl CH), 7.087.06 (m, 2H, aryl CH). 13C{1H} NMR (150.7 MHz, CDCl3): δ 
157.6, 153.4, 135.9, 135.8, 133.1, 133.0, 125.3, 123.3, 121.5, 120.3, 117.0, 115.6, 115.3, 
113.3.  11B NMR (128.3 MHz, CDCl3): δ 0.0 (d, 1JBF = 37 Hz). 19F NMR (376.1 MHz, 
CDCl3): δ –151.1 (q, 1JFB = 37 Hz). FT-IR (ATR): 3351 (br, m), 2924 (m), 2853 (w), 2244 
(m), 1594 (s), 1378 (s), 1310 (s), 1148 (m), 1102 (m), 995 (s) cm–1. UV-vis (CH2Cl2): λmax 
619 nm (ε = 11,700 M−1 cm−1), 577 nm (ε = 13,500 M1 cm1), 445 nm (ε = 5,800 M−1 
cm−1), 318 nm (ε = 11,300 M−1 cm−1). Mass Spec. (EI, −ve mode): exact mass calculated 
for [C14H9BFN5O2]
+: 309.0833; exact mass found: 309.0843; difference: +3.2 ppm. 
Compound 5.12 
Melting point = 217219 oC. 1H NMR (400.1 MHz, CDCl3): δ 
10.50 (s, 1H, OH), 8.058.04 (m, 1H, aryl CH), 7.717.70 (m, 1H, 
aryl CH), 7.517.48 (m, 1H, aryl CH), 7.45 (br s, 1H, NH), 
7.357.33 (m, 1H, aryl CH), 7.157.10 (m, 3H, aryl CH), 7.026.99 (m, 1H, aryl CH). 
13C{1H} NMR (150.7 MHz, CDCl3): δ 159.3, 152.7, 152.4, 136.0, 134.5, 132.3, 129.6, 
170 
 
 
 
124.6, 122.7, 120.9, 120.1, 116.1, 115.9. 11B NMR (128.3 MHz, CDCl3): δ 1.6 (d, 1JBF = 
30 Hz), 0.4 (t, 1JBF = 28 Hz). 
19F NMR (376.1 MHz, CDCl3): δ (–125.0)–(–124.7) (m), –
149.8 (q, 1JFB = 28 Hz). FT-IR (ATR): 3314 (m), 3302 (m), 2924 (m), 2854 (w), 1646 (m), 
1600 (m), 1458 (m), 1406 (s), 1306 (s), 1099 (m), 1116 (m), 1002 (s), 905 (m) cm–1. UV-
vis (CH2Cl2): λmax 560 nm (ε = 27,600 M1 cm1), 412 nm (ε = 7,600 M1 cm1), 348 nm (ε 
= 4,100 M1 cm1), 260 nm (ε = 4,600 M1 cm1). Mass Spec. (EI, +ve mode): exact mass 
calculated for [C14H10B2F3N5O3]
+: 374.0844; exact mass found: 374.0833; difference: −2.9 
ppm. 
Compound 5.13 
Melting point = 207209 oC. 1H NMR (400.1 MHz, CDCl3): δ 
7.827.76 (m, 2H, aryl CH), 7.69 (s, 1H, NH), 7.487.44 (m, 2H, 
aryl CH), 7.167.09 (m, 4H, aryl CH). 13C{1H} NMR (150.7 MHz, 
CDCl3): δ 134.9, 134.1, 122.3, 122.1, 115.9, 115.8, 115.6, 115.5.  11B NMR (128.3 MHz, 
CDCl3): δ 1.6 (d, 1JBF = 33 Hz), 0.9 (d, 1JBF = 42 Hz). 19F NMR (376.1 MHz, CDCl3): δ –
137.6 (q, 1JFB = 42 Hz), –149.8 (q, 1JFB = 33 Hz). FT-IR (ATR): 3169 (m), 1594 (m), 1431 
(m), 1317 (s), 1286 (s), 1065 (s), 998 (m), 902 (m) cm–1. UV-vis (CH2Cl2): λmax 577 nm (ε 
= 35,900 M1 cm1), 407 nm (ε = 6,800 M−1 cm−1), 269 nm (14,600 M−1 cm−1). Mass Spec. 
(EI, +ve mode): exact mass calculated for [C14H9B2F2N5O3]
+: 355.0860; exact mass found: 
355.0861; difference: +0.3 ppm. 
Formazan 5.14 
In air, cyanoacetic acid (0.21 g, 2.4 mmol) was dissolved in deionized 
H2O (50 mL) containing NaOH (0.96 g, 24 mmol).  This colourless 
solution was stirred for 45 min in an ice bath. Meanwhile, 2-
aminobenzyl alcohol (0.59 g, 4.8 mmol) was mixed with concentrated HCl (1.2 mL) in 
deionized H2O (15 mL). This solution was cooled in an ice bath for 10 min before a solution 
of sodium nitrite (0.38 g, 5.5 mmol) in deionized H2O (10 mL) was cooled in an ice bath, 
and then added slowly to the 2-aminobenzyl alcohol solution over a 10 min period. This 
mixture was stirred in an ice bath for 30 min and then added slowly to the basic cyanoacetic 
acid solution. A dark red/orange colour persisted almost immediately, and a dark 
red/orange precipitate formed after a few min. The mixture was stirred in an ice bath for 
an additional 16 h before ethyl acetate (250 mL) was added and the organic layer was 
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isolated, washed with deionized H2O (3  100 mL), dried over MgSO4, gravity filtered and 
concentrated in vacuo. The resulting residue was purified by flash chromatography 
(CH2Cl2, neutral alumina) to afford formazan 5.14 as a dark red solid. Yield = 0.66 g, 87%. 
Melting point = 185187 oC. 1H NMR (400.1 MHz, DMSO-d6): δ major isomer: 12.88 (s, 
1H, NH), 7.66 (d, 3JHH = 9 Hz, 2H, aryl CH), 7.52 (d, 
3JHH = 9 Hz, 2H, aryl CH), 7.407.35 
(m, 4H, aryl CH), 5.81 (s, 2H, OH), 4.94 (s, 4H, CH2). δ minor isomer: 11.72 (s, 1H, NH), 
7.73−7.63 (m, 2H, aryl CH), 7.57−7.54 (m, 2H, aryl CH), 7.31−7.30 (m, 2H, aryl CH), 
7.14−7.12 (m, 2H, aryl CH), 6.33 (s, 2H, OH), 5.02 (s, 2H, CH2), 4.84 (s, 2H, CH2). 
13C{1H} NMR (150.7 MHz, DMSO-d6), both isomers: δ 147.7, 144.3, 141.5, 140.6, 135.6, 
130.9, 128.6, 128.2, 127.2, 124.4, 115.1, 112.6, 108.2, 62.7, 60.5, 58.3.  FT-IR (ATR): 
3535 (w), 3399 (m), 3215 (m), 2218 (m), 1587 (w), 1522 (m), 1461 (m), 1399 (m), 1265 
(m), 1206 (m), 1014 (s), 758 (s), 722 (s) cm–1. UV-vis (CH2Cl2): λmax 438 nm (ε = 20,900 
M1 cm1), 294 nm (ε = 11,400 M−1 cm−1), 267 nm (11,100 M−1 cm−1). Mass Spec. (EI, +ve 
mode): exact mass calculated for [C16H15N5O2]
+: 309.1226; exact mass found: 309.1230; 
difference: +1.3 ppm. 
Compound 5.15 
Formazan 5.14 (0.66 g, 2.1 mmol) was dissolved in dry toluene (70 mL). 
NEt3 (0.65 g, 0.90 mL, 6.4 mmol) was then added slowly and the solution 
was stirred for 10 min before BF3•OEt2 (1.49 g, 1.30 mL, 10.5 mmol) 
was added and the solution was heated with stirring at 80 ºC for 18 h. The solution gradually 
turned from dark red to dark purple during this time. After cooling to 22 ºC, deionized H2O 
(10 mL) was added to quench any excess reactive boron-containing compounds. The purple 
toluene solution was then washed with deionized H2O (3  50 mL), dried over MgSO4, 
gravity filtered and concentrated in vacuo. The resulting residue was purified by flash 
chromatography (CH2Cl2, neutral alumina) to afford bis-methylene-hydroxy-substituted 
complex 5.15 as a dark purple microcrystalline solid. Yield = 0.61 g, 92%. Melting point 
= 235237 oC. 1H NMR (400.1 MHz, CDCl3): δ 7.787.76 (m, 2H, aryl CH), 7.417.35 
(m, 4H, aryl CH), 7.097.08 (m, 2H, aryl CH), 5.305.28 (m, 2H, CH2) 5.155.12 (m, 2H, 
CH2). 
13C{1H} NMR (150.7 MHz, CDCl3): δ 140.3, 134.3, 130.9, 128.2, 125.9, 125.7, 
119.4, 114.9, 65.0.  11B NMR (128.3 MHz, CDCl3): δ     –0.1 (s). FT-IR (ATR): 2986 (m), 
2854 (m), 2235 (m), 1342 (s), 1299 (m), 1084 (s), 1008 (m), 988 (m), 761 (s), 707 (s) cm–
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1. UV-vis (CH2Cl2): λmax 596 nm (ε = 17,400 M1 cm1), 558 nm (ε = 18,800 M1 cm1), 
395 nm (ε = 5,600 M1 cm1), 292 nm (ε = 12,300 M1 cm1). Mass Spec. (EI, +ve mode): 
exact mass calculated for [C16H12BN5O2]
+: 317.1084; exact mass found: 317.1082; 
difference: 0.6 ppm. 
Singly reduced dimer 5.10•− 
In a nitrogen-filled glovebox, 5.10 (0.034 g, 0.059 mmol) was 
dissolved in dry and degassed CH2Cl2 (5 mL). In a separate flask, 
cobaltocene (0.011 g, 0.059 mmol) was dissolved in dry and 
degassed CH2Cl2 (2 mL). The cobaltocene solution was added 
dropwise to a stirred solution of 5.10. This mixture was stirred for 
an additional 30 min before it was filtered and the filtrate was 
collected. The solvent was removed in vacuo to yield a brown microcrystalline powder. 
Yield = 0.031 g, 68%. Melting point = 226228 oC. FT-IR (ATR): 3367 (m), 3109 (m), 
2235 (m), 1667 (s), 1468 (m), 1415 (m), 1321 (s), 1232 (m), 1147 (m), 751 (m) cm–1. UV-
vis (CH3CN): λmax 520 nm (ε = 13,000 M1 cm1), 477 nm (ε = 15,500 M1 cm1), 262 nm 
(ε = 35,700 M1 cm1). Mass Spec. (EI, −ve mode): exact mass calculated for 
[C28H16B2N10O4]
•−: 578.1542; exact mass found: 578.1538; difference: −0.7 ppm. Anal. 
Calcd. (%) for C22H19N5O: C, 59.49; H, 3.42; N, 18.26. Found: C, 57.66; H, 3.31; N, 18.25.  
Doubly reduced dimer 5.10••2− 
In a nitrogen-filled glovebox, 5.10 (0.025 g, 0.043 mmol) was 
dissolved in dry CH2Cl2 (5 mL). In a separate flask, cobaltocene 
(0.016 g, 0.086 mmol) was dissolved in dry CH2Cl2 (3 mL). The 
cobaltocene solution was added dropwise to a stirred solution of 
5.10. This mixture was stirred for an additional 30 min before it 
was filtered and the precipitate was collected. The precipitate was 
collected by dissolving in CH3CN before the solvent was removed in vacuo to yield a green 
microcrystalline powder. Yield = 0.034 g, 82%. Melting point not observed (>250 °C). FT-
IR (ATR): 3359 (m), 3098 (m), 2234 (m), 1661 (s), 1467 (m), 1393 (m), 1321 (m), 1146 
(m), 749 (m) cm–1. UV-vis (CH3CN): λmax 694 nm (ε = 6,500 M1 cm1), 477 nm (ε = 
39,200 M1 cm1), 330 nm (ε = 38,000 M1 cm1), 261 nm (ε = 229,400 M1 cm1). Mass 
Spec. (EI, −ve mode): exact mass calculated for [C28H16B2N10O4]2−: 289.0777; exact mass 
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found: 289.0778; difference: +0.3 ppm. Anal. Calcd. (%) for C48H36B2Co2N10O4•CH2Cl2: 
C, 56.52; H, 3.68; N, 13.45. Found: C, 55.64; H, 3.60; N, 13.50.  
Reduced boron complex 5.16− 
In a nitrogen-filled glovebox, boron complex 5.13 (0.052 g, 0.15 
mmol) was dissolved in dry CH2Cl2 (10 mL). In a separate flask, 
cobaltocene (0.28 g, 0.15 mmol) was dissolved in dry CH2Cl2 (5 
mL). The cobaltocene solution was added dropwise to a stirred 
solution of 5.13. This mixture was stirred for an additional 30 min 
before it was filtered, and concentrated in vacuo. The dark purple/blue residue as dissolved 
in toluene, before pentane was added to this solution, and the mixture was left in the freezer 
overnight (−35 °C). After this time, a dark purple microcrystalline powder had formed, 
which was collected as 5.16−.  Yield = 0.051 g, 58%. Melting point = 116118 oC. 1H NMR 
(400.1 MHz, CD2Cl2): δ 7.707.63 (m, 2H, aryl CH), 7.317.26 (m, 2H, aryl CH), 
7.026.96 (m, 4H, aryl CH), 5.75 (s, 10H, CoCp2+ CH). 13C{1H} NMR (150.7 MHz, 
CD2Cl2): δ 157.8, 157.5, 145.9, 145.8, 134.4, 133.9, 131.2, 130.9, 120.7, 120.0, 114.7, 
114.3, 114.3, 114.0, 85.2.  11B NMR (128.3 MHz, CDCl3): δ 4.5 (br s), 3.1 (d, 1JBF = 40 
Hz). 19F NMR (376.1 MHz, CDCl3): δ –136.4 (q, 1JFB = 28 Hz), –147.4 (q, 1JFB = 40 Hz). 
FT-IR (ATR): 3101 (m), 2961 (m), 2874 (w), 1601 (m), 1414 (m), 1315 (s), 1258 (m), 
1147 (m), 1005 (m), 889 (m), 750 (s) cm–1. UV-vis (CH2Cl2): λmax 589 nm (ε = 18,000 M1 
cm1), 560 nm (ε = 17,000 M1 cm1), 275 nm (ε = 2,500 M1 cm1), 263 nm (ε = 20,700 
M1 cm1). Mass Spec. (EI, −ve mode): exact mass calculated for [C14H8B2F2N5O3]– 
354.0781; exact mass found: 354.0796; difference: +4.2 ppm. 
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Chapter 6 
6 Conclusions and Future Work 
6.1 Conclusions 
The work included in this thesis describes the synthesis and characterization of a new class 
of boron complexes of formazan ligands, from structure-property relationships and unusual 
bonding modes to materials and applications. The straightforward synthesis of BF2 
complexes of formazan ligands from inexpensive starting materials was described. The 
tunability of the complexes was also probed and it was found that the presence of electron 
donating groups red-shifted absorption and emission maxima, as well as made the resulting 
complexes more difficult to reduce. The effect of substituent variation was found to be 
more drastic when the 1,5-N-aryl substituents were probed, than the 3-aryl substituents. It 
was also shown that the synthesis of asymmetrically substituted complexes, in the BF2 
complexes of triaryl formazanates, more than doubled the quantum yields of emission. The 
usefulness of a p-anisole substituted BF2 complex was demonstrated for cell imaging and 
electrochemiluminescence applications. These results will allow for the straightforward 
tuning of these complexes for future applications. 
 
Figure 6.1. Substituent-driven optical and electronic properties of BF2 complexes of 
formazanate ligands.  
 
178 
 
 
 
A second method used to affect the optical and electronic properties of these BF2 
complexes involved extending the π conjugation of the complexes, especially through the 
N-aryl substituents. It was shown that exchanging phenyl substituents for naphthyl 
substituents changed the properties of the resulting complexes. This change was more 
drastic for complexes when the R3 substituents were cyano or nitro groups. In the case of 
triaryl formazanate complexes, there was a more significant change in properties when the 
N-aryl substituents were switched to naphthyl groups, versus the R3 substituent. In all 
cases, the wavelength of maximum absorption and emission were red-shifted, and the 
quantum yield was increased. Dimers were also synthesized through a phenyl substituent 
in the R3 position. In this case, it was found that para-bridged dimers showed some degree 
of communication between BF2 formazanate backbones, with the same change in 
properties observed by extending the conjugation through naphthyl substituents. On the 
other hand, meta-bridged dimers, which are cross-conjugated, showed no communication, 
and exhibited very similar properties to the triphenyl-substituted BF2 formazanate 
monomeric model complex. This work represents a stepping stone towards the 
development of π conjugated polymers with absorption and emission in the near-IR.  
 
Figure 6.2. Extended conjugation through naphthyl substituents and benzene-bridged 
dimers, and the effect on the optical properties. 
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Appending alkyne substituents to BF2 formazanate complexes allowed for the synthesis of 
new polymeric and molecular materials that would not be possible otherwise. We showed, 
using benzyl azide as a model azide, that copper-assisted alkyne-azide cycloaddition 
(CuAAC) was an efficient method for appending new functionalities onto BF2 formazanate 
complexes. The formation of the triazole ring also red-shifted the absorption and emission 
maxima, and increased the emission quantum yields, as well as made the resulting 
complexes easier to reduce electrochemically. Appending one or two ferrocenes to 3-
cyanoformazante BF2 complexes quenched their fluorescence. However, it was 
regenerated upon stoichiometric oxidation of the ferrocenes to ferrocenium. Water-soluble 
BF2 complexes were also synthesized using CuAAC to attach tetraethylene glycol 
substituents, and the resulting complex was studied as a cell imaging agent. It was found 
that the dye stained both the cytoplasm and nucleus of the cells, but due to its low-energy 
emission, could be used for orthogonal imaging with DAPI, a blue dye which localizes in 
the nucleus. Finally, CuAAC was used to synthesize main-chain co-polymers of BF2 
formazanate complexes and 9,9-dihexylfluorene. Through the synthesis of a variety of 
model complexes, we showed that the conjugation did not extend through the triazole rings, 
however because the parent BF2 complex has a small HOMO-LUMO gap, the resulting 
polymer had a low band gap (1.67 eV), and good film-forming properties. This work 
demonstrates a facile modification strategy for BF2 formazanate complexes, which can be 
used to apply these complexes to a wide range of tasks.  
 
Figure 6.3. Copper-assisted alkyne-azide cycloaddition as a useful tool for the synthesis 
of polymeric and molecular materials. 
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Finally, a variety of unprecedented boron-nitrogen containing heterocycles were 
synthesized from the reaction of a single o-phenol substituted 3-cyanoformazan with 
excess BF3•OEt2 and NEt3. The 5 isolated complexes all contained at least one boron atom, 
and displayed interesting optical and electronic properties. The ratios between the five 
products could be controlled based on the reaction conditions employed, and these results 
were explained via density functional theory calculations. Two of these complexes were 
selected to undergo further reduction chemistry, and a stable anion, radical anion, and 
diradical dianion were isolated, and structurally characterized. This work will serve as a 
platform for the rational design of novel boron-nitrogen heterocycles with potential utility 
as light-harvesting and charge-transporting materials in the future.  
 
Figure 6.4. Synthesis of five new BN heterocycles from a single reaction. 
 
Overall, this work showed that BF2 complexes of formazan ligands are an interesting and 
useful new class of materials. They are straightforward and inexpensive to synthesize, and 
the properties can be tuned through simple structural modification. With no extra synthetic 
effort, reactive functionalities such as alkynes and hydroxyl groups can be appended to 
these boron complexes, allowing for a simple starting material that can be reacted to form 
a variety of molecular and polymeric materials. To date, these complexes and materials 
have found application as cell imaging agents, redox sensors and electrochemiluminescent 
materials, but due to their unique optical and electronic properties, have the potential to 
impact many other fields of research. 
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6.2 Future Work 
6.2.1 Molecular Materials: Three-Coordinate Boron Complexes 
Three-coordinate boron complexes have been studied extensively over the last few 
decades, as the empty p orbital on boron, and the optical properties they possess make them 
attractive for a variety of applications.[1] These three-coordinate boron complexes have 
been used for sensing applications,[2-4] non-linear optical materials,[5] OLEDs,[6-7] and 
electroluminescent devices.[8-9] Combining these properties with those of the BF2 
formazanate framework is attractive, and related complexes have exhibited red-shifted 
emission into the near-IR,[10-11] multicolour emission,[12-13] and excellent sensing ability.[10-
11,13-14] 
There are many ways to append 3-coordinate boron species, including reaction with an aryl 
bromide. Bromo-substituted BF2 formazanate complexes could be converted into 6.1 via 
reaction with silyldimesitylborane, as described by the Ito group.[15] It has also been shown 
that BBr3 will add over an alkyne substituent,
[16] and this reaction could be applied to 
alkyne-substituted BF2 formazanates to form complexes such as 6.2. Finally, a lithium-
halogen exchange reaction can lead to the precursor to 6.3, which would allow for 3-
coordinate boron complexes to be appended to the four coordinate boron atom.[17] In all of 
these cases, the same reactivity can be applied to a variety of different BF2 formazanate 
complexes, such as asymmetric and symmetric derivatives, and complexes with various R3 
substituents (e.g. CN, NO2, Ar), though complexes with p-anisole N-aryl substituents, and 
R3 = CN are expected to have the most desirable optical properties. It is expected that the 
optical properties of these complexes would be very interesting, and the three-coordinate 
boron substituents would allow for use in sensing. 
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6.2.2 Polymeric Materials: BF2 Formazanate Platinum Polyynes 
The initial attempts to incorporate BF2 formazanate complexes into polymers were 
intriguing, as even with a lack of extended π conjugation, the properties of the resulting 
material were promising. Another method to create BF2 formazanate polymers, while likely 
maintaining extended conjugation, is incorporation into a platinum polyyne system (e.g. 
6.4). These polymers typically have red-shifted emission properties, are often 
phosphorescent, [18] and have found application as light-emitting diodes,[19-20] in 
photovoltaics,[21-23] organic field effect transistors,[24-25] and batteries,[26] as well as non-
linear optical materials,[27-28] sensors,[29-30] and patternable precursors to metal 
nanoparticles.[31-32] These polymers can be synthesized with a range of BF2 formazanate 
complexes by varying R3 (e.g. R3 = CN for improving fluorescence quantum yield, R3 = 
aryl for increased solubility), and are expected to have lower band gaps than the previously 
described BF2 formazanate polymer synthesized via CuAAC chemistry, and will likely be 
promising light harvesting materials. 
 
6.2.3 Device Fabrication 
BF2 complexes of formazanate ligands, and polymers based upon them, are well-suited for 
organic electronic applications, in large part, due to their inexpensive synthesis. By varying 
the substituents and tuning the properties of these complexes, the materials can be tailored 
for use as the functional component of a variety of electronic devices. For example, 
efficient electrochemiluminescence of BF2 formazanate complexes has already been 
demonstrated. Appending water solubilizing groups could result in a water soluble 
complex with similar electrochemiluminescence properties, which could be incorporated 
into electrochemiluminescence devices. Similarly, polymers containing BF2 formazanate 
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units have been shown to have low band gaps – even with limited π conjugation, and also 
exhibit good film-forming properties. For these reasons, they are excellent candidates for 
use as the active layer of lightweight and flexible organic photovoltaics. Their low-lying 
frontier orbitals are particularly well suited for inverted bulk heterojunction architectures 
(Figure 6.5). 
 
Figure 6.5. Proposed inverted bulk-heterojunction solar cell architecture comprised of an 
active layer containing BF2 formazanate complexes. 
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Appendix A2 Supporting Information for Chapter 2 
 
Figure A2.1 1H NMR spectrum of 2.8g in CDCl3. 
 
 
 
Figure A2.2 13C{1H} NMR spectrum of 2.8g in CDCl3. 
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Figure A2.3 1H NMR spectrum of 2.8h in CDCl3. 
 
 
 
 
Figure A2.4 13C{1H} NMR spectrum of 2.8h in CDCl3. 
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Figure A2.5 1H NMR spectrum of 2.8i in CDCl3. 
 
 
 
Figure A2.6 13C{1H} NMR spectrum of 2.8i in CDCl3. 
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Figure A2.7 1H NMR spectrum of 2.8k in d6-DMSO. 
 
 
 
Figure A2.8 13C{1H} NMR spectrum of 2.8k in d6-DMSO. 
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Figure A2.9 1H NMR spectrum of 2.13b in CDCl3. 
 
 
 
Figure A2.10 13C{1H} NMR spectrum of 2.13b in CDCl3. 
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Figure A2.11 1H NMR spectrum of 2.13c in CDCl3. 
 
 
 
Figure A2.12 13C{1H} NMR spectrum of 2.13c in CDCl3. 
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Figure A2.13 1H NMR spectrum of 2.13d in CDCl3. 
 
 
 
Figure A2.14 13C{1H} NMR spectrum of 2.13d in CDCl3. 
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Figure A2.15 1H NMR spectrum of 2.13e in CDCl3. 
 
 
 
Figure A2.16 13C{1H} NMR spectrum of 2.13e in CDCl3. 
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Figure A2.17 1H NMR spectrum of 2.13f in CDCl3. 
 
 
 
Figure A2.18 13C{1H} NMR spectrum of 2.13f in CDCl3. 
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Figure A2.19 1H NMR spectrum of 2.13g in CDCl3. 
 
 
 
Figure A2.20 13C{1H} NMR spectrum of 2.13g in CDCl3. 
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Figure A2.21 1H NMR spectrum of 2.13h in CDCl3. 
 
 
 
Figure A2.22 13C{1H} NMR spectrum of 2.13h in CDCl3. 
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Figure A2.23 1H NMR spectrum of 2.13i in CDCl3. 
 
 
 
Figure A2.24 13C{1H} NMR spectrum of 2.13i in CDCl3. 
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Figure A2.25 1H NMR spectrum of 2.13j in CDCl3. 
 
 
 
Figure A2.26 13C{1H} NMR spectrum of 2.13j in CDCl3. 
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Figure A2.27 1H NMR spectrum of 2.13k in CDCl3. 
 
 
 
Figure A2.28 13C{1H} NMR spectrum of 2.13k in CDCl3. 
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Figure A2.29 1H NMR spectrum of 2.13l in CDCl3.  
 
 
 
Figure A2.30 13C{1H} NMR spectrum of 2.13l in CDCl3. 
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Figure A2.31 Solid-state structure of flat conformation of 2.13l. Thermal ellipsoids are 
shown at 50% probability and hydrogen atoms have been removed for clarity.  
 
 
 
 
Figure A2.32 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13a in 10-5 M degassed toluene solution. 
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Figure A2.33 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13b in 10-5 M degassed toluene solution. 
 
 
Figure A2.34 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13c in 10-5 M degassed toluene solution. 
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Figure A2.35 Normalized UV-vis absorption spectra of benzene, benzonitrile, and 
anisole in THF. 
 
 
 
Figure A2.36 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13d in 10-5 M degassed toluene solution. 
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Figure A2.37 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13e in 10-5 M degassed toluene solution. 
 
 
 
 
Figure A2.38 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13f in 10-5 M degassed toluene solution. 
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Figure A2.39 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13g in 10-5 M degassed toluene solution. 
 
 
 
 
Figure A2.40 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13h in 10-5 M degassed toluene solution. 
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Figure A2.41 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13i in 10-5 M degassed toluene solution. 
 
 
 
Figure A2.42 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13j in 10-5 M degassed toluene solution. 
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Figure A2.43 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13k in 10-5 M degassed toluene solution. 
 
 
 
Figure A2.44 Normalized UV-vis absorption spectrum (dashed) and emission spectrum 
(solid) of 2.13l in 10-5 M degassed toluene solution. 
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Figure A2.45 Wavelength-dependent emission correction provided by Photon 
Technology International.  
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Figure A2.46 Cyclic voltammograms of 2.13d (black), 2.13e (blue) and 2.13f (red) 
recorded at 250 mV s-1 in 1 mM acetonitrile solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte.  
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Figure A2.47 Cyclic voltammograms of 2.13g (black), 2.13h (blue) and 2.13i (red) 
recorded at 250 mV s-1 in 1 mM acetonitrile solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte.  
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Figure A2.48 Cyclic voltammograms of 2.13a (black), 2.13b (blue) and 2.13c (red) 
recorded at 250 mV s-1 in 1 mM acetonitrile solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte.  
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Figure A2.49 Cyclic voltammograms of 2.13d (black), 2.13e (blue) and 2.13f (red) 
recorded at 250 mV s-1 in 1 mM acetonitrile solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte.  
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Figure A2.50 Cyclic voltammograms of 2.13g (black), 2.13h (blue) and 2.13i (red) 
recorded at 250 mV s-1 in 1 mM acetonitrile solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte.  
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Figure A2.51 Cyclic voltammograms of 2.13j (blue), 2.13k (black) and 2.13l (red) 
recorded at 100 mV s-1 in 1 mM acetonitrile solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte.  
 
 
 
 
 
-3 -2 -1 0 1 2
Potential (V vs. Ferrocene/Ferrocenium)
100 µA
2.13l 
2.13j 
2.13k 
223 
 
 
 
Table A2.1 Total electronic energies of the optimized M06/6-311+G* structures of 
2.13j–l, calculated in vacuum and in toluene using the SCRF(PCM,Solvent=Toluene) 
Int(Grid=UltraFine) keywords. 
Compound Ee (vacuum), hartree Ee (toluene), hartree 
C2v Cs C2v Cs 
2.13j (R = H) –1037.477334 –1037.479048 –1037.483066 –1037.485155 
2.13k (R = CN) –1221.893636  –1221.894770 –1221.904061 –1221.905495 
2.13l (R = OMe) –1266.464622 –1266.465720 –1266.472254 –1266.473716 
 
 
Table A2.2 Lowest electronic excitations and HOMO/LUMO energies of BF2 
complexes 2.13j–l in vacuum calculated at the M06/6-311+G* level of theory. 
Compound Lowest 
excitation 
energya 
εHOMO, eV εLUMO, eV HOMO–
LUMO gap, 
eV 
eV nm 
  C2v structures 
2.13j (R = H) 2.53 489 –6.97 –3.92 3.05 
2.13k (R = CN) 2.46 505 –7.67 –4.70 2.97 
2.13l (R = OMe) 2.29 541 –6.34 –3.60 2.74 
  Cs structures 
2.13j (R = H) 2.77 448 –7.12 –3.79 3.33 
2.13k (R = CN) 2.65 468 –7.78 –4.58 3.20 
2.13l (R = OMe) 2.46 504 –6.46 –3.50 2.96 
aComputed using time-dependent DFT. The first excited states of the C2v and Cs 
structures have B2 and A'' symmetry, respectively. 
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Table A2.3 Lowest electronic excitations and HOMO/LUMO energies of the 
substituted BF2 complexes in toluene solution calculated at the M06/6-311+G* level of 
theory using the SCRF method. 
  Lowest 
excitation 
energya 
εHOMO, eV εLUMO, eV HOMO-
LUMO gap, 
eV 
  eV nm    
C2V 
structures 
2.13j  
(R = H) 
2.39 518 −6.94 −3.89 3.05 
2.13k  
(R = CN) 
2.36 526 −7.49 −4.48 3.01 
2.13l  
(R = 
OMe) 
2.12 58 −6.34 −3.63 2.71 
Cs 
structures 
2.13j  
(R = H) 
2.65 468 −7.12 −3.76 3.36 
2.13k  
(R = CN) 
2.57 483 −7.62 −4.36 3.26 
2.13l  
(R = 
OMe) 
2.30 538 −6.47 −3.54 2.93 
aComputed using time-dependent DFT. The first excited states of the C2v and Cs structures 
have B2 and A'' symmetry, respectively. 
 
 
Figure A2.52 HOMOs and LUMOs for BF2 complexes 2.13j, 2.13k, and 2.13l calculated 
in toluene solution.  
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Appendix A3 Supporting Information for Chapter 3 
 
Figure A3.1 1H NMR spectrum of 3.11b in CDCl3. 
 
 
 
Figure A3.2 13C{1H} NMR spectrum of 3.11b in CDCl3. 
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Figure A3.3 1H NMR spectrum of 3.11c in CDCl3. 
 
 
 
Figure A3.4 13C{1H} NMR spectrum of 3.11c in CDCl3. 
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Figure A3.5 1H NMR spectrum of 3.11d in CDCl3. 
 
 
 
 
Figure A3.6 13C{1H} NMR spectrum of 3.11d in CDCl3. 
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Figure A3.7 1H NMR spectrum of 3.11f in DMSO-d6. 
 
 
 
Figure A3.8 13C{1H} NMR spectrum of 3.11f in DMSO-d6. This spectrum was measured 
for 10,000 scans on a 400 MHz spectrometer. The poor signal-to-noise ratio relates to the 
poor solubility of 3.11f.  
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Figure A3.9 1H NMR spectrum of 3.11h in CDCl3. 
 
 
 
Figure A3.10 13C{1H} NMR spectrum of 3.11h in CD2Cl2. 
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Figure A3.11 1H NMR spectrum of 3.11j in CDCl3. 
 
 
 
Figure A3.12 13C{1H} NMR spectrum of 3.11j in CDCl3. This spectrum was collected for 
10,000 scans on a 600 MHz spectrometer. The poor signal-to-noise ratio relates to the poor 
solubility of 3.11j. 
231 
 
 
 
 
Figure A3.13 1H NMR spectrum of 3.11k in CDCl3. 
 
 
 
Figure A3.14 13C{1H} NMR spectrum of 3.11k in CDCl3.  
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Figure A3.15 1H NMR spectrum of 3.10a in CDCl3. 
 
 
 
 
Figure A3.16 13C{1H} NMR spectrum of 3.10a in CDCl3. 
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Figure A3.17 1H NMR spectrum of 3.10b in CDCl3. 
 
 
 
Figure A3.18 13C{1H} NMR spectrum of 3.10b in CDCl3. 
234 
 
 
 
 
Figure A3.19 1H NMR spectrum of 3.10c in CDCl3. 
 
 
 
Figure A3.20 13C{1H} NMR spectrum of 3.10c in CDCl3. 
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Figure A3.21 1H NMR spectrum of 3.10d in CDCl3. 
 
 
Figure A3.22 13C{1H} NMR spectrum of 3.10d in CDCl3. 
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Figure A3.23 1H NMR spectrum of 3.10f in CDCl3. 
 
 
 
Figure A3.24 13C{1H} NMR spectrum of 3.10f in CDCl3. 
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Figure A3.25 1H NMR spectrum of 3.10g in CDCl3. 
 
 
 
Figure A3.26 13C{1H} NMR spectrum of 3.10g in CDCl3. 
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Figure A3.27 1H NMR spectrum of 3.10h in CDCl3. 
 
 
Figure A3.28 13C{1H} NMR spectrum of 3.10h in CDCl3. 
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Figure A3.29 13C{1H} NMR spectrum of 3.10j in CDCl3.  
 
 
 
Figure A3.30 13C{1H} NMR spectrum of 3.10k in CDCl3.  
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Figure A3.31 UV-vis absorption spectra of 2-naphthylamine in toluene. 
 
 
 
Figure A3.32 UV-vis absorption spectra (left) and emission spectra (right) of 3.10a 
(black, Ar1 = Ar5 = R3 = Ph), 3.10b (blue, Ar1 = Ar5 = Ph, R3 = Np), 3.10c (red, Ar1 = R3 
= Ph, Ar5 = Np) and 3.10d (green, Ar1 = Ar5 = Np, R3 = Ph). All UV-vis absorption and 
emission spectra were recorded for 10−5 M degassed THF solutions. 
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Figure A3.33 UV-vis absorption spectra (left) and emission spectra (right) of 3.10a 
(black, Ar1 = Ar5 = R3 = Ph), 3.10b (blue, Ar1 = Ar5 = Ph, R3 = Np), 3.10c (red, Ar1 = R3 
= Ph, Ar5 = Np) and 3.10d (green, Ar1 = Ar5 = Np, R3 = Ph). All UV-vis absorption and 
emission spectra were recorded for 10−5 M degassed CH2Cl2 solutions. 
 
 
Figure A3.34 Cyclic voltammograms of 3.10a (black, Ar1 = Ar5 = R3 = phenyl), 3.10b 
(blue, Ar1 = Ar5 = phenyl, R3 = naphthyl), 3.10c (red, Ar1 = R3 = phenyl, Ar5 = naphthyl), 
and 3.10d (green, Ar1 = Ar5 = naphthyl, R3 = phenyl) recorded at 100 mV s−1 in 1 mM 
CH3CN solutions containing 0.1 M [nBu4N][PF6] as supporting electrolyte. 
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Figure A3.35 Wavelength-dependent emission correction provided by Photon 
Technology International. 
 
 
 
Figure A3.36 UV-vis absorption spectra (left) and emission spectra (right) of 3.10e (red, 
Ar1 = Ar5 = Ph, R3 = CN), 3.10f (purple, Ar1 = Ar5 = Np, R3 = CN), 3.10g (blue, Ar1 = Ar5 = 
Ph, R3 = NO2) and 3.10h (orange, Ar
1
 = Ar5 = Np, R3 = NO2). All UV-vis absorption and 
emission spectra were recorded for 10−5 M degassed THF solutions. 
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Figure A3.37 UV-vis absorption spectra (left) and emission spectra (right) of 3.10e (red, 
Ar1 = Ar5 = Ph, R3 = CN), 3.10f (purple, Ar1 = Ar5 = Np, R3 = CN), 3.10g (blue, Ar1 = Ar5 
= Ph, R3 = NO2) and 3.10h (orange, Ar
1 = Ar5 = Np, R3 = NO2). All UV-vis absorption and 
emission spectra were recorded for 10−5 M degassed CH2Cl2 solutions. 
 
 
 
Figure A3.38 Cyclic voltammograms of 3.10a (black, Ar1 = Ar5 = R3 = phenyl), 3.10e 
(red, Ar1 = Ar5 = phenyl, R3 = cyano) and 3.10g (blue, Ar1 = Ar5 = phenyl, R3 = nitro) 
recorded at 100 mV s−1 in 1 mM CH3CN solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte. 
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Figure A3.39 Cyclic voltammograms of 3.10f (black, Ar1 = Ar5 = naphthyl, R3 = cyano), 
3.10g (blue, Ar1 = Ar5 = phenyl, R3 = nitro), and 3.10h (red, Ar1 = Ar5 = naphthyl, R3 = 
nitro) recorded at 100 mV s−1 in 1 mM CH3CN solutions containing 0.1 M [nBu4N][PF6] 
as supporting electrolyte. 
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Figure A3.40 Scan rate dependence of 3.10j in 1 mM CH2Cl2 solution containing 0.1 M 
[nBu4N][PF6] as supporting electrolyte run at 100 mV s
−1 (black), 250 mV s−1 (red), 500 
mV s−1 (blue), 1000 mV s−1 (green) and 2000 mV s−1 (orange). 
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Figure A3.41 Scan rate dependence of 3.10k in 1 mM CH2Cl2 solution containing 0.1 M 
[nBu4N][PF6] as supporting electrolyte run at 100 mV s
−1 (black), 250 mV s−1 (red), 500 
mV s−1 (blue), 1000 mV s−1 (green) and 2000 mV s−1 (orange). 
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Figure A3.42 Scan rate dependence of 3.10a in 1 mM CH2Cl2 solution containing 0.1 M 
[nBu4N][PF6] as supporting electrolyte run at 100 mV s
−1 (black), 250 mV s−1 (red), 500 
mV s−1 (blue), 1000 mV s−1 (green) and 2000 mV s−1 (orange).  
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Figure A3.43 Cyclic voltammograms of 3.10j (blue), 3.10k (red) and 3.10a (black) 
recorded at 100 mV s−1 in 1 mM CH2Cl2 solutions containing 0.1 M [nBu4N][PF6] as 
supporting electrolyte. 
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Calculated M06/6-311+G* structures of 3.10a, 3.10e and 3.10g in vacuum. All 
coordinates are in Å. 
 
# M06/6-311+G* Int(Grid=UltraFine) 
 
3.10a (R3 = Ph): Optimized M06/6-311+G* geometry (Cs), vacuum 
 
0,1 
C    -2.299578    0.585313    2.853536 
C    -1.175665   -0.108575    2.411379 
C    -0.668154   -1.174345    3.150842 
C    -1.284588   -1.541730    4.333801 
C    -2.404327   -0.851922    4.782527 
C    -2.905976    0.209619    4.041017 
N    -0.529006    0.292890    1.212974 
B    -1.270421    0.958175    0.000000 
F    -1.029154    2.312271    0.000000 
N     0.745997    0.098380    1.175418 
C     1.377226    0.181856    0.000000 
C     2.849568    0.124243    0.000000 
N     0.745997    0.098380   -1.175418 
N    -0.529006    0.292890   -1.212974 
C    -1.175665   -0.108575   -2.411379 
C    -0.668154   -1.174345   -3.150842 
C    -1.284588   -1.541730   -4.333801 
C    -2.404327   -0.851922   -4.782527 
C    -2.905976    0.209619   -4.041017 
C    -2.299578    0.585313   -2.853536 
F    -2.600368    0.644975    0.000000 
H     0.204047   -1.707898   -2.784313 
H    -0.892865   -2.378594   -4.907002 
H    -2.888756   -1.144453   -5.711072 
H    -3.777678    0.756474   -4.391756 
H    -2.683402    1.422223   -2.278601 
H     0.204047   -1.707898    2.784313 
H    -0.892865   -2.378594    4.907002 
H    -2.888756   -1.144453    5.711072 
H    -3.777678    0.756474    4.391756 
H    -2.683402    1.422223    2.278601 
C     3.557768    0.101448   -1.201996 
C     4.942106    0.038477   -1.199565 
C     5.640459    0.003660    0.000000 
C     4.942106    0.038477    1.199565 
C     3.557768    0.101448    1.201996 
H     3.013165    0.132890   -2.141827 
H     5.480630    0.019967   -2.144471 
H     6.727104   -0.043057    0.000000 
H     5.480630    0.019967    2.144471 
H     3.013165    0.132890    2.141827 
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# M06/6-311+G* Int(Grid=UltraFine) 
 
3.10e (R3 = CN): Optimized M06/6-311+G* geometry (Cs), vacuum 
 
0,1 
C     2.184147    0.281273    0.000000 
N     1.592054    0.178650    1.193952 
N     0.310659    0.227134    1.237759 
B    -0.549547    0.698134    0.000000 
F    -1.767671    0.086222    0.000000 
N     0.310659    0.227134   -1.237759 
N     1.592054    0.178650   -1.193952 
F    -0.621312    2.069365    0.000000 
C    -0.276053   -0.106306   -2.489581 
C     3.614908    0.305524    0.000000 
C    -0.276053   -0.106306    2.489581 
N     4.766829    0.336450    0.000000 
C     0.380141   -0.980914   -3.352634 
C    -0.184198   -1.277993   -4.579801 
C    -1.396999   -0.707861   -4.948618 
C    -2.045561    0.162932   -4.083236 
C    -1.493941    0.466078   -2.849707 
H     1.325718   -1.421122   -3.050307 
H     0.323173   -1.965514   -5.251801 
H    -1.838958   -0.945645   -5.913137 
H    -2.990577    0.616148   -4.371271 
H    -1.995460    1.156584   -2.179414 
C     0.380141   -0.980914    3.352634 
C    -0.184198   -1.277993    4.579801 
C    -1.396999   -0.707861    4.948618 
C    -2.045561    0.162932    4.083236 
C    -1.493941    0.466078    2.849707 
H     1.325718   -1.421122    3.050307 
H     0.323173   -1.965514    5.251801 
H    -1.838958   -0.945645    5.913137 
H    -2.990577    0.616148    4.371271 
H    -1.995460    1.156584    2.179414 
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# M06/6-311+G* Int(Grid=UltraFine) 
 
3.10g (R3 = NO2): Optimized M06/6-311+G* geometry (Cs), vacuum 
 
0,1 
C    -1.728116    0.458177    2.847695 
C    -0.508151   -0.115266    2.495884 
C     0.152265   -0.974679    3.371506 
C    -0.412065   -1.257196    4.601737 
C    -1.628077   -0.687641    4.961672 
C    -2.279483    0.169123    4.084700 
N     0.078292    0.204595    1.240653 
B    -0.775539    0.692758    0.000000 
F    -0.819486    2.063567    0.000000 
N     1.357319    0.123670    1.188209 
C     1.925597    0.225301    0.000000 
N     3.408092    0.213485    0.000000 
N     1.357319    0.123670   -1.188209 
N     0.078292    0.204595   -1.240653 
C    -0.508151   -0.115266   -2.495884 
C     0.152265   -0.974679   -3.371506 
C    -0.412065   -1.257196   -4.601737 
C    -1.628077   -0.687641   -4.961672 
C    -2.279483    0.169123   -4.084700 
C    -1.728116    0.458177   -2.847695 
F    -2.002605    0.100989    0.000000 
H     1.102650   -1.410422   -3.078049 
H     0.098722   -1.931692   -5.284165 
H    -2.069688   -0.914306   -5.929015 
H    -3.226271    0.622642   -4.366210 
H    -2.232219    1.138191   -2.168881 
H     1.102650   -1.410422    3.078049 
H     0.098722   -1.931692    5.284165 
H    -2.069688   -0.914306    5.929015 
H    -3.226271    0.622642    4.366210 
H    -2.232219    1.138191    2.168881 
O     3.954054    0.218392   -1.078741 
O     3.954054    0.218392    1.078741 
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Calculated M06/6-311+G* structures of 3.10a, 3.10e and 3.10g in toluene solution. 
All coordinates are in Å. 
 
# M06/6-311+G* Int(Grid=UltraFine)SCRF=(PCM,Solvent=Toluene) 
 
3.10a (R3 = Ph): Optimized M06/6-311+G* geometry (Cs), toluene 
solution 
 
0,1 
C    -0.611350   -2.279560    2.867417 
C     0.104011   -1.179417    2.400459 
C     1.206309   -0.701602    3.105236 
C     1.589108   -1.324593    4.280354 
C     0.877827   -2.420599    4.754425 
C    -0.220441   -2.892768    4.046850 
N    -0.311587   -0.524373    1.210790 
B    -0.985853   -1.253685    0.000000 
F    -2.341242   -0.992310    0.000000 
N    -0.106454    0.749541    1.174641 
C    -0.189131    1.382462    0.000000 
C    -0.123721    2.854518    0.000000 
N    -0.106454    0.749541   -1.174641 
N    -0.311587   -0.524373   -1.210790 
C     0.104011   -1.179417   -2.400459 
C     1.206309   -0.701602   -3.105236 
C     1.589108   -1.324593   -4.280354 
C     0.877827   -2.420599   -4.754425 
C    -0.220441   -2.892768   -4.046850 
C    -0.611350   -2.279560   -2.867417 
F    -0.700175   -2.591220    0.000000 
H     1.757648    0.150682   -2.718579 
H     2.454186   -0.957127   -4.826777 
H     1.182164   -2.909949   -5.676411 
H    -0.783767   -3.745034   -4.418228 
H    -1.478149   -2.638472   -2.320971 
H     1.757648    0.150682    2.718579 
H     2.454186   -0.957127    4.826777 
H     1.182164   -2.909949    5.676411 
H    -0.783767   -3.745034    4.418228 
H    -1.478149   -2.638472    2.320971 
C    -0.096846    3.562675   -1.202275 
C    -0.025124    4.946992   -1.199985 
C     0.014372    5.645258    0.000000 
C    -0.025124    4.946992    1.199985 
C    -0.096846    3.562675    1.202275 
H    -0.131411    3.019430   -2.142747 
H    -0.003057    5.485176   -2.144886 
H     0.068311    6.731474    0.000000 
H    -0.003057    5.485176    2.144886 
H    -0.131411    3.019430    2.142747 
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# M06/6-311+G* Int(Grid=UltraFine)SCRF=(PCM,Solvent=Toluene) 
 
3.10e (R3 = CN): Optimized M06/6-311+G* geometry (Cs), toluene 
solution 
 
0,1 
C     2.186655    0.286978    0.000000 
N     1.595515    0.184729    1.194429 
N     0.314638    0.242583    1.236854 
B    -0.535905    0.726978    0.000000 
F    -1.767225    0.140288    0.000000 
N     0.314638    0.242583   -1.236854 
N     1.595515    0.184729   -1.194429 
F    -0.584603    2.102405    0.000000 
C    -0.278213   -0.104836   -2.482029 
C     3.617127    0.302617    0.000000 
C    -0.278213   -0.104836    2.482029 
N     4.769362    0.327999    0.000000 
C     0.352002   -1.025943   -3.315512 
C    -0.216635   -1.338035   -4.537350 
C    -1.407390   -0.736394   -4.928442 
C    -2.030670    0.180259   -4.091368 
C    -1.474626    0.498448   -2.863456 
H     1.277777   -1.493989   -2.994080 
H     0.268703   -2.062159   -5.186506 
H    -1.852803   -0.985815   -5.888262 
H    -2.957745    0.657477   -4.397742 
H    -1.954943    1.225967   -2.216822 
C     0.352002   -1.025943    3.315512 
C    -0.216635   -1.338035    4.537350 
C    -1.407390   -0.736394    4.928442 
C    -2.030670    0.180259    4.091368 
C    -1.474626    0.498448    2.863456 
H     1.277777   -1.493989    2.994080 
H     0.268703   -2.062159    5.186506 
H    -1.852803   -0.985815    5.888262 
H    -2.957745    0.657477    4.397742 
H    -1.954943    1.225967    2.216822 
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# M06/6-311+G* Int(Grid=UltraFine)SCRF=(PCM,Solvent=Toluene) 
 
3.10g (R3 = NO2): Optimized M06/6-311+G* geometry (Cs), toluene 
solution 
 
0,1 
C    -1.702774    0.502704    2.861272 
C    -0.512572   -0.114662    2.482338 
C     0.107934   -1.040583    3.318257 
C    -0.465476   -1.344361    4.539549 
C    -1.650732   -0.729698    4.927865 
C    -2.263486    0.192252    4.088952 
N     0.085660    0.225908    1.238492 
B    -0.750350    0.743507    0.000000 
F    -0.743785    2.117743    0.000000 
N     1.363411    0.127875    1.188524 
C     1.932407    0.230393    0.000000 
N     3.409584    0.207030    0.000000 
N     1.363411    0.127875   -1.188524 
N     0.085660    0.225908   -1.238492 
C    -0.512572   -0.114662   -2.482338 
C     0.107934   -1.040583   -3.318257 
C    -0.465476   -1.344361   -4.539549 
C    -1.650732   -0.729698   -4.927865 
C    -2.263486    0.192252   -4.088952 
C    -1.702774    0.502704   -2.861272 
F    -2.000060    0.200581    0.000000 
H     1.030993   -1.516047   -3.000226 
H     0.012225   -2.071241   -5.191153 
H    -2.099771   -0.972866   -5.887574 
H    -3.185604    0.679852   -4.393724 
H    -2.174852    1.234515   -2.213576 
H     1.030993   -1.516047    3.000226 
H     0.012225   -2.071241    5.191153 
H    -2.099771   -0.972866    5.887574 
H    -3.185604    0.679852    4.393724 
H    -2.174852    1.234515    2.213576 
O     3.961070    0.208547   -1.077611 
O     3.961070    0.208547    1.077611 
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Appendix A4 Supporting Information for Chapter 4 
 
Figure A4.1 1H NMR spectrum of 4.8 in DMSO-d6. Asterisks indicate signals from the 
minor isomer. 
 
 
Figure A4.2 13C{1H} NMR spectrum of 4.8 in DMSO-d6.  
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Figure A4.3 1H NMR spectrum of 4.9 in CDCl3.  
 
 
 
Figure A4.4 13C{1H} NMR spectrum of 4.9 in CDCl3.  
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Figure A4.5 1H NMR spectrum of 4.10 in CDCl3.  
 
 
 
 
Figure A4.6 13C{1H} NMR spectrum of 4.10 in CDCl3.  
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Figure A4.7 1H NMR spectrum of 4.11 in CDCl3.  
 
 
 
Figure A4.8 13C{1H} NMR spectrum of 4.11 in CDCl3.  
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Figure A4.9 1H NMR spectrum of 4.12 in CDCl3. 
 
 
 
 
Figure A4.10 13C{1H} NMR spectrum of 4.12 in DMSO-d6. 
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Figure A4.11 1H NMR spectrum of 4.13 in CDCl3. 
 
 
 
 
Figure A4.12 13C{1H} NMR spectrum of 4.13 in CDCl3.  
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Figure A4.13 1H NMR spectrum of 4.14 in CDCl3. 
 
 
 
Figure A4.14 13C{1H} NMR spectrum of 4.14 in CDCl3. 
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Figure A4.15 1H NMR spectrum of 4.15 in CDCl3. 
 
 
 
 
Figure A4.16 1H NMR spectrum of 4.16 in CDCl3.  
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Figure A4.17 13C{1H} NMR spectrum of 4.16 in CDCl3.  
 
 
Figure A4.18 Wavelength-dependent emission correction provided by Photon 
Technology International. 
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Figure A4.19 UV-vis absorption spectrum of 4.11 in CH2Cl2. 
 
 
Figure A4.20 UV-vis absorption spectrum of 4.15 in CH2Cl2. 
0
5000
10000
15000
20000
25000
30000
35000
300 400 500 600 700 800
M
o
la
r 
A
b
so
rp
ti
v
it
y
 (
M
−
1
cm
−
1
)
Wavelength (nm)
0
5000
10000
15000
20000
25000
30000
35000
300 400 500 600 700 800
M
o
la
r 
A
b
so
rp
ti
v
it
y
 (
M
−
1
cm
−
1
)
Wavelength (nm)
265 
 
 
 
 
Figure A4.21 1H NMR spectrum of 1-p-ethynylphenyl-3,5-phenyl formazan in CDCl3. 
 
 
 
Figure A4.22 13C{1H} NMR spectrum of 1-p-ethynylphenyl-3,5-phenyl formazan in 
CDCl3. 
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Figure A4.23 1H NMR spectrum of 4.17 in CDCl3. 
 
 
 
Figure A4.24 13C{1H} NMR spectrum of 4.17 in CDCl3. 
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Figure A4.25 1H NMR spectrum of 1,5-p-ethynylphenyl-3-phenyl formazan in CDCl3. 
 
 
 
Figure A4.26 13C{1H} NMR spectrum of 1,5-p-ethynylphenyl-3-phenyl formazan in 
CDCl3. 
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Figure A4.27 1H NMR spectrum of 4.18 in CDCl3. 
 
 
 
Figure A4.28 13C{1H} NMR spectrum of 4.18 in CDCl3. 
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Figure A4.29 1H NMR spectrum of 4.19 in CDCl3. 
 
 
Figure A4.30 13C{1H} NMR spectrum of 4.19 in CDCl3. 
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Figure A4.31 1H NMR spectrum of 4.24 in CDCl3. 
 
 
 
Figure A4.32 13C{1H} NMR spectrum of 4.24 in CDCl3. 
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Figure A4.33 1H NMR spectrum of 4.25 in CDCl3. 
 
 
 
Figure A4.34 13C{1H} NMR spectrum of 4.25 in CDCl3. 
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Figure A4.35 1H NMR spectrum of 4.26 in CDCl3. 
 
 
 
Figure A4.36 13C{1H} NMR spectrum of 4.26 in CDCl3. 
 
273 
 
 
 
 
Figure A4.37 GPC traces for aliquots of polymer 4.21 taken at 12 h (black), 24 h (purple), 
48 h (blue), 72 h (green) and 168 h (red).  
 
 
 
Figure A4.38 TGA trace for 4.21. 
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Figure A4.39 DSC thermogram collected for 4.21. 
 
Figure A4.40 Powder X-ray diffractogram for 4.21 collected on a glass slide. 
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Figure A4.41 SEM images of a thin film of 4.21 prepared from a chlorobenzene solution 
on a silicon wafer. 
 
 
Figure A4.42 Normalized UV-vis absorption and emission spectra of 4.21 with number 
average molecular weight of 6,000 g mol−1 (red), 10,000 g mol−1 (blue) and 17,000 g mol−1 
(black) for 10−5 M DMF solution.  
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Figure A4.43 Normalized thin-film UV-vis absorption spectra of 4.21 (purple), 4.23 
(black), 4.24 (green), 4.25 (red), and 4.26 (blue). 
 
 
Figure A4.44 Emission spectra of 4.21 recorded at excitation wavelength of 327 nm 
(black) and 557 nm (red) for a 10−5 M degassed DMF solution. 
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Figure A4.45 Cyclic voltammogram of 4.22 recorded at 100 mV s−1 in a 1 mM DMF 
solution containing 0.1 M [nBu4N][PF6] as supporting electrolyte. 
 
Figure A4.46 Cyclic voltammogram of 4.23 recorded at 100 mV s−1 in a 1 mM DMF 
solution containing 0.1 M [nBu4N][PF6] as supporting electrolyte. 
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Figure A4.47 Cyclic voltammogram of 4.24 recorded at 100 mV s−1 in a 1 mM DMF 
solution containing 0.1 M [nBu4N][PF6] as supporting electrolyte. 
 
Figure A4.48 Cyclic voltammogram of 4.25 recorded at 100 mV s−1 in a 1 mM DMF 
solution containing 0.1 M [nBu4N][PF6] as supporting electrolyte. 
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Figure A4.49 Cyclic voltammogram of 4.26 recorded at 100 mV s−1 in a 1 mM DMF 
solution containing 0.1 M [nBu4N][PF6] as supporting electrolyte. 
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Appendix A5 Supporting Information for Chapter 5 
 
Figure A5.1 Silica TLC plate showing the separation of the 6 components of the reaction 
mixture of formazan 5.7 with BF3•OEt2 and NEt3. 
 
 
 
Figure A5.2 1H NMR spectrum of 5.9 in CDCl3.  
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Figure A5.3 13C{1H} NMR spectrum of 5.9 in CDCl3.  
 
 
 
Figure A5.4 1H NMR spectrum of 5.10 in CDCl3.  
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Figure A5.5 13C{1H} NMR spectrum of 5.10 in CDCl3.  
 
 
 
Figure A5.6 1H NMR spectrum of 5.11 in CDCl3. 
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Figure A5.7 13C{1H} NMR spectrum of 5.11 in CDCl3. This spectrum was rapidly 
collected for a saturated solution of compound 5.11. Efforts to improve the S/N ratio were 
thwarted by the conversion of 5.11 to formazan 5.7 in solution.  
 
 
Figure A5.8 1H NMR spectrum of 5.12 in CDCl3. 
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Figure A5.9 13C{1H} NMR spectrum of 5.12 in CDCl3. 
 
 
 
Figure A5.10 1H NMR spectrum of 5.13 in CDCl3.  
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Figure A5.11 13C{1H} NMR spectrum of 5.13 in CDCl3. 
 
 
 
 
Figure A5.12 1H NMR spectrum of 5.14 in DMSO-d6. Signals due to the major isomer 
have been marked with black squares, and those due to the minor isomer have been marked 
with black circles. Only signals from the major isomer have been integrated. 
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Figure A5.13 13C{1H} NMR spectrum of 5.14 in DMSO-d6. Formazan 5.14 was sparingly 
soluble in common NMR solvents. This spectrum was collected for a saturated solution 
over 10,000 scans on a 600 MHz NMR spectrometer. 
 
 
 
Figure A5.14 1H NMR spectrum of 5.15 in CDCl3.  
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Figure A5.15 13C{1H} NMR spectrum of 5.15 in CDCl3.  
 
 
 
 
Figure A5.16 Solid-state structure of 5.15. Thermal displacement ellipsoids are shown at 
the 50% probability level and hydrogen atoms have been removed for clarity. 
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Figure A5.17 UV-vis absorption spectrum of complex 5.9 in Toluene. 
 
 
 
Figure A5.18 EPR spectra of 5.10•− (red) and 5.10••2− (black) in CH2Cl2. 
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Figure A5.19 UV-vis absorption spectrum of complex 5.11 in toluene. 
 
 
Figure A5.20 Cyclic voltammograms of complex 5.11 recorded at 100 mV s−1 in 1 mM 
CH2Cl2 solution containing 0.1 M [nBu4N][PF6] as supporting electrolyte.  
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Figure A5.21 UV-vis absorption spectrum of complex 5.12 in toluene. 
 
 
 
Figure A5.22 UV-vis absorption spectrum of complex 5.13 in toluene. 
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Figure A5.23 Cyclic voltammograms of complex 5.13 recorded at 100 mV s−1 in 1 mM 
CH2Cl2 solution containing 0.1 M [nBu4N][PF6] as supporting electrolyte.  
 
 
 
Figure A5.24 1H NMR spectrum of 5.16− in CD2Cl2. 
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Figure A5.25 13C{1H} NMR spectrum of 5.16− in CD2Cl2. 
 
 
Figure A5.26 UV-vis absorption spectrum of complex 5.16− in CH2Cl2. 
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Table A5.1 Changes in the total electronic energy, enthalpy and Gibbs free energy for 
the reactions of 5.7 to form 5.8−5.13 and the reaction of 5.14 to form 5.15 in the gas phase 
and in a toluene solution calculated with the PBE1PBE density functional using the 6-
311+G(d,p) basis set. All values are per mole of 7 or 14. 
Reaction ΔEe (kJ mol−1) ΔH°353 (kJ mol−1) ΔG°353 (kJ mol−1) 
Gas phase    
5.7→5.8 180.7 161.2 91.2 
5.7→5.9 100.7 85.7 47.1 
5.7→5.10 105.9 90.7 53.4 
5.7→5.11 35.8 26.9 2.1 
5.7→5.12 −125.6 −124.4 −76.9 
5.7→5.13 −49.7 −57.3 −54.0 
5.14→5.15 90.5 70.9 −1.9 
Toluene solution (polarized continuum model) 
5.7→5.8 164.8 145.3 75.7 
5.7→5.9 87.4 72.4 34.1 
5.7→5.10 91.7 76.6 39.9 
5.7→5.11 27.4 18.3 −6.2 
5.7→5.12 −133.4 −132.3 −84.2 
5.7→5.13 −64.9 −72.6 −68.6 
5.14→5.15 72.6 52.9 −19.4 
 
Table A5.2 Frontier-orbital energies and first singlet-singlet electronic excitation 
energies (ΔE) of complexes 5.13 and 5.16− in CH2Cl2 solution calculated with time-
dependent density-functional theroy at the PBE1PBE/6-311+G(d,p) level using the SCRF 
method. 
 Orbital energies (eV)  
 HOMO LUMO 
Oscillator 
strength 
ΔEcalc’d 
(eV) 
ΔEcalc’d 
(nm) 
ΔEexp 
(nm) 
5.13 −6.49 −3.52 f = 1.03 2.44 508 577 
5.16− −5.66 −2.78 f = 1.06 2.40 516 589 
 
Reaction stoichiometries used to compute ΔEe, ΔH°, and ΔG°. 
5.7 + BF3 → 5.11 + 2HF 
5.7 + 2BF3 + H2O → 5.12 + 3HF 
5.7 + 2BF3 + H2O → 5.13 + 4HF 
5.7 + BF3 → 5.8 + 3HF 
5.7 + BF3 → ½ 5.10 + 3HF 
5.7 + BF3 → ½ 5.9 + 3HF 
5.14 + BF3 → 5.15 + 3HF 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.7 / Optimized geometry 
 
0,1 
C    -1.338145    2.674505    0.000000 
C     0.060995    2.592382    0.000000 
C     0.827022    3.755473    0.000000 
C     0.199532    4.991736    0.000000 
C    -1.190403    5.071922    0.000000 
C    -1.959715    3.913899    0.000000 
N     0.607554    1.314706    0.000000 
N     1.887252    1.109437    0.000000 
C     2.315928   -0.135718    0.000000 
C     3.741418   -0.280770    0.000000 
N     4.889296   -0.403417    0.000000 
O    -2.015987    1.492038    0.000000 
N     1.639914   -1.330272    0.000000 
N     0.369505   -1.287434    0.000000 
C    -0.268958   -2.527007    0.000000 
C     0.404712   -3.759547    0.000000 
C    -0.300372   -4.943512    0.000000 
C    -1.700308   -4.916026    0.000000 
C    -2.382720   -3.714018    0.000000 
C    -1.679345   -2.508578    0.000000 
O    -2.398118   -1.374320    0.000000 
H     0.000000    0.488219    0.000000 
H     1.907020    3.669400    0.000000 
H     0.797535    5.895805    0.000000 
H    -1.682226    6.038164    0.000000 
H    -3.044743    3.971027    0.000000 
H    -2.964836    1.648221    0.000000 
H    -3.466307   -3.678220    0.000000 
H    -2.259920   -5.845584    0.000000 
H     0.226808   -5.890820    0.000000 
H     1.488066   -3.748244    0.000000 
H    -1.821047   -0.599281    0.000000 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.8 / Optimized geometry 
 
0,1 
C     0.327682    2.046580   -1.230335 
C    -0.591983    2.260988   -0.184316 
C    -1.209127    3.480774    0.040633 
C    -0.910848    4.509973   -0.840920 
C     0.000000    4.310056   -1.885252 
C     0.640276    3.091823   -2.087651 
N    -0.559487    1.081419    0.564956 
N    -0.544847    1.077341    1.849963 
C     0.000000    0.000000    2.435296 
C     0.000000    0.000000    3.864885 
N     0.000000    0.000000    5.018247 
O     0.862773    0.812684   -1.250301 
B     0.000000    0.000000   -0.376825 
O    -0.862773   -0.812684   -1.250301 
C    -0.327682   -2.046580   -1.230335 
C     0.591983   -2.260988   -0.184316 
C     1.209127   -3.480774    0.040633 
C     0.910848   -4.509973   -0.840920 
C     0.000000   -4.310056   -1.885252 
C    -0.640276   -3.091823   -2.087651 
N     0.559487   -1.081419    0.564956 
N     0.544847   -1.077341    1.849963 
H    -1.355864   -2.949056   -2.888653 
H    -0.215152   -5.132256   -2.559799 
H     1.384174   -5.477305   -0.719292 
H     1.893690   -3.613035    0.870418 
H    -1.893690    3.613035    0.870418 
H    -1.384174    5.477305   -0.719292 
H     0.215152    5.132256   -2.559799 
H     1.355864    2.949056   -2.888653 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.9 / Optimized geometry 
 
0,1 
B     1.627137    0.378695    0.072504 
O     1.722202   -0.605396    1.138390 
O    -0.929242    0.028181    1.110874 
N     3.144283    0.677343   -0.190132 
N     3.599868    1.671095   -0.851315 
N     1.097367    1.808158    0.379998 
N     1.558815    2.794668   -0.322321 
N     3.339786    4.596541   -2.577468 
C     2.676549    2.637870   -1.031152 
C     3.046530    3.728337   -1.876812 
C     3.904235   -0.262135    0.480285 
C     3.000120   -0.989586    1.273159 
C     3.467576   -1.986048    2.118057 
H     2.780157   -2.549107    2.737915 
C     4.835804   -2.230604    2.128814 
H     5.223000   -3.012384    2.773810 
C     5.731179   -1.499060    1.335293 
H     6.790721   -1.723278    1.378794 
C     5.275405   -0.490840    0.501800 
H     5.946304    0.097945   -0.112865 
C     0.114101    2.162238    1.332017 
C    -0.918930    1.263014    1.645999 
C    -1.892557    1.649503    2.563564 
H    -2.677717    0.942664    2.808957 
C    -1.851642    2.904902    3.152143 
H    -2.617199    3.186116    3.867421 
C    -0.827760    3.795247    2.836478 
H    -0.785975    4.772316    3.304096 
C     0.151542    3.421875    1.933536 
H     0.962816    4.094570    1.681084 
B    -1.627107   -0.378712   -0.072503 
O    -1.722176    0.605358   -1.138409 
O     0.929268   -0.028170   -1.110884 
N    -3.144247   -0.677380    0.190127 
N    -3.599817   -1.671130    0.851325 
N    -1.097315   -1.808170   -0.379978 
N    -1.558746   -2.794681    0.322351 
N    -3.340351   -4.595963    2.577969 
C    -2.676483   -2.637890    1.031177 
C    -3.046443   -3.728361    1.876841 
C    -3.904211    0.262070   -0.480319 
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C    -3.000099    0.989521   -1.273198 
C    -3.467564    1.985956   -2.118123 
H    -2.780148    2.549014   -2.737986 
C    -4.835797    2.230488   -2.128901 
H    -5.223000    3.012247   -2.773919 
C    -5.731167    1.498944   -1.335375 
H    -6.790712    1.723141   -1.378893 
C    -5.275384    0.490750   -0.501856 
H    -5.946279   -0.098035    0.112813 
C    -0.114063   -2.162240   -1.332014 
C     0.918946   -1.262999   -1.646020 
C     1.892542   -1.649463   -2.563628 
H     2.677680   -0.942607   -2.809045 
C     1.851625   -2.904857   -3.152217 
H     2.617160   -3.186051   -3.867527 
C     0.827770   -3.795222   -2.836521 
H     0.785984   -4.772288   -3.304146 
C    -0.151507   -3.421872   -1.933543 
H    -0.962764   -4.094580   -1.681070 
 
# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.10 / Optimized geometry 
 
0,1 
B    -1.700471    0.509194   -0.107182 
B     1.700472    0.509177    0.107217 
N    -3.220933    0.246358    0.183959 
N    -3.738638   -0.855451    0.570755 
N    -1.312952   -0.829184   -0.795996 
N    -1.836592   -1.943572   -0.377926 
N     3.220923    0.246339   -0.183970 
N     3.738618   -0.855465   -0.570794 
N     1.312954   -0.829213    0.795993 
N     1.836581   -1.943597    0.377897 
N    -3.706508   -4.157069    1.395973 
N     3.706311   -4.157078   -1.396170 
O    -1.770810    1.690750   -0.944689 
O     0.950576    0.792131   -1.082173 
O     1.770835    1.690698    0.944773 
O    -0.950598    0.792083    1.082231 
C    -2.905957   -1.906988    0.414555 
C     2.905935   -1.907003   -0.414598 
C    -3.349152   -3.156814    0.946475 
C     3.349126   -3.156820   -0.946541 
C    -3.925915    1.376585   -0.187112 
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C    -3.009218    2.192802   -0.874748 
C    -3.439291    3.385626   -1.440766 
H    -2.744562    4.019428   -1.978713 
C    -4.775905    3.729629   -1.282136 
H    -5.130005    4.663939   -1.705087 
C    -5.682752    2.908083   -0.596173 
H    -6.717298    3.216603   -0.499999 
C    -5.269285    1.706403   -0.046137 
H    -5.950694    1.045553    0.476911 
C    -0.464071   -0.946658   -1.921737 
C     0.662502   -0.115204   -2.037872 
C     1.460938   -0.219714   -3.174454 
H     2.315594    0.441958   -3.263738 
C     1.170606   -1.154704   -4.157406 
H     1.805650   -1.224609   -5.034037 
C     0.071517   -1.999899   -4.022080 
H    -0.156458   -2.730989   -4.789169 
C    -0.745854   -1.889923   -2.910945 
H    -1.619711   -2.520746   -2.795251 
C     3.925915    1.376559    0.187113 
C     3.009239    2.192755    0.874800 
C     3.439330    3.385567    1.440834 
H     2.744620    4.019355    1.978819 
C     4.775938    3.729575    1.282168 
H     5.130046    4.663878    1.705131 
C     5.682764    2.908049    0.596153 
H     6.717306    3.216575    0.499953 
C     5.269280    1.706383    0.046100 
H     5.950674    1.045550   -0.476989 
C     0.464084   -0.946704    1.921745 
C    -0.662498   -0.115266    2.037904 
C    -1.460921   -0.219804    3.174494 
H    -2.315586    0.441854    3.263788 
C    -1.170564   -1.154799    4.157433 
H    -1.805598   -1.224728    5.034068 
C    -0.071461   -1.999974    4.022086 
H     0.156540   -2.731065    4.789164 
C     0.745894   -1.889972    2.910940 
H     1.619758   -2.520783    2.795234 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.11 / Optimized geometry 
 
0,1 
C     3.137551   -0.122566   -0.671405 
C     2.016730   -0.550157    0.083456 
C     1.991622   -1.856224    0.598267 
C     3.024673   -2.733914    0.351399 
C     4.111296   -2.320629   -0.423563 
C     4.163946   -1.034388   -0.923588 
N     0.919135    0.285088    0.344763 
N     1.068154    1.559894    0.132999 
C     0.010362    2.380472    0.146223 
C     0.296764    3.773332    0.017687 
N     0.531390    4.899111   -0.070755 
O     3.274001    1.109968   -1.172111 
N    -1.277329    2.014651    0.056429 
N    -1.455260    0.766106    0.281011 
B    -0.434690   -0.188805    0.950403 
F    -0.383692   -0.007635    2.320339 
O    -0.946691   -1.489976    0.563143 
C    -2.186571   -1.324952    0.069419 
C    -3.064051   -2.334857   -0.292145 
C    -4.298161   -1.958970   -0.811425 
C    -4.655052   -0.614833   -0.986207 
C    -3.777088    0.400843   -0.644272 
C    -2.552142    0.021371   -0.108384 
H     1.146301   -2.174992    1.194231 
H    -2.789345   -3.375206   -0.166151 
H    -5.006136   -2.731867   -1.091123 
H    -5.627944   -0.368805   -1.395566 
H    -4.024131    1.447551   -0.777216 
H     5.006100   -0.688804   -1.512383 
H     4.926435   -3.006616   -0.627469 
H     2.988985   -3.736377    0.760911 
H     2.566033    1.666776   -0.792450 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.12 / Optimized geometry 
 
0,1 
B     2.183982   -1.818880   -0.324651 
B    -2.576550   -1.293297    0.467259 
F     2.794967   -2.485348    0.723446 
F     2.827831   -2.049986   -1.524950 
F    -2.487766   -1.608838    1.807733 
O     2.353382    2.674671    0.192720 
H     1.568960    2.088756    0.232222 
O    -3.910545   -1.414227   -0.070854 
O    -1.522043   -2.021486   -0.265747 
N     2.178547   -0.245079   -0.019915 
N     1.104651    0.430554    0.159909 
N    -2.279097    0.236072    0.259781 
N    -1.128772    0.766826    0.199260 
N     0.717416   -2.254473   -0.429989 
H     0.526691   -3.222647   -0.666672 
C    -0.111283   -0.125689    0.138254 
C    -0.327416   -1.524143   -0.168996 
C     3.391923    0.475786    0.020751 
C     3.435242    1.892063    0.116319 
C     4.677329    2.529749    0.124216 
H     4.679379    3.611778    0.192972 
C     5.851827    1.807817    0.053652 
H     6.802831    2.329496    0.065680 
C     5.814804    0.414770   -0.027109 
H     6.731978   -0.160113   -0.075331 
C     4.600524   -0.237330   -0.044065 
H     4.577646   -1.315961   -0.101848 
C    -3.494579    0.861251    0.040302 
C    -4.427837   -0.174969   -0.160851 
C    -5.745825    0.135536   -0.456307 
H    -6.472309   -0.651806   -0.617670 
C    -6.091767    1.480691   -0.537000 
H    -7.119982    1.743770   -0.762057 
C    -5.156514    2.504437   -0.339137 
H    -5.470922    3.539110   -0.410808 
C    -3.833794    2.205064   -0.052759 
H    -3.088105    2.976891    0.098523 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.13 / Optimized geometry 
 
0,1 
B     2.385130   -1.336210    0.126747 
B    -2.347129   -1.308270    0.106778 
F     2.508466   -1.986910    1.348581 
F    -2.352928   -1.985475    1.309615 
O     3.623565   -1.384274   -0.634046 
O    -3.599302   -1.391877   -0.609392 
O    -1.148607   -1.700069   -0.658618 
N     2.208091    0.206168    0.355151 
N     1.127780    0.841489    0.551741 
N    -2.214067    0.234732    0.352357 
N    -1.133013    0.867997    0.540447 
N     1.103261   -1.764396   -0.569938 
H     1.015293   -2.637253   -1.078303 
C    -0.008086    0.128070    0.398521 
C    -0.027729   -1.174380   -0.262042 
C     3.454729    0.784433    0.150357 
C     4.249229   -0.206926   -0.454656 
C     5.546942    0.093318   -0.840370 
H     6.167056   -0.659773   -1.311917 
C     6.014452    1.381220   -0.598637 
H     7.030212    1.632223   -0.885780 
C     5.215604    2.361386    0.002164 
H     5.619790    3.352379    0.173479 
C     3.912107    2.074585    0.379739 
H     3.268659    2.816107    0.838917 
C    -3.468428    0.791289    0.148994 
C    -4.248116   -0.225130   -0.434961 
C    -5.557299    0.040044   -0.804458 
H    -6.166528   -0.732205   -1.258712 
C    -6.049423    1.321033   -0.572860 
H    -7.073914    1.546115   -0.850262 
C    -5.265062    2.326746    0.004291 
H    -5.689201    3.310653    0.167806 
C    -3.950883    2.074028    0.368871 
H    -3.319038    2.835147    0.811793 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.14 / Optimized geometry 
 
0,1 
C     3.387406    0.992871    0.977377 
C     2.588139    0.231097    0.117467 
C     3.091206   -0.955283   -0.441124 
C     4.402363   -1.325808   -0.141871 
C     5.192402   -0.573239    0.717147 
C     4.676334    0.589142    1.282301 
N     1.261979    0.629391   -0.181077 
N     1.122066    1.883518   -0.154276 
C    -0.150483    2.389086   -0.283820 
C    -0.185718    3.817377   -0.401786 
N    -0.207433    4.966778   -0.509229 
C     2.285114   -1.840673   -1.347882 
O     1.676476   -2.924912   -0.637495 
N    -1.330873    1.820083   -0.209617 
N    -1.478275    0.542473   -0.112405 
C    -2.767927    0.009546    0.068976 
C    -3.892720    0.825885   -0.050169 
C    -5.155660    0.290980    0.148564 
C    -5.306148   -1.055483    0.462844 
C    -4.179908   -1.861462    0.573978 
C    -2.899227   -1.351130    0.388049 
C    -1.695694   -2.232986    0.548940 
O    -0.882656   -2.108811   -0.599685 
H    -0.681943   -0.095611   -0.223851 
H    -3.762452    1.872184   -0.296536 
H    -6.026270    0.930516    0.050233 
H    -6.293993   -1.477480    0.611747 
H    -4.290230   -2.915504    0.810420 
H     4.814237   -2.218429   -0.606084 
H     6.206373   -0.887933    0.939399 
H     5.281043    1.183335    1.959196 
H     2.972610    1.897797    1.405453 
H    -0.030440   -2.555573   -0.450820 
H    -1.136878   -1.933558    1.450310 
H    -2.026412   -3.268108    0.697884 
H     1.464525   -1.296882   -1.814370 
H     2.928360   -2.241543   -2.139021 
H     2.321798   -3.318660   -0.044242 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Toluene) 
  Temperature=353.15 
 
Compound 5.15 / Optimized geometry 
 
0,1 
B     0.000037   -0.336692    0.000062 
O    -0.181540   -1.100147   -1.196879 
O     0.181672   -1.099981    1.197097 
N    -1.231434    0.611572    0.107399 
N    -1.201660    1.886079    0.085106 
N     1.231429    0.611652   -0.107383 
N     1.201585    1.886156   -0.085105 
N    -0.000445    5.057917    0.000089 
C    -0.000057    2.476449    0.000007 
C    -0.000096    3.903644    0.000020 
C    -2.488008   -0.029378    0.069899 
C    -2.530304   -1.299397   -0.517263 
C    -3.758868   -1.954293   -0.556333 
H    -3.818552   -2.936374   -1.016959 
C    -4.902145   -1.364418   -0.036667 
H    -5.848752   -1.892280   -0.081028 
C    -4.838465   -0.093667    0.534985 
H    -5.730997    0.367004    0.943615 
C    -3.631396    0.578931    0.588698 
H    -3.550921    1.563154    1.034857 
C    -1.302381   -1.948128   -1.116114 
H    -1.071132   -2.848764   -0.526580 
H    -1.536217   -2.279958   -2.132411 
C     2.488028   -0.029242   -0.069952 
C     2.530426   -1.299194    0.517351 
C     3.759002   -1.954068    0.556301 
H     3.818774   -2.936109    1.017004 
C     4.902199   -1.364225    0.036410 
H     5.848815   -1.892075    0.080686 
C     4.838420   -0.093533   -0.535357 
H     5.730888    0.367111   -0.944161 
C     3.631326    0.579031   -0.588976 
H     3.550760    1.563200   -1.035240 
C     1.302616   -1.947854    1.116519 
H     1.071419   -2.848728    0.527334 
H     1.536580   -2.279279    2.132925 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Dichloromethane) 
 
Compound 5.13 / Optimized geometry in a CH2Cl2 solution, T 
= 298.15 K 
 
0,1 
B     2.384224   -1.334376    0.123754 
B    -2.346392   -1.305692    0.103232 
F     2.513945   -1.985812    1.351204 
F    -2.361593   -1.989152    1.308473 
O     3.624383   -1.384797   -0.633353 
O    -3.598066   -1.390898   -0.613656 
O    -1.149162   -1.703410   -0.655319 
N     2.208447    0.205645    0.354730 
N     1.127235    0.839656    0.551356 
N    -2.214508    0.233497    0.353941 
N    -1.132306    0.865285    0.541522 
N     1.103279   -1.768768   -0.565686 
H     1.019334   -2.639115   -1.080017 
C    -0.007912    0.125836    0.398189 
C    -0.026595   -1.177304   -0.261295 
C     3.454770    0.785014    0.149926 
C     4.250328   -0.205059   -0.455066 
C     5.547542    0.094815   -0.841632 
H     6.168751   -0.656500   -1.314748 
C     6.014666    1.383454   -0.599949 
H     7.029891    1.635142   -0.888026 
C     5.215179    2.362894    0.001587 
H     5.618611    3.354179    0.172683 
C     3.911669    2.075595    0.379652 
H     3.269685    2.817984    0.839388 
C    -3.468720    0.791320    0.150464 
C    -4.248635   -0.222041   -0.437511 
C    -5.556659    0.043196   -0.808936 
H    -6.166383   -0.726112   -1.267672 
C    -6.049110    1.324216   -0.574335 
H    -7.072786    1.550494   -0.853322 
C    -5.265082    2.327565    0.007492 
H    -5.688928    3.311170    0.173171 
C    -3.951283    2.073666    0.373704 
H    -3.321716    2.834410    0.820365 
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# PBE1PBE 6-311+G(d,p) SCRF=(PCM,Solvent=Dichloromethane) 
 
Compound 5.16- / Optimized geometry in a CH2Cl2 solution, T 
= 298.15 K 
 
0,1 
B     2.323919   -1.342081    0.129995 
B    -2.300714   -1.311908    0.036186 
F     2.504349   -1.927498    1.412011 
F    -2.339330   -2.013645    1.252958 
O     3.619594   -1.410295   -0.597200 
O    -3.593570   -1.390732   -0.649896 
O    -1.151250   -1.685585   -0.739451 
N     2.204764    0.214572    0.330991 
N     1.121906    0.863949    0.500872 
N    -2.202028    0.220056    0.329378 
N    -1.115243    0.865147    0.504368 
N     1.107758   -1.858968   -0.528442 
C     0.000025    0.130903    0.347922 
C     0.036065   -1.223452   -0.287823 
C     3.454167    0.777511    0.126748 
C     4.249485   -0.242533   -0.436158 
C     5.560035    0.039315   -0.802772 
H     6.182481   -0.731364   -1.243269 
C     6.041017    1.328596   -0.588573 
H     7.065292    1.559252   -0.863496 
C     5.241937    2.333039   -0.031946 
H     5.652143    3.325198    0.119565 
C     3.926021    2.067182    0.326975 
H     3.283365    2.830255    0.751570 
C    -3.459925    0.775067    0.150865 
C    -4.246082   -0.233981   -0.440112 
C    -5.564092    0.031827   -0.778658 
H    -6.177547   -0.734065   -1.239329 
C    -6.064688    1.305979   -0.514324 
H    -7.095468    1.528511   -0.770304 
C    -5.275682    2.302245    0.067073 
H    -5.699606    3.281891    0.257071 
C    -3.950491    2.047316    0.403487 
H    -3.316883    2.806048    0.848557 
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